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ABBREVIATIONS 
ACD acid-citrate-dextrose anticoagulant 
ADΡ adenosinediphosphate 
AMP adenosinemonophosphate 
ATP adenositietriphosphate 
ATPase adenosinetriphosphatase 
DNP 2,4 - dinitrophenol 
EDTA ethylenediaminetetraacetate 
I.U. international unit 
Lipid-P lipid-phosphorus 
MKH moles converted per kg dry weight per hour 
NADH nicotinamide dinucleotide reduced form 
NADPH nicotinamide dinucleotide phosphate reduced form 
N.I.H. national institute of health 
PRP platelet-rich plasma 
PRS platelet-rich suspension 
Tris trtea^hydroxymethyl)-aminomethane 
SD standard deviation 
SE standard error of the mean 
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GENERAL INTRODUCTION 
Familial thrombopathic thrombocytopenia is a dominant hereditary 
bleeding disorder in which thrombocytopenia is accompanied by a 
platelet function defect. The clinical, haematological, morpholo-
gical and genetical features of this type of thrombocytopathy have 
been studied by Kurstjens et al. (1968) , Vossen et al. (1968) and 
Kurstjens (1969) . Although familial thrombocytopathy is a rare 
disease, the nature of this platelet function defect is a very 
frequently occurring disorder and knowledge regarding the bioche-
mical disturbances in these platelets can add to our understanding 
of basic mechanisms in platelet function. 
Aspects of platelet metabolism, lipid content and composition, as 
well as aspects of the platelet membrane function were investigated. 
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1. PLATELET FUNCTION IN HAEMOSTASIS AND BLOOD CLOTTING 
1.1 PLATELETS AND PLATELET FUNCTIONS 
The mammalian blood platelets are non-nucleated formed elements 
derived from the megakaryocytes of the bone marrow. In the circulation, 
blood platelets are disc shaped, with a diameter varying between 1 and 
4 pm. They have an outer membrane which encloses cytoplasm and 
structures such as storage granules, lysosomes, mitochondria, glycogen, 
microfilaments and microtubules. The most important role of blood 
platelets is their contribution to the haemostatic mechanism. 
Haemostasia has to be understood as the process which arrests the 
bleeding, which occurs when the vesselwall is ruptured. The platelets 
stick to the damaged endothelial cells, to the underlying tissue 
structures and to each other. In this way they provide a provisional 
plug in the endothelial gap. The haemostatic mechanism has been 
extensively reviewed (Haanen, 1968; Marcus, 1969). The haemostatic 
process is initiated by "foreign" surfaces and by tissue fluid which 
interact with platelets and plasma clotting factors when the endo-
thelial lining is damaged or interrupted. The role of platelets in 
haemostasis can be divided into five basic steps: platelet adhesion, 
platelet aggregation, platelet fusion, fibrin formation and clot 
retraction, 
Platelet adhesion. The vesselwall being ruptured exposes in addition 
to the injured endothelium cells many types of connective tissue, 
such as basement membranes, elastin and collagen fibers. Bounameaux 
(1961) and Zucker & Borelli (1962) showed that platelets adhere to 
collagen fibers and basal membranes. This adhesion phenomenon is 
accompanied by a degranulation of the platelets, together with an 
extrusion of several platelet components such as ADP, ATP, potassium, 
serotonin, histamine, epinephrine, free amino acids, lipoproteins, 
mucopolysaccharides. Enzymes, like acid phosphatase and fi-glucoroni-
dase and platelet factors 3 and 4 are released as well (Grette, 1962; 
Spaet & Zucker, 1964; Mills et al., 1968; Horowitz, 1969; Holmsen 
et al., 1969). The term "release reaction" for this phenomenon was 
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introduced by Grette (1962) . 
Platelet aggregation. Under the influence of ADP (Hellem, 1960; 
Gaarder et al., 1961) and in the presence of minimal concentrations 
of calcium ions, platelets stick to each other, a process which is 
called platelet aggregation. Many substances, e.g. adrenalin, 
serotonin and other vasoactive agents, promote platelet aggregation. 
There is abundant evidence that ADP is involved in the final common 
pathway for the induction of platelet aggregation with all of 
these agents (Marcus i Zucker, 1965; Bridges et al., 1965). 
Most of the knowledge about the aggregating response of platelets 
upon addition of ADP has been derived from in vitro studies. In-
vivo studies from Honour & Mitchell (1964) and Silver et al. (1965) 
confirmed the aggregating capacity of ADP. 
Several possibilities have been proposed to explain the mechanism 
of ADP aggregation, but no single theory has been fully proven. A 
recent theory proposes that ADP aggregation results from the pro­
duct inhibition of a platelet "ecto-ATPase" (Chambers et al., 1967). 
This enzyme system, located on the outside of the cell, which is 
Ca - and Mg - dependant would deliver the energy to maintain the 
platelets in an unsticky state. Platelet aggregation would there­
fore represent the low energy state of the platelet and would be 
favoured by a decrease in activity of this ATPase. Moake et al. 
(1970), however, suggested that ADP interacts with the external 
platelet surface membrane to inhibit the Mg - dependent, (Na -
К ) stimulated ATPase. They proposed that the inhibition of this 
membrane ATPase activity results in a diminished Na and К trans­
port and consequently in a diminished membrane potential. This in 
turn would favour the aggregating tendency. As for the role of Ca 
in platelet aggregation, it has been suggested by Davey & Lüscher 
(1968) that aggregation requires the binding of external calcium 
ions by platelet membrane phospholipids and a modification of mem-
brane-associated proteins. This is in accordance with the ideas 
of Silver (1965), who suggested that ADP might cause "uncovering" 
of phospholipid in platelets. The newly available negative charges 
on the polar ends of the phospholipid moieties on adjacent plate-
lets would be bridged by divalent cations or neutralized by release 
of basic proteins (Weiss, 1971). 
When platelets adhere to collagen fibers or basal membranes, ADP 
is released and new platelets aggregate to these bound cells and 
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to each other. The aggregation is completely reversible and when 
ADP is broken down, the clumped platelets disperse again. (Odegaard 
et al., 1964; Kerby & Tailor, 1965). The purpose of this reversible 
aggregation seems to be the temporary trapping of plasma between the 
platelets, permitting activation of clotting factors without inter-
ference by dilution in the blood stream. 
Fig. 
Role of the platelets in haemostasis (modified from Haanen, 1968) 
'• t 
ADP 
Tissue damage 
exposure of connective tissue 
I 
Adhesion of platelets 
and release 
Mg* 
. Î 
1 t 
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• " 
Platelet fusion and 
release 
* 
Fibrin formation 
in vitro clot retraction 
traces of thrombin 
in trapped plasma 
·- platelet factor-3 — 
thrombin 
Platelet fusion. The aggregated platelets furnish a lipoprotein 
surface which catalyses the interactions of the intrinsic coagula-
tion system, culminating in the formation of thrombin (Marcus, 1966; 
Hardisty, 196Θ). The participation of the platelets in enhancing 
the intrinsic coagulation is known as "platelet factor-3". At that 
time minute amounts of thrombin have been formed, which seems to 
serve two purposes. First, thrombin causes an additional release of 
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most platelet organelles and other constituents, after which the 
platelets are packed irreversibly together, a process which is 
called platelet fusion. 
Fibrin formation. The second result of thrombin is that fibrinogen 
at the surface of the platelet plug is converted to fibrin. In this 
way the "definitive haemostatic plug" is formed, consisting of 
fused platelets, reinforced by fibrin strands. For this reinforcement 
of the provisional platelet plug an intact plasma clotting system is 
essential. 
Clot retraction. During a time-interval, ranging from minutes to 
hours after platelet fusion and fibrin formation, the clot retracts, 
as observed at ln-vitro conditions. This retraction is produced by 
contraction of platelet pseudopods, which are attached to fibrin 
strands. This process is mediated by a contractile protein: throm-
bostenin, which amounts 15% of the total platelet protein (Bettex-
Galland & Lüscher 1961) . 
The sequence of events listed above are schematically presented in 
fig. 1. 
1.2. PLATELET LIPIDS AND SO-CALLED PLATELET FACTOR-3 
It has long been known that lipids play an important role in blood 
coagulation. Wooldridge (1883) could promote intravascular clotting 
in animals by intravenous administration of water soluble extracts 
of erythrocytes, leucocytes and other tissues. He believed the 
active component to be a protein-lecithin complex. Howell (1912) 
reported that a lipoprotein is responsible for the clot-promoting 
capacity. The lipid portion could be separated from the protein 
moiety by extraction with lipid solvents. Early experiments of 
Bizzozero (1882) and Hayem (1878) recognized the clot-promoting 
activity of the blood platelets. Collingwood et al. (1912) and 
Howell (1935) established the clot-promoting ability of a phospha-
tide component to be furnished by the blood platelets during the 
coagulation process. The clot-promoting (thromboplastic) effect of 
platelets can best be illustrated by the prolonged coagulation time 
of plasma (without anticoagulant) from which the platelets have been 
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removed. When the platelets are added again, the clotting time Is 
shortened. This activity, residing in the platelets, has been called 
platelet factor-3. 
The first quantitative studies on human platelet lipids were carried 
out by Erickson et al. (1939). They found that 16 per cent of the 
dry weight of platelets was lipid, 73 per cent of the lipid was 
phospholipid and 68 per cent of the phospholipid was "cephalin". As 
time elapsed, a series of new analytical techniques came available. 
Firstly, lipid extraction methods were refined (Folch et al., 1957; 
Bligh and Dyer, 1959; Ways and Hanahan, 1964). Secondly, platelet 
lipid extracts were fractionated on silicic acid columns (Rouser et 
al., 1958; Marcus and Spaet, 1958; Barkhan et al., 1961; Speer and 
Ridgway, 1962; Marcus et al., 1962) or by a combination of silicic 
acid column and paper chromatography (Troup et al., I960) or by 
column and counter current distribution techniques (Woodside et al., 
1964) . The development of thin layer chromatography and gas-liquid 
chromatography has finally added the most detailed information about 
the platelet phospholipid composition (chapter 3). 
The thromboplastic activity of isolated phospholipids is demonstrated 
by the fact that addition of a crude mixture of phospholipids or of 
certain individual phosphatides can serve as a suitable platelet 
substitute in shortening the in-vitro clotting time of plasma. Prior 
to about I960 lipid methodology was not sufficiently refined to 
permit satisfactory extraction and separation techniques. This is the 
reason for the confusion which has existed for several years concer­
ning the particular phospholipid class, which was to be considered 
the most potent clot-promoting activator. Until about 1930 it had been 
assumed that the acetone-insoluble, ether-soluble fraction from brain 
tissue consisted of two components; "lecithin", soluble in ethanol 
and "cephalin", insoluble in ethanol. Rudy and Page (1930) demonstra­
ted the classic "lecithin" to be composed of at least three 
components: phosphatidylethanolamine (ΡΕ), phosphatidylserine (PS) 
and phosphatidylinositol (PI). Hence, the early studies, which had 
been carried out with so-called purified phospholipid components, 
were in fact carried out with phospholipid mixtures. After Folch in 
1949 reported methods to obtain a fractionation in distinct fractions 
of brain cephalin by adding increasing amounts of alcohol to a 
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Chloroform solution of the crude preparation, a number of investiga-
tors carried out these procedures and used the thus obtained phos-
pholipid fractions in clotting tests to examine the clot-promoting 
activity (Chargaff, 1944; Garret, 1956; Barkhan et al., 1956). 
Conflicting results were obtained either PC (Poole, 1956) , PE 
(Chargaff, 1944; Rouser et al., 1958; Billimoria et al., 1965), or 
PS (Marcus & Spaet, 1958) being the most potent thromboplastic acti-
vator. The conflicting results were probably due to the following 
causes : 
a) the preparations were by fact of their biological origin only 
partially pure. 
b) the preparations may have been altered by oxidation during the 
isolating and purification procedures. 
The problem approached its solution by the observations of Bangham, 
who studied in 1961 the relation between net electrophoretic charge 
of lecithin-amphipathic molecule mixtures and clot-promoting proper-
ties. Egg lecithin was mixed with varying amounts of the amphipathic 
compound dicetylphosphoric acid. The more negatively charged suspen-
sions produced shorter clotting times. Excellent correlation existed 
between the clotting activity of the lecithin-dicetylphosphoric acid 
mixtures and other known clot-promoting materials with the same 
electrophoretic charge. Neutralization of the negative charge of the 
lecithin-dicetylphosphoric acid mixture by addition of Cj^-pyridinium 
bromide, markedly prolonged the clotting times. Papahad]opoulos et al. 
(1962) extended this work by combining purified phospholipids, pre-
pared from brain and egg yolk, in a wide range of concentration ratios. 
Maximal clot-promoting activity was obtained with mixtures having an 
electrophoretic mobility of -4.5 u.sec. V. cm" . When for example, 
phosphatidylserine alone was emulsified at pH 7.4, its surface was too 
negative and clot-promoting activity was low. Emulsifying at pH 5 gave 
an electrophoretic mobility closer to the optimal range and activity 
was higher. Using synthetic phosphatide preparations, Daemen et al. 
(1965) in general confirmed the surface charge concept, finding weak 
or no activity with the individual phosphatides. Any combination of 
phospholipids to be active required the presence of negative charges 
derived from an acidic phosphatide. The current theory thus states that 
a phospholipid micelle with net negative charge provides a catalytic 
surface to which the coagulation proteins, together with Ca , attach 
themselves, forming a complex able to activate the next coagulation 
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F l g . 2 
Pathway of t h e i n t r i n s i c b lood c o a g u l a t i o n (Heraker & Kahn, 1967) 
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protein in the reaction sequence. Such phospholipid-protein complexes 
are now believed to function in at least two intermediate stages 
during fibrin formation (Hemker & Kahn, 1967) (flg. 2 ). 
Although these in-vitro experiments indicate the role of a catalytic 
phospholipid surface in clotting, there is evidence that in circulation 
this catalytic surface is not available as such. First,Marcus et al. 
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(1965) noticed that centrifugation and washing of platelets 
increases their ability to shorten the in-vitro clotting time. Secondly, 
Marcus (1966) showed that mixed or individual phospholipids were 
always less active in shortening clotting times than the platelet 
phospholipid, which is in its natural lipoprotein environment. 
During the process of initial platelet adhesion to collagen and the 
subsequent formation of minor amounts of thrombin, it is possible that 
the protective protein is removed or at least changed in structure in 
order to expose phospholipid moieties. This process is called "plate-
let factor-3 availability". It is this alteration in-situ of the 
lipid-protein configuration which is in all likelyhood responsible for 
the most potent clot-promoting activity. 
1.3. PLATELET DISORDERS 
Any bleeding tendency which is caused completely or partly by a defect 
in the blood platelets can, regardless of their number, be classified 
as a thrombocytopathy (Kurstjens, 1969) . In clinical diagnosis there 
are a few well established tests to determine whether one is dealing 
with a disturbed platelet function. Laboratory tests which can be indi-
cative for a platelet function defect are the bleeding time, the 
prothrombin consumption test, the thromboplastin generation test, tests 
for platelet adhesiop, platelet aggregation and availability and release 
of platelet factors. The principles and methods of these tests have 
been described by Haanen (1971) . It is obvious that the interpretation 
of the results depends also on the platelet count and an intact plasma 
clotting mechanism. Although these more or less specific platelet 
tests have revealed much about various platelet functions, it should 
be stressed that they are only of relative importance, since the iso-
lation of platelets involves the addition of anticoagulants and some-
times centrifugation and washing procedures, which may introduce 
various artefacts. It is therefore difficult to study platelets in a 
condition that can be described as the "resting state". Moreover, the 
diagnosis of a thrombocytopathy is further subject to the following 
pitfalls: 
a. Platelet functions like adhesion, aggregation, availability and 
release of factors are so interdependent that an isolated defect 
is rarely encountered. 
b. Too little is known about the correlation between disturbed plate-
let functions and changes in cell metabolism to permit conclusions 
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about pathogenesis. 
с. Disturbances in platelet functions may be accompanied or partly 
caused by abnormalities in plasma and vessels, making it difficult 
to decide whether the platelet defect is primarily responsible for 
the bleeding tendency. 
In general the following forms of thrombocytopathies can be distin­
guished: 
Thrombasthenia (disease of Glanzmann-Naegeli) which is characterized 
as an autosomal recessive inherited disease with a normal platelet 
count. The platelets are unable to aggregate under the Influence of 
ADP. Aggregation by substances which operate through the ADP-release 
mechanism, such as the collagen-, norepinephrine- and serotonin-
induced aggregation, is also absent. The platelets do not adhere to 
foreign surfaces and clot retraction is absent. In some cases a 
decreased platelet factor-3 availability has also been reported 
(Hardisty et al., 1967; Weiss, 1967) . 
Thrombocytopathy in sensu strictu has been mainly attributed to a 
diminished capacity of the clot-promoting property or platelet factor-
3 (Bowie & Owen, 1968).Primary or congenital (Pavlovsky et al., 1967) 
and secondary or symptomatic forms (Karaca & Stefanini, 1966) have 
been described. Primary thrombocytopathy, based solely on a qualita­
tive platelet factor-3 deficiency is rare. 
In most cases this disorder is secondary to an underlying systemic 
disease such as uremia, myelofibrosis etc. Weiss (1967), Hardisty 
(1968) and Marcus et al. (1971) maintain that there is strong evidence 
that an isolated platelet factor-3 deficiency does not exist. They 
have all demonstrated that the platelet factor-3 availability is so 
closely related to platelet aggregation, that the clot-promoting 
activity of platelets will not manifest itself in the absence of nor­
mal aggregation. 
The Portsmouth syndrome reflects platelet disturbances first described 
by O'Brien (1967) . The platelets show a defective aggregation in the 
presence of connective tissue suspensions, epinephrine and thrombin. 
ADP-release and platelet factor-3 availability are reduced. Platelet 
adhesion is poor, but not absent. ADP-induced platelet aggregation is 
present, although the desaggregation phase seems to be rapid 
(Hardisty & Hutton, 1967) . It is worth mentioning that most of the 
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symptoms of this bleeding phenomenon are also seen in platelets from 
subjects who have ingested aspirin (Ball et al., 1969; Weiss & Aledort, 
1967) . 
Hereditary Thrombocytopathlc Thrombocytopenia. This rare bleeding 
disorder is caused by a decreased number of platelets which themselves 
are already functionally defective. The mode of inheritance is of the 
autosomal dominant type (Walther, 1953; Rak et al., 195Θ; Quick & 
Hussey, 1963; Kurstjens et al., 1968) and is characterized by large and 
abnormally shaped platelets. Functionally, the platelets show normal 
ability to aggregate under influence of ADP, inability to aggregate 
in the presence of substances which mediate aggregation via ADP-release 
(connective tissue, serotonin, thrombin), decreased platelet factor-3 
activity as measured by the thromboplastin-generation-test (Biggs & 
Douglas, 1953) or the platelet factor-3 availability-test (Weiss, 1967) 
and normal clot retraction. In most of the affected families the 
platelet survival time appears to be shortened. Kurstjens et al. (1968), 
however reported a normal life-span of the platelets of patients with 
this platelet disorder. 
Apart from the genetical and morphological findings and from the 
occurrence of thrombocytopenia in these patients, this platelet defect 
resembles the Portsmouth syndrome. 
1.4. PURPOSE OF OUR INVESTIGATIONS 
Our understanding of the factors which can induce a platelet disease 
is faint and confusing. Therefore, the occurrence of a clinically 
well-defined platelet disorder (Kurstjens et al., 1968; Kurstjens, 
1969) offers an attractive starting-point in establishing some of the 
basic factors which are of significance for the bleeding tendency 
in these patients. Moreover, investigation of a disturbed function 
may contribute to our understanding of the normal platelet function in 
haemostasis. 
Investigation was Initiated with metabolic and enzymatic studies. The 
glycolytic enzyme pattern, the energy rich phosphate-content and the 
behaviour of hexokinase after treatment with connective tissue were 
studied (Chapter 2). The lipid content and composition of the platelets 
were also studied (Chapter 3). With the extracted lipids, the in-vitro 
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clot-promoting activity was measured. Together with the study of the 
microelectrophoretic behaviour of the pathological platelets and of 
the lipids prepared from them, this served to explore possible 
relationships between the decreased platelet factor-3 activity, the 
lipid composition and the net surface charge of the lipid components 
(Chapter 4). Important platelet functions such as adhesion, aggregation, 
release and availability of factors point to the importance of the 
platelet membrane in haemostasia. We, therefore, studied the distribu-
tion and movement of cations across the platelet membrane (Chapter 5). 
Existing methods were modified and new ones were devised in order to 
avoid conditions favouring the occurrence of artefacts when working 
with blood platelets. Finally, studies on platelet osmotic resistance 
(Chapter 6) were carried out, serving to give a more complete picture 
of the platelet cell membrane. A new method was devised and compared 
with other platelet lysis techniques. The metabolic and enzymatic 
studies have already been published (Baadenhuijsen et al., 1971). 
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2. METABOLIC AND ENZYMATIC STUDIES 
2.1. INTRODUCTION 
2.1.1. Normal platelet metabolism 
For their basic haemostatic functions of adhesion/ aggregation and 
release reaction the platelets are dependent on energy metabolism. 
Waller et al. (1959) studied the fate of glucose and found that 
about 50% of glucose was metabolized as pyruvic or lactic acid and 
only 20% was recovered as CO, and water; the remaining glucose was 
believed to be converted to glycogen, amino acids and lipids. These and 
other studies (Bettex-Galland & Liischer, 1960; Karpatkin & Langer, 
1968) stressed the significance of glycolysis for platelet energy 
production. Increasing evidence has accumulated however, suggesting the 
contribution of a respiration-coupled oxidative energy supply. First, 
the elevation of platelet glycolysis under anaerobic conditions (Wu 
et al., 1964) indicates that platelet mitochondria normally generate 
ATP. Secondly, despite the strongly elevated glycolytic rate, platelets 
under anaerobic conditions are no longer able to maintain their normal 
ATP level (Gross & Schneider, 1968) . This finding is not surprising 
in view of the much higher efficiency of oxidative phosphorylation 
in yielding energy rich phosphates. The inability of earlier workers 
to note this may be due to their use of platelet preparations which 
had been treated entirely at 4° C. It has become clear that this may 
cause deleterious effects, since platelets at 4° С loose their disk 
shape, are much more liable to spontaneous aggregation (Zucker & 
Borelli, 1960) and their volume increases by approximately 20% (Bull 
& Zucker, 1965), probably as a result of inhibition of the cation 
pump. Short cooling periods induce rapid, reversible formation of pseu-
dopodia and disappearance of the marginal bundle of microtubules 
(Skj0rten, 1968; White & Krivit, 1967). Prolonged cooling made these 
alterations irreversible . In addition, Gross & Schneider (1968) 
confirmed the uncoupling of oxidative phosphorylation due to cooling, 
expressed in a reduction of oxygen consumption together with a parallel 
fall in ATP. This is apparently due to the fact that the mitochondrial 
coupling factor I contains a protein with Mg-ATPase activity, which at 
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low temperature dissociates into ten monomeric subunits with the 
loss of its enzymatic activity (Pullman & Schatz, 1967; Gross & 
Schneider, 1971). It can thus be concluded that platelets prepared 
at 4° С suffer uncoupling of oxidative phosphorylation, leading to 
abnormal metabolic findings. The commonly used washing procedures may 
also lead to such uncoupling (Rock & Nemerson, 1969) . 
Another complication in studies of platelet metabolism is the require­
ment for the presence of a bivalent cation-chelating agent in order 
to prevent spontaneous aggregation. The presence of the chelating 
agent, however, cause metabolic changes (Karpatkin, 1967; Karpatkin & 
Langer, 1968). The use of EDTA in platelet preparation procedures induces 
morphological changes (Zucker & Borelli, 1954), increase of platelet 
volume (Bull S Zucker, 1965) and a rise in glucose consumption and 
lactate formation (Rossi, 1967). Citrated platelet rich plasma is 
subject to metabolic interference by the citrate molecules, e.g. inhi­
bition of the phosphofructokinase reaction (Gross & Schneider, 1968) . 
In addition citrate can be metabolized as a substrate in the citrate 
cycle, leading to reduced lactate formation as a result of increased 
decarboxylation of pyruvate (Karpatkin, 1967) . 
Thus it is difficult to study platelets under conditions which are 
comparable to the physiological situation. At the same time, it 
emphasizes the need for test methods which cause minimal damage to the 
platelets. However it is fair to state that comparative observations 
of metabolism under different experimental conditions or comparison 
between normal and pathological platelets should enable us to study 
the response of the platelets to various stimuli as well as the 
factors underlying the pathogenesis of platelet disorders. 
The effects of aggregation-inducing agents on energy metabolism are 
of Interest for our understanding of the role of the latter process 
in platelet function, both in normal and pathological platelets. 
Thrombin produces a stimulation of glucose oxidation by the Embden-
Meyerhof pathway and the citric acid cycle as well as a transient 
increase in lactate production (Warshaw et al., 1966). Epinephrine 
and ADP were shown to have a similar, though smaller effect (Karpat­
kin & Langer, 1968) . The effects of collagen on platelet metabolism 
are similar to those of thrombin. Upon addition of collagen, lactate 
production increased markedly, accompanied by a release of ATP and 
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ADP (Loder et al., 1968). It is of Interest that Doery et al. (1967) 
observed that the Increased lactate production upon exposure to 
collagen was correlated with a shift of platelet hexokinase activity 
from the particle-bound fraction to the soluble form. Since hexokinase 
is the main rate-limiting enzyme of glycolysis, an increased activity 
of this enzyme may, therefore, correlate with the observed increase 
in lactate production. 
2.1.2 Metabolic observations on abnormal platelets 
A considerable number of studies concern observations on thrombopathic 
platelets. The Glanzmann-NaegeM. syndrome or thrombasthenia is a form 
of thrombopathy characterized by the inability of the platelets to 
adhere or to aggregate under the influence of ADP or substances which 
mediate aggregation through the ADP mechanism. (Hardisty et al., 1964: 
Nachman & Marcus, 1968). In addition the platelets fail to support 
clot retraction in-vitro. Low platelet activities of the enzymes glyce-
raldehydephosphate dehydrogenase and pyruvate kinase, together with 
low concentrations of ATP were found in this condition by Löhr & Gross 
(1961 a, b), who concluded that too little energy-rich phosphate was 
available for clot retraction. Furthermore, it was demonstrated that 
addition of Ю - 5 M ATP and 10~ 5 M MgCl, to the platelets restored clot 
retraction. These results were confirmed by other workers (Caen et al., 
1963; Larrieu et al., 1961). Other studies however could not confirm 
these reported abnormalities (Zucker & Levine, 1963; Hardisty et al., 
1964; Schettini, 1962) . The conclusion was therefore reached that there 
exist at least two types of thrombasthenia, type I with the reported 
low enzyme and substrate levels and type II with normal activities and 
concentrations. Subsequent studies reported thrombasthenic platelets 
with an isolated pyruvate kinase deficiency together with low ATP 
concentrations (Lechner et al., 1968) and also with a glutathione 
reductase deficiency together with an increased ATP content (Moser et 
al., 1968). Thus the reported abnormalities are diverse and make a 
suitable classification impossible at this time. 
The "Giant platelet thrombopathy" is a platelet function disorder 
defined on morphological aspects. It is a collection of thrombopathies 
which share in common the bizarre forms of the platelets, reaching 2 
to 5 times the normal diameter. The so called "Dystrophie thrombo-
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cytaire hémorragipare congénitale" of Bernard & Soulier (1948) is 
included in this form of thrombocytopathy. In this ill-defined 
group of platelet disorders, Löhr (1968) found elevated glycolytic 
enzyme activities, calculated on cell count base, and decreased ATP 
content and lactate production, calculated on platelet volume. 
Clinically and haematologically, the platelets of the affected mem-
bers of the family in our study differ from those in the cases 
reported by Löhr (1968) , resembling much more those described by 
Quick & Hussey (1963) . 
2.2. CLINICAL MATERIAL 
The patients studied are members of a family, which has been 
evaluated clinically by Kurstjens (Kurstjens et al., 1968; Kurstjens, 
1969). The family tree is depicted in fig. 3. The bleeding tendency 
in these patients is manifested by spontaneous ecchymoses, epistaxis, 
gastrointestinal haemorrhages in adult life and profuse loss of blood 
Fig. 3 
Pedigree of the family with hereditary thrombopathic thrombocytopenia 
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following tooth extractions and surgical interventions. The 
transmission of this thrombocytopenia proved to be of the autosomal 
dominant type. Of 23 siblings examined in three generations nine 
suffered from thrombopathic thrombocytopenia with platelet counts 
g 
ranging from 20 to 80 χ 10/1, one fifth of the normal levels. The 
bone marrow of the patients contained an adequate number of megakaryo­
cytes. Light microscopy showed that a large number of the platelets 
were abnormally large, some having a more than twice normal diameter. 
Electron microscopy disclosed an abnormal platelet structure in the 
affected siblings. The number and size of the o-granules (dense 
granules) are diminished and the number of mitochondria and size of 
the surface-connected tubular system are increased (Vossen et al., 
1968). A diminished thromboplastin generation was obtained with the 
platelets of affected siblings. Treatment of the platelets with 
distilled water in order to expose maximally platelet factor-3 failed 
to correct the defect. Platelet factor-3 availability measured accor­
ding to Weiss (1967) was also decreased. Platelet aggregation under 
the influence of ADP was normal, when related to platelet count. 
Aggregation under the influence of connective tissue suspensions, 
however, was absent in the platelets of the examined patients. The 
in-vivo life span of the platelets, determined with the aid of radio­
active di-isopropylfluorophosphate according to Murphy & Mustard 
(1961) proved to be within the normal range of 8-12 days. 
2.2.1. Comments 
The studies described in the previous section are mainly derived from 
the work of Kurstjens (Kurstjens et al., 1968; Kurstjens, 1969), which 
was carried out in this laboratory. Most of his findings are in 
agreement with the classification as formulated in chapter 1.3. under 
hereditary thrombopathic thrombocytopenia. However, the observed nor­
mal platelet survival time appears to be in contradiction with other 
reports of the same type of thrombocytopathy (Cullum et al., 1967; 
Gröttum & Solum, 1969). Cullum found arguments for the existence of 
two populations of platelets in this disease, one with a very short 
and one with a normal survival time. Possibly, the existence of a 
short living population may have been missed in the determination of 
Kurstjens et al. (1968). Together with other arguments which throw some 
doubt on the observed normal platelet life span, this point will be 
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discussed in more detail in chapter 2.5. 
The inability of the pathological platelets to develop full platelet 
factor-3 activity in the thromboplastin generation test after treat­
ment with distilled water contrasts with our findings, as will be 
discussed in chapter 4.4. 
2.3. MATERIALS AND METHODS 
2.3.1. Isolation of platelets 
Blood was obtained by venipuncture using disposable needles (internal 
diameter 1.5 mm) and was collected in polypropylene tubes containing 
Acid Citrate Dextrose (ACD) solution (8g citric acid, 22 g trisodium 
citrate, 25 g dextrose per litre of solution; N.I.H. formula A): 9 vol. 
blood were added to 1 vol. of ACD. Platelet-rich plasma (PRP) was 
obtained by centrifugation for 90 sec. at 1500 g. After removal of the 
supernatant plasma the remaining cell suspension was centrifuged again 
and the resulting supernatant was combined with the previous one. The 
whole procedure was carried out at room temperature to prevent platelet 
aggregation and release. Normally, erythrocyte contamination was less 
than five erythrocytes per 1000 platelets. In patients, contamination 
amounted to 20-50 erythrocytes per 1000 platelets, due to anisocytosis 
of both the erythrocytes and platelets. In cases where concentrated 
platelet preparations were needed, subsequent centrifugation of the 
PRP for 15 min at 1500 g, followed by washing and centrifugation 
steps, performed as described in the chapters in question, was carried 
out. 
2.3.2. Determination of platelet count 
Platelet count determinations were carried out electronically with a 
Model В Coulter Counter. For this purpose PRP was diluted 1 : 1000 
with 0.85% (w/v) NaCl solution. Internal machine settings were: Vernier-
90,· Matching Switch-32H. Particles were counted with two different 
Amplification/Aperture Current/Threshold combinations, namely: Amplifi­
cation - 1/4/Aperture Current -\/ Threshold-12 for all suspended 
particles and Amplification -4/Aperture Current -yThreshold-12 for 
particles the size of erythrocytes and greater. The latter count was 
subtracted from the first one to obtain the real number of platelets. 
Platelet count was corrected for coïncidence and blank readings. In 
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the case of the patients there was no possibility to subtract the con-
taminating erythrocyte count with one simple discriminating threshold 
setting, because of the existing considerable overlap between the 
size of the largest platelets and the erythrocytes. Therefore, conta-
minating erythrocytes were estimated either by the visual method 
according to Feissly & Lüdin (1949) or by the determination of the 
haemoglobin content in centrifuged platelet preparations,by the haemi-
globin-cyanide reaction (van Kampen & Zijlstra, 1961). One mg haemo-
7 
globin was assumed to represent 3 χ 10 erythrocytes. 
2.3.3. Platelet mean cell volume 
A 50 mm long precision capillary of 0.58 mm internal diameter was fused 
onto a 55 χ 7 mm glass tube. The other end of the capillary was sealed. 
Into the tube 1.5 ml of PRP was pipetted. The tubes were centrifuged 
in a suitable centrifugation adaptor for 30 min at 1500 g. After centri-
fugation, the platelets were sedimented in the capillary tube and the 
height of the platelet column was recorded (1 cm column-height equaled 
2.63 μΐ). Determination of the trapped plasma volume was carried out 
with the aid of either 1 C-inulin or 14C-mannitol. To 1 ml of PRP 
50 μΐ (+ 0.05 pC) of the marker was added. After centrifugation a 
known length of the packed platelet column was cut off and the content 
of the tube was -transferred to a liquid scintillation vial containing 
1 ml 0.5% aqueous Triton X-100 solution. After thorough mixing of the 
contents of the vial, the latter was filled with 9 ml Instagel (Packard 
Instrument Cy.) and the material was counted in a Packard Tri-Carb 
Scintillation Counter. In addition to a correction for trapped plasma, 
the total packed platelet column height was also corrected for 
trapped erythrocytes by multiplication of the known erythrocyte count 
with the mean erythrocyte cell volume of 87 fl. 
2.3.4. Platelet size distribution 
Size distribution curves were determined electronically with the model 
В Coulter Counter to which a Model J Size Distribution Plotter had been 
connected. Platelet suspensions were diluted 1 : 1000 with Isoton 
(Coulter Electronics) . 
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2.3.5. Preparation of platelet lysates for enzyme studies was carried 
out according to the modified methods of Löhr et al. (1957). Platelet 
pellets were resuspended in EDTA-phosphate buffer (100 mM - Na^HPO./ 
ΚΗ,ΡΟ., 2 mM - EDTA, pH 7.4) to a concentration of 10 platelets/ml. 
To this suspension digitonin was added to a concentration of 1 mg/ml. 
The mixture was left for 1 hr at 4° C, cooled to -60° С and thawed 
to + 4° C. The lysate was centrifuged at 10.000 g for 15 min at 4° C. 
Determination of enzyme activities was carried out within 4 hrs after 
the lysing procedure. 
2.3.6. Preparation of extracts for determination of platelet adenine 
nucleotides was carried out according to the modified methods of 
Hohorst et al. (1959). After centrifugation of PRP for 15 min at 
1500 g,metabolism was stopped by freezing the packed platelets at 
-20° С immediately after centrifugation. The pellet was thawed with 
ice-cold 0.6 N perchloric acid, under continuous vigorous stirring. 
The precipitate was removed by centrifugation at 10.000 g for 10 min 
at 4° С The sediment was treated again with perchloric acid and after 
centrifugation the two supernatants were combined and neutralized 
with 4 N KOH to pH 6.5. The insoluble potassium Perchlorate was 
removed by centrifugation at 4° С for 10 min at 1000 g. The super­
natant was used for determination of adenine nucleotides (2.3.Θ). 
2.3.7. Determinations of enzyme activities were carried out at pH 
7.4 at a constant temperature of 25° С in a Beckmann DBG recording 
spectrophotometer. The enzyme activities were measured using systems 
linked to the oxidation or reduction of pyridine nucleotides, under 
conditions where the enzyme to be measured was rate-limiting. For the 
millimolar extinction coefficient of both NADH and NADPH at 334 nm a 
2 
value of 6.00/cm was used. Assays were performed in a total volume 
of 1.0 ml in a cuvette of 1 cm path-length. Enzyme activities are 
expressed as ymol substrate converted per min by 10 platelets. 
Below,the technique used for each enzyme assay is indicated. 
ATP: D-hexose-phosphotransferase (hexokinase, HK, EC 2.7.1.1.) was 
determined according to Grignani and Löhr (1960). D-Glucose-6-phos-
phate ketolisomerase (HIM, EC 5.3.1.9) according to Slein (1955). 
ATP: D-fructose-6-phosphate 1-phosphotransferase (Phosphofructokinase, 
PFK, EC 2.7.1.11) according to Ling et al. (1955) as modified by 
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Vogell et al. (1959) . 
Ketose-1-phosphate aldehyde-lyase (Aldolase, ALD, EC 4.1.2.7) according 
to Racker (1947) . 
D-Glyceraldehyde-3-phosphate Ketollsomerase (Trlose-phosphate Isomerase, 
TIM, EC 5.3.1.1) according to Delbrück et al. (1959). D-Glyceraldehyde-
3-phosphate: NAD oxidoreductase (phosphorylating) (glyceraldehyde-phos-
phate dehydrogenase, GAPDH, EC 1.2.1.12) according to Delbrück et al. 
(1959) . 
ATP: D-3-phosphoglycerate 1-phosphotransferase (Phosphoglycerate kinase, 
PGK, EC 2.7.2.3) according to Vogell et al. (1959). D-2,3-Diphospho-
glycerate: D-2-phosphoglycerate phosphotransferase (Phosphoglycerate 
mutase, PGM, EC 2.7.5.3) according to Vogell et al. (1959). 
D-2-Phosphoglycerate hydrolyase (Enolase,EN, EC 4.2.1.11) according to 
Bock et al. (1958). ATP: pyruvate phosphotransferase (Pyruvate Kinase, 
PK, EC 2.7.1.40) according to Bock et al. (1958). L-Lactate: NAD 
oxidoreductase (Lactate dehydrogenase, LDH, EC 1.1.1.27) according to 
Kubowitz and Ott (1943). 
D-Glucose-6-phosphate: NADP oxidoreductase (Glucose-6-phosphate 
dehydrogenase, G6PDH, EC 1.1.1.49) according to Romberg and Horecker 
(1955) . 
6-Phospho-D-gluconate: NAD oxidoreductase (6-Phosphogluconaat dehydro-
genase, 6 PGDH, EC 1.1.1.43) according to Horecker & Smyrniotis (1955), 
NADPH,: glutathione oxidoreductase (glutathione reductase, GR, EC 
1.6.4.2) according to Racker (1955). 
L-Glycerol-1-phosphate: NAD oxidoreductase (Glycerol-1-phosphate 
dehydrogenase. GDH, EC 1.1.99.5) according to Delbrück et al. (1959). 
L-Isocitrate: NADP oxidoreductase (decarboxylating) (Isocitrate dehy-
drogenase, IDH, EC 1.1.1.42) according to Delbrück et al. (1959). 
L-Malate; NAD oxidoreductase (Malate dehydrogenase, MDH, EC 1.1.1.37) 
according to Delbrück et al. (1959). 
L-Malate: NADP oxidoreductase (decarboxylating) (Malic enzyme, ME, EC 
1.1.1.40) according to Pette et al. (1964). 
L-Glutamate: NAD oxidoreductase (Glutamate dehydrogenase, GluDH, EC 
1.4.1.2) according to Olson & Anfinsen (1952). ATP phosphohydrolase 
2+ ("soluble" Mg -activated ATPase, s-Mg-ATPase, EC 3.6.1.3) according 
to Adam (1961) . 
ATP: AMP p h o s p h o t r a n s f e r a s e (Adenylate k i n a s e , AdK, EC 2 . 7 . 4 . 3 ) 
according t o Adam (1961) . 
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2.3.θ . Adenine nucleotides were determined according to Lamprecht 
& Trautschold (1963) and Adam (1963) and expressed as pmol substrate 
per 10 platelets. 
2.3.9. The effect of collagen on the hexoklnase-actlvity in the soluble 
and particulate fraction; The distribution of the hexokinase activity 
between the soluble and particulate fraction upon incubation with 
collagen was studied according to the method described by Doery et al. 
(1967), modified as follows: Platelet suspensions were prepared in a 
modified Krebs-Ringer-bicarbonate buffer (composition in mmol/1: Na + 
142; K + 3; Cl" 118; HC0 3" 23; HP0 4
=
 1.62; HjPO,," 0.39; glucose 22.2; 
pH 7.2 -7.4). Two-ml aliquots of this platelet suspension were incu­
bated with either 0.2 ml collagen suspension, essentially prepared 
as described by Zucker t Sorelli (1962), or 0.2 ml buffer for 15 min 
at 370C. After cooling the incubation mixture to 0oC the platelets 
were lysed by digitonin-treatment as described before. Determination 
of the hexokinase activity was carried out on the supernatant frac­
tions of the collagen-treated and non-treated platelet preparations 
after centrifuging the lysates for 20 min at 10.000 g. 
2.4. RESULTS 
2.4.1. Mean platelet volume 
The mean normal platelet cell volume was 7.7 fl (determined on 9 
normal control persons, SD 1.1 fi). The platelet volumes of the patients 
were all considerably enlarged (table I), ranging from 1.5 times to 3 
times the normal mean volume. The greatest enlargement, three times 
the normal value, occurred in patient III-18, clinically the severest 
affected patient. 
2.4.2. Platelet size distribution 
Size distribution curves of normal platelets and platelets of patients 
II-5, III-ll, III-ia, III-22, III-26 and IV-1 were determined (2.3.4) 
and compared with those obtained from six normal platelet preparations 
(fig. 4). The size distribution curves of the pathological platelets 
show an asymmetrical shape, skewed to the right, pointing to larger 
volumes and increased anisocytosis. Patients III-18 and III-ll showed 
the largest abnormalities in platelet volume distribution. 
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TABLE I 
Mean cell volume of normal and pathological platelets 
Platelets studied 
Normal controls 
Patient II- 5 
III-ll 
III-18 
III-22 
III-26 
IV- 1 
Mean platelet volume 
7.7 І 1.1 (9) 
14.8 
17.9 
23.1 
12.6 
12.9 
12.1 
— 12 All values expressed as fl (femtolitre, 10 1.). For the 9 normal 
controls the mean value with standard deviation is given. The values 
were obtained by cytocrit determinations on 1.5-ml samples of PRP. The 
volume of the packed platelets was corrected for trapped plasma and 
erythrocyte contamination. 
Fig. 4 
Relative size distribution curves of normal and pathological 
platelets as obtained by analysis with a Particle Size Distribution 
Analyzer {model J) connected to a Coulter Counter {model B) 
relative frequency 
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2.4.3. Platelet enzyme activities 
The results of the enzyme assays, performed on the platelet lysates, 
are shown In table II. The enzyme activities in the lysates of 
pathological platelets are three to five times as high as normal 
when expressed per 10 platelets. When the enzyme activities are 
expressed as ratios to the GAPDH activity, only the glycolytic enzymes 
EN, PK and LDH are relatively increased in the pathological platelets. 
When the activities are expressed per ml cell volume most enzyme 
activities are also approximately normal, except for the same glycolytic 
enzymes EN, PK and LDH, which remain relatively increased. 
2.4.4. Platelet nucleotide content 
Platelet extracts from the three patients III-ll, ΙΙΙ-1Θ and III-22 
tested contain about two to three times the normal adenine nucleotide 
levels (table II). Calculated on volume base, the contents of these 
metabolites appear to be normal or slightly subnormal. The ATP/ADP 
quotients in the extracts of thrombopathic platelets are within normal 
limits. 
2.4.5. Effect of collagen on the distribution of hexoklnase activity 
The results of the hexoklnase determinations on platelets which were 
treated with collagen show that after collagen treatment the soluble 
hexoklnase activity increased in variable degree from a mean activity 
of 6.1 I.U. per 10 platelets without treatment, to a mean activity 
of 7.β I.U. per 10 1 1 platelets after treatment with collagen (fig.5). 
The mean percentage increase in the soluble activity after incubation 
with collagen appeared to be 30% (SD 18%; Ρ < 0.01, two-sample test 
of Wilcoxon). No such increase was found with the other enzymes 
studied (PFK, ALD, LDH). From the normal control persons tested only 
one failed to give a positive response upon treatment with collagen. 
The 10.000 g supernatant fraction of lysates of platelets from patient 
III-18, after incubation in the presence or absence of collagen showed 
the same hexoklnase activity of 13.2 I.U. per 10 platelets (fig. 5). 
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TABLE II 
Platelet enzyme-activities and nucleotide concentrations in four 
patients 
Enzyme 
or 
nucleotide 
HK 
HIM 
PFK 
ALD 
TIM 
GAPDH 
PGK 
PGM 
EN 
PK 
LDH 
G6PDH 
6PGDH 
GR 
IDH 
MDH 
GDH 
ME 
GluDH 
s-Mg-ATPase 
AdK 
ATP 
ADP 
AMP 
Normal 
Mean 
(n=6) 
4.0 
35 
Θ.3 
3.7 
486 
109 
104 
30 
25 
171 
168 
14 
3.6 
5.9 
3.0 
30 
0.40 
0.4 
0.11 
8.8 
18 
4.6 
2.8 
1.4 
control group 
SD 
0.6 
7 
2.3 
0.7 
86 
24 
9 
8 
2 
34 
53 
5 
1.0 
0.6 
1.2 
4 
0.04 
0.2 
0.1 
1.0 
4.0 
1.4 
1.6 
0.6 
III-ll 
10 
91 
20 
12 
1702 
288 
321 
110 
120 
1000 
684 
34 
9.7 
17 
2.4 
98 
1.2 
1.8 
0.2 
18 
51 
9.9 
3.3 
2.3 
Patient 
III-18 
16 
138 
35 
20 
2601 
360 
464 
189 
176 
1380 
1127 
53 
10 
23 
8.6 
118 
1.9 
1.6 
0.1 
29 
72 
14.5 
6.1 
3.1 
group 
III-22 
10 
104 
13 
12 
2556 
251 
303 
106 
113 
950 
814 
38 
5.9 
17 
9.2 
93 
1.2 
0.4 
0.5 
22 
42 
9.4 
5.9 
3.1 
IV-1 
7.8 
84 
17 
7.8 
932 
213 
282 
87 
92 
754 
670 
27 
4.5 
15 
5.2 
93 
0.5 
1.9 
0.2 
20 
43 
Enzyme activities are expressed as ymol substrate/min per 10 
platelets and adenine nucleotides as ymol per 10 1 1 platelets. 
The enzyme activities of the patients are corrected for erythrocyte 
contaminât ion 
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Fig. 5 
Soluble hexokinase acitivity before and after treatment with collagen. 
Values represent μπιοί substrate/min per 10 platelets. Platelet-rich 
suspens.ons were treated with collagen-suspension (right ordinate) 
or buffer (left ordinate) for 15 m m at 37° С 
before treatment after treatment 
with collagen 
14 
12 
io 
- β 
- β 
- 2 
2.5. DISCUSSION 
In general,the values for the enzyme activities in normal platelets 
found in this study are of the same order as the values reported by 
other investigators (table III). The existing differences can be 
ascribed to slight differences in experimental conditions. The normal 
values for the platelet adenine nucleotide content are subject to a 
somewhat greater variation, partly due to differences in experimental 
conditions but for the greatest part due to differences in methods 
of platelet isolation. The values reported here and the ATP/ADP ratio's 
are comparable to those found by Loder et al. (1968), and Karpatkin 
(1971) 
-36-
TABLE III 
Comparison of enzyme activities and adenine nucleotide levels in 
normal platelets in this and previous studies 
HK 
HIM 
PFK 
ALD 
TIM 
GAPDH 
PGK 
PGM 
EN 
PK 
LDH 
G6PDH 
6PGDH 
GR 
IDH 
MDH 
GDH 
ME 
GluDH 
s-Mg-ATPase 
AdK 
ATP 
ADP 
AMP 
ATP/ADP 
This 
study 
4.0 
35 
8.3 
3.7 
486 
109 
104 
30 
25 
171 
168 
14 
3.6 
5.9 
3.0 
30 
0.40 
0.4 
0.11 
8.8 
18 
4.6 
2.8 
1.4 
1.6 
Waller 
et al. 
(1959) 
2.2 
73 
7.0 
4.1 
274 
78 
92 
39 
24 
60 
97 
6.9 
1.0 
6.8 
3.3 
38 
1.2 
0.6 
16 
12 
21.5 
6.9 
8.1 
3.1 
Caen 
et al. 
(1966) 
7.5-15.8 
5.6-16.9 
5.8-13.3 
0.8-1.4 
Doery 
et al. 
(1967) 
8.3 
98 
17 
7.0 
35 
189 
Loder 
et al. 
(1968) 
8.0 
4.5 
0.1 
1.8 
Moser 
et al. 
(1968) 
3.9 
81 
9.2 
251 
120 
115 
65 
85 
148 
10 
2.4 
8.5 
26.5 
3.8 
7.0 
Schnei-
der 
et al. 
(1971) 
1.2 
61 
6.9 
4.5 
125 
121 
27 
35 
87 
134 
7.9 
2.6 
4.0 
1.2 
100 
5.5 
2.7 
4.3 
2.0 
Karpat-
kin 
(1971) 
3.5 
2.3 
0.6 
1.5 
Platelet enzyme activities are expressed as ymol substrate/min per 
1011 platelets and adenine nucleotides as pmol per 10 1 1 platelets 
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Comparative observations of the values for patients and controls 
revealed no deficiency in any of the glycolytic enzymes. On the con-
trary, all enzymes measured showed a marked increase in activity 
when expressed on a cell count base. Since, however,most of the enzymes 
are located in the cytoplasm, the elevated mean cell volumes of the 
patients' platelets have to be taken into account. When the activities 
are expressed on a volume base, most activities are within normal 
limits, except for the activities of EN, PK and LDH which are relative-
ly increased. These increased enzyme activities may reflect a relative-
ly young cell population, since young cells exhibit high enzyme acti-
vities (Karpatkin, 1971). The existence of such a young cell population, 
however, is not apparent from the study of Kurst^ens et al. (1968), 
who found a normal survival time of the pathological platelets (2.2). 
In general the existence of a young cell population causes a short 
survival time, due to the functional inferiority of these cells. Other 
reports on similar types of thrombocytopathy (Cullum et al., 1967; 
Gröttum & Solum, 1969) give evidence for the existence of a consi-
derable fraction of platelets with a very short life span (0.5 - 0.6 
days, compared to normal platelet life spans of 9 - 13 days). It might 
be possible that the existence of such a short lived population has 
not been noticed in the determination of Kurstjens. Electron micros-
copic studies on these pathological platelets by Vossen et al. 
(1968) suggest that this type of thrombocytopathy is caused by a pre-
mature sprouting of the platelets from the megakaryocytes. This 
observation favours the supposition that a relatively young, defective, 
platelet population exists in these patients. 
However it should also be kept in mind that the enzyme activities 
were measured in homogenates and under optimal or near-optimal 
conditions, and thus these activities may be quite different from the 
in-vivo capacities of these enzymes. 
The adenine nucleotide levels on a volume base were normal or slightly 
subnormal in the patients. Measurements of the lactate production and 
oxygen consumption were made in the laboratory of Gross (Köln) on the 
platelets of patients III-22 and III-26. The oxygen consumption based 
on platelet volume was about 50% below the normal value. The lactate 
production appeared to be normal when based on cell volume, which 
implies a two-fold increase of the ratio of lactate production to 
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oxygen consumption. A nearly normal ATP content in combination with 
a sub-optimal oxygen consumption Is rather peculiar, since for example 
Gross & Schneider (1968) showed that after blocking respiration with 
cyanide, platelets were unable to maintain their level of ATP in spite 
of a doubled lactate production. This discrepancy may perhaps be 
explained by a membrane defect in the pathological platelets. When 
platelets were treated with the uncoupling agent 2,4 - dinitrophenol 
(DNP) Gross & Schneider (1968) observed a marked decrease in oxygen 
consumption together with a three-fold increase in lactate production. 
In contrast with other uncoupling agents the ATP levels in the plate-
lets remained essentially normal. This led them to suggest that DNP 
not only causes uncoupling of respiration from oxydative phosphory-
lation, but changes also the membrane permeability. There are other 
indications which suggest the occurrence of altered membrane proper-
ties in the pathological platelets. First, the absence of a collagen-
induced platelet aggregation cannot be caused by a decreased ADP 
content, since this appears to be nearly normal. It must therefore 
be related to an impaired release and/or abnormal compartmentation. 
The absent collagen-induced platelet aggregation is accompanied by 
an abnormal behaviour of the hexokinase activity with respect to its 
distribution between the soluble and particulate fraction after colla-
gen-treatment of the platelets. In contrast to the increase in 
soluble hexokinase activity found in normal platelets, the pathological 
platelets of patient III-18 do not show such an increase in activity. 
This may mean that either all hexokinase activity exists in "soluble" 
form, such that addition of collagen per definition cannot influence 
its activity, or the hexokinase is bound so firmly to the membrane 
components that collagen-treatment fails to release any additional 
activity into the soluble form. The latter possibility seems to be 
the most likely one, since the pathological platelets fail to release 
many other substances after an appropriate stimulation. These 
considerations point to a disturbed membrane function in the patho-
logical platelets. In our study we have, therefore, directed our 
efforts to obtain more information about the membrane function of 
the pathological platelets. 
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3. LIPID COMPOSITION OF BLOOD PLATELETS 
3.1. INTRODUCTION 
In chapter 1.2 the role of lipids (platelet factor-3) in blood 
coagulation has been discussed. In congenital thrombocytopathies the 
most common in-vitro finding is a sub-optimal function of platelet 
factor-3. A study of the composition of platelet lipids thus seemed 
indicated in order to establish any alterations which can induce the 
abnormality observed in our patients. Since phospholipids are inti-
mately ir.volved in maintaining the structural integrity of the cell 
membrane, it seems justified to assume that changes in phospholipid 
composition could be responsible for a disturbance in the platelet 
membrane function. In this chapter the isolation and quantitative 
analysis of the over-all platelet lipid composition, together with the 
phospholipid composition of normal and pathological platelets, will 
be described. 
3.2. MATERIALS AND METHODS 
3.2.1. Extraction of platelet lipids 
Extraction of platelet lipids was performed with a 1:1 mixture of 
chloroform and methanol (Folch et al., 1957; Ways & Hanahan, 1964). 
Platelet sediments (2.3.1.) which had been washed twice with 0.9% 
NaCl/ACD (33:1, v/v) were first stirred with 15 ml methanol during 
30 min, then 15 ml of chloroform was slowly poored on the methanol-
stirred suspension. After 15 min of further stirring the suspension 
was centrifuged and the sediment treated two more times with chloroform-
methanol. The combined chloroform-methanol supernatants were evaporated 
under reduced pressure at 350C. The residue was freed from the glass wall 
by means of alternative treatments with methanol and chloroform (1:2), 
aided by swirling with a glass bead. After filtration through a glass 
filter (G 3) 0.2 vol. of 0.1 M KCL (Folch et al., 1957) was added to 
the extract and mixed in a separatory funnel. After the two phases had 
-40-
clearly separated, the lower chloroform phase was collected ard 
combined with a 10 ml chloroform washing of the water-phase. The chlo-
roform-methanol extract was evaporated to dryness under reduced pres­
sure at 35° C. Treatment with small portions of absolute ethanol and 
successive evaporation to dryness was continued till constant weight 
of the lipid extract was obtained. This weight was assumed to be the 
weight of the total lipid content of the amount of platelets extracted. 
Lipid extracts were dissolved in a 4:1 (v/v) mixture of benzene-ethanol 
(Vorbeck & Marinetti, 1965) and stored at -25° C. Care was taken to 
avoid exposure of the lipid extract to air and to excessive day light. 
All manipulations were carried out in a nitrogen or C02-atmosphere 
whenever possible. 
3.2.2. Quantitative two-dimensional thin layer chromatography of 
platelet lipids 
Purification of silicagel H was performed according to the methods of 
Broekhuyse (1968). The purified silicagel in a 10% aqueous solution 
had a pH of 7.0 (S.E. 0.2). To 35 g silicagel 0.7 g basic magnesium 
silicate (Woelm, Eschwege, Germany) and 70 ml of distilled water was 
added. This mixture was stirred for 30 sec in a Waring Blendor. The 
resulting slurry (pH 8.1 - 8.5) was spread in a 0.3 mm layer on five 
20 χ 20 cm glass-plates by standard methods. After the plates had 
been air -dried, the plates were activated at 130° С for 90 m m and 
stored in vacuum over cone. H2SO.. Chromatography was carried out in 
vessels lined with filter paper. Equilibration with the developing 
solvent mixture was carried out 30 min before chromatography. Two 
different developing systems were used, system I (chloroform-
methanol-conc.ammonia-water, 75:34:3.5:3.5, v/v) for the first dimen­
sion and system II (chloroform-methanol-acetic acid-water, 75-25-8-1, 
v/v) for the second dimension (Broekhuyse, 1968). After development 
with system I the plates were air -dried for 15 min. After development 
with system II and drying, detection of the separated lipid components 
was carried out by treatment with iodine vapor (Branté, 1949). Fig. 6 
gives an example of a developed chromatogram of a total lipid extract 
from platelets. Identification of the separated phospholipid compo-
nents was carried out by comparison of the chromatographic behaviour 
of standard phospholipids, combined with the use of specific staining 
reagents. Synthetic diphosphatidyl glycerol and chromatographic pure 
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Fig. 6 
Drawing of a two-dimensional thin layer chromatogram of a platelet 
total lipid extract on purified siligagel H (Merck) containing 2%. 
Mg-Silicate (Woelm, Eschwege). The spots are identified as: 0,origin; 
1, lysophosphatidylcholine; 2, phosphatidylserine; 3, phosphatidic 
acid; 4, sphingomyelin; 5, phosphatidylinositol; 6, phosphatidyl 
choline; 7, phosphatidylethanolamine; 8, diphosphatidyl glycerol; 9, 
neutral lipids. 
Development in the first dimension was carried out with chloroform-
methanol-conc. ammonia- dist. water (75/3S/3.5/3.5, v/v) and in the 
second dimension with chloroform-methanol-conc. acetic acid- dist. 
water (75/25/8/1, v/v). 
phosphatidic acid was obtained from Dr. P.P.M. Bonsen (Utrecht). 
Commercial phosphatidyl choline, phosphatidyl ethanolamine, phos-
phatidylserine, phosphatidyl inositol and lyso-phosphatidylcholine 
(Pierce Chemicals) were purified by means of preparative thin layer 
chromatography. Cholesterol (Sigma, 99 + grade) was used without 
further purification. In addition to iodine as a general staining 
agent the following reagents were used for specific components: 
Primary aminogroups were visualized with the ninhydrin-spray according 
to Skldmore t Enteman (1962) and choline with Dragendorff's reagent 
(Skidroore & Enteman, 1962) . 
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3.2.3. Estimation of llpld-phosphorus 
Lipid-phosphorus in dry lipid extracts or in chromatographic lipid 
spots was estimated by the methods of Bartlett (1959) and Böttcher 
et al. (1961), modificated according to Broekhuyse (1968). To the 
organic material (less than 400 pg) 0.4 ml of a cone. H2SO4-70% 
HC10. (10:2) mixture was added. After the tubes had been stoppered 
by glass beads, the contents were digested for 45 min at 180 C. 
After cooling, 9.2 ml of 0.26% ammonium hepta molybdate and 0.4 ml of 
a solution of 14.73% Na-S-O., 0.50% Na2S03 and 0.25 % 1- amino-2-
naphtol-4-sulphonic acid (Parker & Peterson, 1965) was added. After 
mixing the contents, the tubes were heated for 30 min at 70oC. 
After cooling, the absorbance of the resulting blue colour at 820 mm 
was determined in cuvettes with 1 cm pathlength. If silicagel was 
present, the tubes were first centrifuged for 5 min at 1000 g and the 
supernatant was used for colorimetry. Blanks and standards (2.5, 5 
and 10 yg P) were also run. The values obtained for the phosphorus 
content of total lipid extracts were multiplied with a factor 25 
in order to obtain the phospholipid content of the extracts. The 
value of this factor is derived from the mean molecular weight and 
phosphorus content of naturally occurring phospholipids. Subtrac-
ting the phospholipid weight from the total lipid weight gave the 
weight of the neutral lipid fraction present in the total lipid extract. 
3.2.4. Miscellaneous determinations 
Platelet dry weight was determined by weighing freeze-dried platelet 
suspensions in 0.9% NaCl/ACD (33:1, v/v). Corrections were made for 
the dry weight of the chemicals present in the platelet preparations. 
Protein was measured according to Lowry et al. (1951) using bovine 
serum albumin as standard. 
Cholesterol was measured according to the method of Zlatkis et al. 
(1953). Aliquots of platelet lipid extracts were submitted to thin layer 
chromatography on silicagel G (Merck), developing with petroleum ether-
diethyl ether-cone, acetic acid (90 : 10:2, v/v). The cholesterol bands 
were identified by comparison to the bands of reference cholesterol, 
applied to the plate in known amounts. Sample and standard cholesterol 
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bands were scraped from the plates and brought into test tubes with 
3 ml cone, acetic acid. After treating for 5 min at 80° C, the tubes 
were centrifuged for 5 min at 1000 g, the supernatant was decanted 
and treated with 2 ml of colour reagent (3.7 mM FeCl3.6H20 in cone. 
H 2SO 4). 
Fatty acid analysis. Preparation of fatty acid methylesters for gas 
liquid chromatography was carried out with a 5 percent solution of 
HCl in methanol (w/v). A known volume of platelet lipid extract was 
evaporated to dryness in a stream of nitrogen, and 5 ml 5% HCl-methanol 
was added. The tubes were tightly stoppered and heated for 2 hours 
at 70oC. After cooling, 3 ml pentane and 3 ml distilled water were 
added. The water layer was removed and washed with another 3 ml pentane. 
The combined pentane layers were washed with distilled water till 
neutral and dried overnight over anhydrous Na-SO.. After filtering off 
the Na-SO., the pentane solutions, containing the methylesters of the 
fatty acids, were stored under nitrogen at -20 C. Fatty acid analysis 
was carried out over a column of 15* diethylene-glycolsuccinate on 
Chromosorb Q (Applied Sciences) at 180 С 
3.3. RESULTS 
3.3.1. Platelet lipid content and composition 
In order to gain a proper insight into the possible differences 
between the normal and pathological platelets, the results are express­
ed in several ways. From the affected family members, three patients, 
III-ll, III-18 and III-22, have been examined. The total lipid content 
of the normal and pathological platelets is given in table IV. 
A significant difference in total lipid content between the patient 
group and the normal controls existed when expressed on a platelet 
count basis. Analysis of the cholesterol content of the platelets 
revealed that in all cases the percentage of esterified cholesterol was 
too small (0.1 - 0.3% of the total lipid) to permit meaningful compa­
rison. It was only 1-2% of the free cholesterol content, which can 
therefore be taken as indicative for the total cholesterol content. 
The cholesterol content found in normal and pathological blood plate­
lets are listed in table V. Generally, no significant differences 
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TABLE IV 
Total lipid content of normal and pathological platelets 
Total lipid content 
expressed as 
Q 
mg/10 platelets 
mg/mg dry weight 
mg/mg protein 
Normal control group 
mean SD η 
0.71 0.05 12 
0.19 0.17 15 
0.37 0.17 14 
Patient group 
III-ll III-18 111-22 
2.23 1.08 0.83 
0.34 0.30 
0.39 0.55 0.35 
P-value 
+ 
(+) 
For each parameter the number of normal control persons on which the 
calculation was based is given in the column under n. If patients 
were exëimined more than once, the results per patient were averaged. 
Statistical comparisont of the results of the normal and patient 
group was carried out with the two-sample test of Wilcoxon. In this 
table and the following ones the symbols in the column under P-value 
(P) stand for: 
+ + : Ρ < 0.01 
+ : 0.0K Ρ < 0.05 
(+) : 0.05< Ρ < 0.10 
- : 0.10< Ρ 
TABLE V 
Cholesterol content of normal and pathological platelets 
Cholesterol content 
expressed as 
wg/10 9 platelets 
vg/mg dry weight 
pg/mg protein 
pg/mg total lipid 
wg/wg lipid-p 
Normal 
mean 
96 
28 
40 
160 
74 
control 
SD 
19 
10 
13 
60 
31 
group 
η 
11 
12 
11 
14 
14 
Patient group 
III-ll III-18 III-22 
159 151 93 
25 21 
30 44 39 
90 109 111 
54 62 59 
P-value 
( + ) 
-
-
( + ) 
-
Results represent duplicate determinations on aliquots of the total 
lipid extracts. 
For explanation of symbols, see legends to table IV. 
Statistical analysis was carried out by drs. M.A. van 't Hof (Univer­
sity Computer Centre, Statistical department; head drs.Ph. van Eiteren) 
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differences in cholesterol content were observed in the patients' 
platelets. The platelet phospholipid content expressed as lipid 
phosphorus content of normal and pathological platelets is presented 
in table VI. 
TABLE VI 
Lipid-phosphorus content of normal and pathological platelets 
Lipid-phosphorus con­
tent expressed as 
yg/109 platelets 
yg/mg dry weight 
pg/mg protein 
pg/mg total lipid 
Normal 
mean 
16.2 
4.5 
7.8 
23.4 
control group 
SD η 
3.4 13 
1.2 14 
3.6 13 
4.5 19 
Patient 
III-ll III-18 
29.9 26.8 
4.7 6.4 
5.7 7.9 
17.9 21.8 
group 
III-22 
15.9 
18.8 
P~value 
(+) 
-
-
-
Results were obtained by lipid-phosphorus determinations in triplo on 
known amounts of the platelet total lipid extracts. 
For explanation of symbols, see legends to table IV. 
TABLE VII 
Phospholipid composition of normal and pathological platelets 
Components 
origin 
lysophosphatidyl-
chollne 
phosphatidylserine 
phosphatidic acid 
sphingomyelin 
phosphatidylinositol 
phosphatidylcholine 
phosphatidylethanol-
amine 
diphosphatidyl-
glycerol 
solvent front 
Recovery 
Normal 
mean 
1.1 
0.8 
9.8 
0.6 
17.7 
4.8 
33.5 
23.8 
1.4 
1.1 
95.6 
control 
SD 
0.6 
0.9 
1.2 
0.7 
2.3 
0.8 
1.4 
1.2 
0.8 
0.7 
3.7 
group 
η 
15 
15 
15 
15 
15 
15 
15 
15 
15 
14 
14 
Patient group 
III-ll 
2.5 
0.7 
6.5 
4.2 
13.6 
5.7 
32.4 
21.6 
2.8 
0 
95.0 
III-18 
4.4 
0.5 
8.7 
0.5 
19.5 
5.3 
34.3 
17.5 
2.0 
1.1 
94.7 
III-22 
4.0 
0 
8.6 
1.3 
17.0 
5.5 
36.4 
18.6 
3.8 
4.3 
99.6 
+ + 
-
+ 
( + ) 
-
-
-
+ + 
+ + 
-
-
Results, obtained by quantitative thin layer chromatography of duplicate 
aliquots of platelet lipid extracts, are expressed as percent of total 
lipid-phosphorus. For explanation of symbols, see legends to table IV. 
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No significant differences between the phospholipid values of the 
patient-group and the normal control-group could be observed, except 
that the lipid-phosphorus content in the patients, expressed on a 
cell count base, appeared to be slightly higher than normal. Data 
on the phospholipid composition, obtained by thin layer chromatography, 
are shown in table VII. Significant differences in the contents of 
phosphatidylserine, phosphatidylethanolamine and diphosphatidylglycerol 
were observed: PS and PE were lowered and DPG was increased in the 
pathological platelets. 
3.3.2 fatty acid composition''' 
Preliminary studies on the fatty acid composition of the total lipids 
of platelets from three control persons and from patient III-22 and 
patient III-18 were carried out. Patient III-18 was examined at two 
different times. The results of the control lipid extracts show good 
reproducibility within each person examined. The same is true for the 
two separate determinations performed on the lipid extracts of patient 
III-18. 
A strong decrease in the arachidonic acid (20:4) content was observed 
in both patients. The molar ratio of total saturated to total unsatura-
ted fatty acids appeared to be increased in the pathological platelets 
(table VIII). 
3.4. DISCUSSION 
Data on platelet lipid analysis, which are based on the more recent 
techniques of lipid fractionation, are scarce. A comparisom of our 
results with those reported by other investigators is presented in 
table IX and fig. 7. From this comparison it can be concluded that the 
analytical data in our study are in good agreement with the values 
reported by the other investigators. 
Thanks are due to Dr. J.H. Veerkamp and Dr. R.M. Broekhuyse for their 
cooperation in performing fatty acid analysis 
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TABLE Vili 
Fatty acid composition of the total lipid fractions of normal and 
pathological platelets 
Fatty acid 
14 : 0 
16 : 0 
16 . a 
17 : 0 
18 : 0 
18 : 1 
18 : 2 
18 : 3 
20 : 0 
20 : 1 
20 : 3 
20 : 4 
other 
S 
U 
S/и 
Normal controls 
1.6 1.1 1.2 
17.8 17.5 16.7 
1.2 1.2 1.0 
19.3 19.1 19.3 
13.1 11.9 11.7 
16.2 16.4 17.0 
9.9 10.3 13.1 
3.1 4.6 4.0 
2.5 1.8 3.9 
12.2 11.6 10.б 
3.1 4.5 1.5 
42.4 42.8 40.5 
57.6 57.2 59.5 
0.73 0.75 0.68 
Patients 
III-18 III-22 
1.2 1.2 1.2 
18.8 18.3 17.4 
0.3 0.2 1.1 
28.8 24.2 22.4 
12.9 12.7 13.4 
18.4 18.6 17.4 
10.5 13.7 10.6 
3.8 4.4 3.9 
0.6 0.9 0.9 
3.1 2.3 5.9 
1.5 3.6 5.8 
51.6 47.8 46.4 
48.4 52.2 53.6 
1.07 0.92 0.87 
Results are given in mole per cent of total fatty acid content for 
three separate analyses of normal platelet lipids. Patient III-22 
was examined once and patient III-18 was examined twice. Fatty acid 
methylesters were prepared by HCl-methanol esterification ( 3 2 4 ) 
Dimethylacetals of 16:0, 18:0 and 18:1 gave separate peaks, which 
could be identified, but their contents were not involved in the 
calculation. Present at levels below 1% were: 12:0, 15:0, 20:2 and 
two unidentified acids with more than 22 carbon atoms ("other"). The 
fatty acid peaks were identified by comparing their retention times 
with those for known fatty acid methyl ester mixtures (Applied Science) 
S and U are the mole fractions (in %) of saturated (S) and unsaturated 
(U) fatty acids. S/U is the ratio of saturated to unsaturated fattv 
acids. 
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Considering the lipid analysis of the pathological platelets it must 
be taken into account that it is difficult to produce a pure preparation 
of the patients' platelets, due to the overlapping sizes of the largest 
platelets and the erythrocytes (see also 2.3.1.). When comparing the 
results of the lipid analysis of normal and pathological platelets, 
we have to take into account that the pathological platelets are about 
two to three times larger than normal platelets. 
Fig. 7 
Comparison of phospholipid composition of normal blood platelets from 
literature reports with the results of this study 
lipid phosphorus ( 'bi­
so 
40-
3 0 
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7).Mordoy et al, 1969 
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TABLE IX 
Comparison of lipid analysis data of normal blood platelets with the 
results of this study 
Authors 
Billimoria et al., 
Karaca a 
Stefanini 
Cullum et al., 
Hovmand et al. , 
Marcus et al., 
Nordoy et al., 
This study 
1965 
1966 
1967 
1969 
1969 
1969 
Total lipids 
expressed as 
g 
ng/10 mg/mg d.w. 
0.73 0.25 
0.45 
0.71 0.19 
Lipid-phosphorus 
expressed 
yg/io9 
13.3 
17.2 
16 
12 
16.2 
Mg/mg d 
6.0 
4.3 
5.0 
4.5 
as 
w. ug/mg total 
lipid 
23.6 
32 
31.5 
23.4 
For explanation of symbols, see legends to table IV 
In table X we list therefore the values of dry weight and protein 
g 
content per 10 platelets for normal controls and patients. 
TABLE X 
Miscellaneous platelet parameters 
Platelet parameters 
mg dry weight/ 
10 9 platelets 
mg protein/ 
10 9 platelets 
mg protein/ 
mg dry weight 
Normal control group 
mean SD η 
3.8 1.4 13 
2.7 0.9 12 
0.54 0.21 15 
Patient group 
III-ll Ill-IB III-22 
6.3 6.9 
5.1 3.8 2.4 
0.81 0.48 
P-value 
( + ) 
(+) 
For explanation of symbols, see legends to table IV 
It appears that the total lipid content of the pathological platelets 
is increased when expressed on a cell count basis. 
Taking into account the increased dry weight/platelet count 
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ratio (table X) the lipid content falls within normal limits. The same 
holds true for the platelet lipid-phosphorus and cholesterol content 
of these pathological platelets. It can therefore be concluded that 
the phospholipid/total lipid ratio is not abnormal in these platelets 
(table VI). The quantitative analysis of the platelet phospholipids 
(table VII) revealed a decrease of phosphatidylethanolamine content 
and an Increase of the diphosphatidylglycerol content. However, it 
was not always possible to obtain complete separation of the diphos-
phatidylglycerol and phosphatidylethanolamine spots, which were located 
close to each other. Hence, these findings may be interrelated. The 
sum of the phosphatidylethanolamine and diphosphatidylglycerol contents 
is not significantly different in the patients. Besides these differen-
ces a decreased phosphatidylserine content and an indication of an 
increased phosphatidic acid content were found. The question may now 
be posed whether such small differences may indeed be responsible for 
the platelet defect observed in the in-vitro test systems. 
Papahadjopoulos et al. (1962) and Daemen et al. (1965) clearly showed 
that the thromboplastic activity of phospholipid emulsions is 
positively correlated with the electrophoretic mobility of the emul-
sified lipid particles. Since the electrophoretic mobility is related 
to the particle surface charge, there appears to exist an optimal 
surface charge/below and beyond which a diminished clot-promoting 
activity occurs. Both groups concluded that maximal clot-promoting 
activity was not dependent on a particular phospholipid but had to be 
understood as the resultant of all contributing lipid components, 
present in the extract. 
The observed decrease in phosphatidylserine content might theoreti-
cally bring about a decreased net negative charge of the resulting 
activating phospholipid moiety, because PS carries a net negative 
surface charge at physiological pH. 
The results of our preliminary fatty acid analysis of platelet lipids 
from normal control persons differ from the results reported by 
Marcus et al. (1969) and by Cohen S Derksen (1969). While palmitic, 
stearic and oleic acid do not differ, we find a higher linoleic acid 
content (16.5 versus 3.7 and 5.1 mol%) and linolenic acid content 
(11.1 versus 2.9 and 2.7 mol%). Our values for the arachidonic acid 
content are lower (11.5 versus 16.7 and 18.7 mol%) than the values of 
Marcus et al. and Cohen t Derksen. We can offer no suitable explana-
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tion for these differences. The retention times of the 16:0, 18:0 and 
18:1 dimethylacetals differed sufficiently from those of the methyl-
esters to make it unlikely that the presence of these compounds could 
have caused the discrepancies. Renaud et al. (1970) also found a 
higher linoleic acid content than Marcus et al. and Cohen & Derksen. 
It is possible that the lowered arachidonic acid content and the 
increased linoleic acid content found by us are related, since linoleic 
acid is required for the biosynthesis of arachidonic acid (Klenk & 
Debuch, 1959; Mead, 1961). Future studies to clarify the differences 
observed are indicated. 
Our comparative studies indicate a significant decrease of the arachi-
donic acid content in the pathological platelets. Together with the 
increased stearic acid content this caused an increased ratio of 
saturated to unsaturated fatty acids. It is known that phosphatidyl-
ethanolamine has a high unsaturated fatty acid content, especially of 
arachidonic acid. This finding agrees with the decreased phosphatidyl-
ethanolamine content observed in the pathological platelets. 
Several workers have stressed the importance of polyunsaturated fatty 
acids in determining clot-promoting activity (Daemen et al., 1965; 
Billimoria et al., 1965). The presence of unsaturated fatty acids 
seems to promote the formation of small clotting-active lipid micelles 
(Wallach et al., 1959; see also chapter 4.4.). O'Brien (1965) as well as 
Fleischer & Rouser (1965) have distinguished differences between two 
types of membrane structures»represented by myelin, which is meta-
bolically very stable and mitochondria, which are metabolically very 
active. The stable membranes are characterized by high contents of 
cholesterol, sphlngolipids and saturated fatty acids. The labile, 
dynamic membrane structures, on the other hand, contain more unsatura-
ted fatty acids constituents. The myelin lipids possess characteristics 
which lead to tightly organized, closely packed, stable membrane 
structures. Although no changes in cholesterol and sphingomyelin 
content were found, the observed increase of the S/U ratio in the 
fatty acids of the pathological platelets could yet may mean a partial 
transition from a labile type of membrane to a more stable membrane. 
In order to investigate whether the observed alterations in lipid and 
fatty acid composition are important with respect to surface charge 
and clot-promoting activity, studies on electrophoretic mobility and' 
thromboplastlc properties of the emulsified lipid extracts will be 
described in chapter 4. 
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4. THROMBOPLASTIC ACTIVITY AND MEMBRANE SURFACE CHARGE 
4.1. INTRODUCTION 
Many attempts have been made to correlate the clot-promoting activity 
of blood platelets with the content and composition of phospholipids in 
these cells. In these experiments the clot-promoting ability of lipid 
preparations extracted from brain tissue or from the platelets them-
selves was tested in various different clotting tests. Many difficulties 
in interpreting the various results were met in the past, which have 
been discussed already in chapter 1.2. Now, the commonly accepted theory 
states that the clot-promoting activity of phospholipids is related to 
the net negative surface charge of the lipid micelles, at least in the 
in-vitro test assays used (Bangham, 1961; Papahadjopoulos et al., 1962; 
Daemen, 1963; Daemen et al., 1965). As was shown by Kurstjens et al. 
(1968),clot-promoting activity of the pathological platelets, studied 
here, is disturbed. In our studies on platelet lipid content and com-
position (chapter 3) slight differences in phospholipid composition 
were found in the pathological platelets: a decreased content of 
phosphatidylethanolamine and phosphatidylserine and an increased con-
tent of phosphatidic acid. The question can be posed whether this 
altered phospholipid composition could be responsible for the decreased 
thromboplastic activity. Therefore the thromboplastic activity of 
normal and pathological platelets and of emulsified lipid extracts from 
platelets was studied. In connection with these studies, the microelec-
trophoretic behaviour of whole platelets and of lipid emulsions prepared 
from platelets, was investigated. It was thus possible to study by 
means of the cell-electrophoresis system the relation between observed 
thromboplastic activity and negative surface charge of the lipid emul-
sions prepared from platelets. 
4.2. MATERIALS AND METHODS 
4.2.1. Thromboplastin generation test 
This test (Biggs & Douglas, 1953) is based on the principle that 
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incubation of a mixture containing the various factors of the intrinsic 
coagulation mechanism develops an active prothrombin activator. The 
resulting prothrombin activator can be measured by recording the clot­
ting time after addition of an aliquot of the incubation mixture to 
fresh, platelet-poor plasma. The extent of prothrombin activation can 
be followed by the progressive shortening of the clotting time in 
relation to the incubation period of the prothrombin activation mixture. 
For producing such a mixture the following components are used: serum 
(containing coagulation factors XII, XI, X and IX). Al(OH)3-adsorbed 
citrate plasma or BaSO.-adsorbed oxalate plasma (containing factors 
XII, XI, VIII and V), calcium ions and phospholipids (platelet factor-
Si (fig. 8). Keeping all factors constant, except for the source of 
platelet factor-3,this test gives reliable information concerning the 
clot-promoting activity of the phospholipids tested. 
F i g . 8 
Assay p r i n c i p l e of the thromboplastin generat ion t e s t 
Diluted,Al(ОН)з- or BaSCV 
adsorbed platelet poor plasma 
(factors Д . ДШ, Д and ΣΠ ) 
+ 
Diluted serum 
(factors EX , X , SI and ΣΠ ) 
Platelet or lipid suspension 
(platelet factor - 3 ) 
Calcium ions 
(factor Ш ) 
When whole p l a t e l e t prepara t ions were t o be t e s t e d , Al(OH)3-adsorbed, 
p l a t e l e t - p o o r , c i t r a t e plasma was used and when emulsif ied l i p i d ex­
t r a c t s were t o be t e s t e d , BaSO.-adsorbed, p l a t e l e t ^ p o o r , oxa late plasma 
was used. These were prepared by c o l l e c t i n g blood i n t o 9 volumes of 
e i t h e r 0.1 M sodium oxa la te s o l u t i o n or 3.8% t n s o d l u m - d i h y d r a t e solu­
t i o n . The mixture was centr i fuged for 20 min a t 1500 g and the upper 
two-thi rd of the plasma layer was c o l l e c t e d and shaken for 10 mm a t 
37° С e i t h e r with BaS04 (Merck, 100 mg/ml) or with A1(0H)3 (moist g e l , 
- 5 4 -
Prothrombin activation 
mixture 
Citrated test plasma 
(factors I and Π ) 
clot formation 
BDH, 100 mg/ml) . After removal of BaS04 or Α Κ Ο Η ) , by centrifligation 
(10 min, 1500 g), the plasma was diluted with 4 volumes of 0.9% saline 
solution. This diluted plasma was prepared freshly each day, particular 
in view of the lability of factors VIII and V. 
Serum was obtained by incubating whole blood for 3 hrs at 370C. After 
centrifuging for 10 m m at 1500 g, the supernatant serum was stored in 
small portions at -22° C. Before use it was thawed and diluted with 9 
volumes of 0.9% saline solution. The determinations were carried out 
2 hrs after dilution of the serum in order to obtain maximal activation 
of the factors IX and X. 
Platelets were obtained by centrifugation of citrated blood for 10 m m 
at 300 g. Platelet-rich plasma,which was pipetted off,was centrifugea 
for 15 min at 1500 g in order to sediment the platelets. The sedimented 
platelets were resuspended in 0.9% saline solution and centrifuged. 
After additional resuspending and centrifugation, the platelets were 
finally resuspended either in 0.9% saline solution or m distilled 
water to give a concentration of 6.7 χ 10 platelets per ml incubation 
mixture. 
Lipid suspensions were prepared from platelets by means of the lipid 
extraction procedure described in 3.2. The benzene/ethanol solution 
was thawed, the organic solvent evaporated and the residual lipid film 
dispersed in veronal buffer of pH 7.35 and ionic strength 0.154 (H]ort 
et al., 1955) by ultrasonic vibration for 15 seconds. From this 
original suspension serial dilutions were made with buffer. 
Platelet-poor, citrate plasma was prepared by collecting fresh human 
blood in 1/9 volume of 3.8% trisodiumcitrate-dihydrate and centrifuging 
for 20 min at 1500 g. 
All reagents, except the diluted serum, were kept on melting ice during 
the experiments. 
The test procedure was carried out as follows. In a non-siliconized 
test tube 0.3 ml of diluted, adsorbed, platelet-poor plasma, 0.3 ml of 
diluted serum, 0.3 ml of platelet suspension or lipid emulsion and 
0.9 ml of 0.025 M calcium chloride were mixed in this order and placed 
in a waterbath of 37° C. At the moment of addition of calcium chloride 
a stopwatch was started. After 1,3,5,7 and 9 min, when testing platelet 
preparations and after 3,5,7,9 and 15 mm, when testing lipid prepa­
rations, 0.2 ml of the incubation mixture was added to 0.1 ml aliquots 
of the platelet-poor, test plasma and the clotting time recorded. In 
order to correct as far as possible for the steady decrease of enzy­
matic activity in the reagent solutions during the time-course elapsing 
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during the testing period, each series of determinations was followed 
by a duplicate series in reversed order. Thus, all reported values 
are the average of at least two determinations and were compared with 
the clotting times obtained in tests where the lipid suspension had 
been replaced by the same volume of buffer (buffer blank value) and 
by a suspension prepared from a single batch of crude soybean lipid 
preparation, stored in small portions at -22° С in veronal buffer in 
a concentration of 0.5 mg/ml, corresponding to a concentration of 
2 v<3 lipid phosphorus/ml incubation mixture (standard soybean cephalin) . 
4.2.2. Separation of neutral lipids from a total lipid extract was 
carried out as follows. An aliquot of the total lipid extract in 
benzene/ethanol was evaporated to dryness in a stream of nitrogen and 
was then dissolved in chloroform. The chloroform solution was brought 
onto a silicic acid column (100 χ 8 mm) and the neutral lipids were 
eluted with chloroform-methanol 9 : 1 . The elutlon process was followed 
by means of micro thin layer chromatography on microscope slides 
layered with silicagel-G and chloroform-methanol-ammonia (65:35:3.5 
v/v) as developing system. The resulting solution was evaporated 
to dryness under reduced pressure and the lipid film was dispersed as 
described (4.2.1.) . 
4.2.3. Microelectrophoretic determinations on platelets and platelet 
lipids 
The platelets and lipid extracts were subjected to cylindrical micro­
electrophoresis in an apparatus designed by Bangham et al. (1958) and 
manufactured by Rank Brothers, Cambridge, England. The chamber was 
fitted with two B7 socket joints to permit measurements on 2-ml 
volumes. The stationary level was determined by velocity measurements 
of washed human erythrocytes in phosphate buffer (ionic strength 
0.154) at pH 5.8 and 8.0 and was found to be at a distance of 0.738 mm 
from the axis of the tube, in good agreement with the calculated 
distance of 0.728 mm (0.707 times the radius of 1.030 mm). The po­
tential gradient was calculated from the applied voltage and the 
tube length between the two irreversible grey platinum electrodes of 
160 mm. The currents generally used varied between 0.9 and 1.5 
milliampere, care being taken to avoid currents higher than 2.0 
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milliampere. Mobility measurements were usually made by timing 10 
focussed particles in each direction and averaging the results. 
All measurements were made at 25 С ± 0.2° C, and the electrophoretic 
mobility was expressed in μ.sec. .V .cm" . All values are negative, 
since the platelets as well as the lipids migrate towards the positive 
electrode, but for the sake of simplicity, the negative sign is omitted. 
Mobility measurements on platelets were carried out on a mixture of 
1 vol. of PRP and 9 vol. of either platelet-poor plasma or veronal 
buffer (pH 7.35, ionic strength 0.154). Constant mobility values could 
be obtained when one hour equilibration at room temperature was allowed, 
as previously reported by Hampton & Mitchell (1966 ) . Mobility measure­
ments of the emulsified platelet lipid extracts were carried out with 
dispersions in veronal buffer (0.01% solution, w/v). 
4.3 RESULTS 
4.3.1. Thromboplastin generation of whole platelet preparations 
The pathological platelets (6.7 χ 10 , saline washed, platelets per ml 
incubation mixture) were strikingly less active in the formation of 
the prothrombin activator as compared to normal platelets (fig.9). 
However after a final washing in distilled water, the pathological 
platelets had the same prothrombin-activation capacity as those from 
normal persons. The number of platelets in our experiments was choosen 
rather arbitrarily so as to permit observation of a decreased or an 
increased clot-promoting activity. A number of 6.7 χ 10 platelets 
normally represents 0.11 vq lipid phosphorus, but in the case of the 
patients III-ll and III-18 it represents respectively 0.20 yg and 
0.18 цд lipid-phosphorus. 
4.3.2. Thromboplastin generation of extracted platelet lipids 
Table XI gives an example of an experiment, in which an emulsified 
platelet total lipid extract was serially diluted. The clotting times 
observed after 3,5,7,9 and 15 min pre-incubation for each lipid 
concentration tested, were summated. The concentration showing the 
smallest sum of clotting times was the one with the highest clot-
promoting activity. The data in table XI indicate that the maximum clot-
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TABLE XI 
Clot-promoting activity of lipid emulsions in the thromboplastin generation test 
Tested substance 
Total lipids 
extract no. 37 
m Neutral lipids 
f extract no. 37 
Standard soybean 
phospholipid 
Buffer blank 
value 
Concentration 
pg/ml pg lipid-P/ml 
1000 
500 
167 
83 
42 
21 
10.5 
350 
175 
87.5 
44 
83 
25 
12.5 
4.2 
2.1 
1.05 
0.5 
0.25 
0.7 
0.35 
0.17 
0.09 
2 
Clotting time in seconds 
after various 
pre-incubation times 
3' 5' 7' 9' 15' 
72.5 69 52 42 21.5 
64 51 41 29 13 
60 46 25 16.5 12 
63.5 36 25 14 11 
60 42 26.5 16 11 
64 44 30.5 18.5 13 
70 54 35.5 22.5 13 
102 90 79 73 51 
112 97 88 78 57 
125 110 97 84 69 
111 115 90 87 71 
53 44 28 21 14 
104 94 94 90 77 
Sum of 
clotting 
times 
257 
198 
159.5 
139.5 
155.5 
170 
195 
395 
432 
485 
474 
160 
459 
Sum of 
clotting times 
.. 
minimal sum of 
clotting times 
185 
142 
114 
100 
112 
122 
140 
100% 
The test was carried out as described in 4.2.1. For each lipid concentration, the sum of the 
clotting times observed was calculated. The minimal suro of clotting times, representing the 
most active lipid concentration, was taken as 100 percent. The activity (sum of clotting times) 
with the other concentrations were related to the most active concentration as percentage 
beyond 100 (last column). 
Fig. 9 
Thromboplastin generation test of normal and pathological platelets 
suspended either in 0.9% saline (left) or in dist. water (right). 
Platelet count was adjusted to 6.7 χ 106/ml of incubation mixture 
clotting time (sec) 
incubation time (min ) incubation time (mm) 
with saline suspension with disi water suspension 
promoting activity with emulsified total lipids was reached at a 
concentration of about 2 pg lipid-phosphorus per ml incubation mixture. 
The neutral lipid fraction showed no activity relative to the buffer 
blank. This fraction contained a contamination with lipid-phosphorus 
due to some phosphatidylethanolamlne and phosphatidylserine. 
Day-to-day fluctuation of activation of clotting factors in the adsor­
bed diluted plasma caused a variation in clotting times in tests with 
a single lipid preparation. In order to permit comparison of results 
for different lipid preparations, the clotting times observed after 
3,5,7,9 and 15 min preincubation were summated and compared with the 
sum of clotting times obtained with the most active concentration. 
This latter sum, which is always the smallest, was taken as 100% and 
the summated clotting times obtained with the other lipid concentra­
tions were related to this as percentages beyond 100. 
The thromboplastic activity of the pathological platelet lipids was 
evaluated by testing the activities obtained with the total lipid 
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extracts, since these showed a sharper defined optimal concentration 
range than the phospholipid fraction. The results obtained with the 
normal extracts and with the extracts of patients III-ll and III-18 are 
presented in fig. 10. The absolute values of the minimal clotting times 
were equal for patients and controls, though they were reached at dif­
ferent phospholipid concentrations. Whereas for normals maximal clot-
promotion was reached at concentrations between 1 and 2.5 pg lipid-
phosphorus per ml incubation mixture, maximal clot-promotion for 
patients III-ll and III-18 occurred at concentrations of 2.7 \ig and 
4.5 vq, respectively. Fig. 10 also indicates that the higher lipid con­
centrations inhibited clot-promotion much less than normal control 
extracts. With 15 pg lipid-phosphorus per ml the percentage was about 
110 and 130 for patients III-18 and III-ll as compared to a mean of 
163% for the 5 controls. 
Fig. 10 
Thromboplastic activity expressed in relative clotting times as a 
function of lipid-phosphorus concentration. The minimal sum of 
clotting times after 3,5,7,9 and 15 min incubation, representing the 
most active lipid-phosphorus concentration, was taken as 100%. The 
activities obtained with the other concentrations were related to 
this optimal concentration. 
sum of dottino times .лп« 
minimal sum of clotting times 
ZOO-i 
1Θ0 
A 10 4 0 100 
jjg llpkl-prtosphorus/mi incubation mtxtij*e 
- 6 0 -
4.3.3. Electrophoretlc mobilities of platelets and platelet lipid 
particles 
Normal platelets had a mean electrophoretlc mobility of 1.00 
μ.sec .V .cm (determined on platelets from 12 normal controls; 
SD 0.04 μ.sec .V .cm ), when suspended in veronal buffer and of 
.V~ .cm (mean of 0.84 and 0.8Θ μ.sec V 1.cm~1 0.86 μ.sec ''  ''. * 8 * .  ^.cm * for 
2 normal controls) when suspended in platelet poor plasma. Each 
patient was examined once (table XII). 
TABLE XII 
Electrophoretlc mobility of normal and pathological platelets 
Platelets tested 
Normal controls 
Patient III-ll 
Ill-IB 
III-22 
Dilution of 
own plasma 
0.86 (2) 
0.79 
0.84 
PRP 1:10 in: 
veronal buffer 
1.00 + 0.04 (12) 
1.05 
1.06 
0.98 
Mobility is expressed as μ.sec .V .cm (+ SD). Figures in parentheses 
represent the number of control persons. 
No differences could be detected in the electrophoretlc mobilities 
observed with the pathological platelets as compared to control plate­
lets, either when suspended in platelet-poor plasma or in veronal buffer 
No differences were observed between the mobilities of the smallest 
pathological platelets (diameter 2-3μ) and the largest ones (5-6μ). 
The same lipid emulsions used in the thromboplastin generation test 
were also used for determination of the electrophoretlc mobility. Sus­
pensions of total lipid extracts yielded an electrophoretlc mobility of 
1.95 μ.sec .V .cm (determined on 7 normal extracts; SD 0.13 
μ.sec .V .cm ). 
Total lipid dispersions from the pathological platelets do not show 
clear deviations in electrophoretlc mobility (table XIII). 
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TABLE XIII 
Electrophoretic mobility of normal and pathological platelet 
total lipids 
Emulsion tested 
Normal controls 
Patient III-ll 
III-18 
III-22 
Electrophoretic mobility of 
platelet total lipid emulsions 
1.95 + 0.13 (7 persons) 
2.07 
2.13 (2 determinations:2.12 and 2.14) 
1.95 
Mobility is expressed as μ.sec .V .cm (+ SD). Lipids were 
emulsified in veronal buffer as a 0.01% solution (w/v). 
4.4. DISCUSSION 
The platelets from the patients showed a disturbed ability to parti­
cipate in the formation of an active prothrombin activator. This 
apparently is not due to a reduced content of lipid activator, as was 
shown by the equilization of the prothrombin activation ability upon 
treatment of the platelets with distilled water. This observation 
suggests that the lipids of the pathological platelets become for some 
as yet unexplained reason less easily available for prothrombin acti­
vation. 
The experiments with the total lipid extracts show that the lipids of 
the pathological platelets have a normal clot-promoting ability. 
However slightly more lipid was needed to achieve the same activation 
as normal controls. In fact the lipid content per pathological platelet 
is higher than normal, so whatever the cause of the in-vivo decreased 
platelet factor-3 activity may be, a decreased content of lipids in 
these platelets can never explain the abnormality observed. 
As was shown by Hemker & Kahn (1967) a coagulation complex (complex I, 
fig.2) is formed by the interaction of clotting factors Xa and V, 
together with Ca -ions on the surface of negatively charged lipid 
micelles. It is understandable that there exists an optimum lipid 
concentration for the promotion of this interaction. When too less 
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surface-area is available, many Xa and V molecules remain unbound. 
Otherwise, too much surface area means that too many binding sites are 
occupied by single Xa and V molecules. Under both circumstances 
clot-promotion will be low. Maximum activation is only achieved by 
the simultaneous binding of Xa and V molecules on the lipid micelle. 
Indeed a fairly pronounced concentration optimum in thromboplastic 
activity of total lipid emulsions was found (fig. 10) . 
The higher quantity of lipids needed to achieve equal activation with 
the pathological platelet extracts (fig. 10) must be related to altered 
surface properties of the pathological micelles. Wallach et al. (1959) 
showed that the colloidal configuration of phosphatidylethanolamine 
dispersions is closely related to their clot-promoting activity, the 
configuration depending upon the degree of unsaturation of the phos-
pholipid fatty acids and upon the temperature, pH and ionic composition 
of the suspending medium. Phospholipids with a low degree of fatty 
acid unsaturation tend to form large and tightly packed micelles, 
whereas phospholipids with a high degree of unsaturation tend to 
produce smaller micelles, due to the higher repulsive forces between 
the unsaturated fatty acids. At the same time these smaller micelles 
possess a higher clot-promoting activity perhaps by giving rise to a 
more easily interaction with charged moieties of other molecules e.g. 
the coagulation proteins factor Xa and V. 
In fact we found indications that the pathological platelet lipids 
have a lower degree of fatty acid unsaturation as compared to 
normal control platelet lipids. The decreased clot-promoting activity 
of the pathological platelets can therefore be explained by changes 
in membrane structure: 
1. The disturbed tromboplastin generation of whole pathological 
platelets and the normalization upon lysis with distilled water 
(4.3.1.) suggest a more rigid platelet membrane and needs therefore 
more drastic désintégration treatments for maximal exposure of the 
active thromboplastic membrane sites. 
2. In-vitro,the pathological lipid micelles are more tightly packed, 
explaining the higher quantities of lipid needed for equal clot-
promoting activity (4.3.2.) . 
3. The less pronounced inhibition of clot-promotion with lipid 
concentrations beyond the optimum concentration is also explained 
by the lower affinity of the lipid surface for the coagulation 
factors. 
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The surface charge which is characterized by the zeta-potential (ζ) is 
the electrokinetic potential at the surface of shear between the 
suspended particles and the bulk electrolyte solution. According to 
Smoluchowski (1921),the relationship between zeta-potential and elec-
trophoretic mobility is given by the equation 
r
 4 π η U 
D 
where U is the electrophoretlc mobility; D the dielectric constant of 
the bulk medium and η the viscosity of the medium. It is conceivable 
that the platelets which were suspended in veronal buffer showed a 
larger mobility than those which were suspended in plasma, due to the 
smaller viscosity of the former medium (the dielectric constant not 
differing much between buffer and plasma). 
The surface charges on platelets are contributed to approximately 40% 
by the carboxyl groups of sialic acid in the cell membrane (Madoff et 
al., 1964). According to Merishi (1970) another 40% of the negative 
charges are derived from alkaline phosphatase-susceptible phosphate 
groups. 
Since a normal microelectrophoretical behaviour of the pathological 
platelets was observed,it can be concluded that no changes in these 
membrane components are to be expected. 
The electrophoretlc behaviour of dispersed total lipid extracts is 
determined by the net charge of the polar head groups. In natural 
phospholipid mixtures this charge is almost always negative as a result 
of an excess of acidic phospholipids. The dispersed total lipids of 
pathological platelets appeared to exhibit the same electrophoretlc 
behaviour as the normal extracts. This once again emphasizes that the 
lipids themselves in these pathological platelets are normal in this 
respect. The question whether the observed changes in phospholipid 
composition are at least partly responsible for the existing thrombo-
plastic deficiency has thus to be answered in a negative sense. The 
results in this chapter at the same time suggest that the platelet 
defect lies in a disturbed ability to release or make available the 
required lipid activators. 
It should be stressed that comparison of results obtained by thrombo-
plastic activity-studies of whole platelets and platelet lipids is 
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hazardous. Dispersed total lipids in a concentration of about 2 ug 
lipid-phosphorus per ml of incubation mixture exhibit about the same 
activity, in terms of clotting times, as whole, lysed, platelets in a 
concentration of about 6.7 xlO platelets per ml of incubation mixture. 
9 
Using the value of 16.2 ug lipid-phosphorus/10 platelets (chapter 3.3), 
this amoant of platelets represents an amount of only 0.11 цд of llpid-
phosphorus per ml of incubation mixture. So the lipids in their normal 
environmental condition are about 20 times as active as in extracts. 
This is essentially similar to the findings of Marcus (1966), mentioned 
in chapter 1.2. Nevertheless comparative studies should certainly make 
use of these isolated test systems, but caution should be exercized 
in extrapolating the results to the physiological situation. 
There is only one report, in which the electrophoretic behaviour of 
platelets with similar defects, has been studied. Gröttum * Solum 
(1969) reported on the platelets from patients with congenital 
macrothrombocytic thrombocytopenia, in which they found a markedly 
reduced platelet electrophoretic mobility, while the sialic acid content 
of the platelets was also abnormally low. The autosomal dominant 
inheritance, the abnormally large platelets, the normal ADP-aggregation 
and the disturbed platelet factor-3 function were all features, which 
are similar to those of the platelets of the family in our study. They 
found however a strikingly increased protein content (6-10 times) per 
platelet. In our patients the platelet protein content was found to be 
only slightly increased. Together with the normal electrophoretic 
mobilities observed in our patients, it appears that we are dealing 
with two different forms of disease. 
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5. DISTRIBUTION AND MOVEMENTS OF CATIONS 
5.1. INTRODUCTION 
The cell membrane of most mammalian cells is able to maintain large 
concentration gradients of sodium and potassium ions between the 
intra- and extracellular space. Generally, cells are rich in potassium 
and poor in sodium, whereas low potassium and high sodium concentrations 
are found in the extracellular fluid. Skou (1957) discovered the enzyme 
system sodium-potassium activated adenosine-triphosphatase (Na-K 
ATPase), which is located in nearly all cell membranes over which these 
cation gradients exist (Bonting et al., 1961). This enzyme-system is 
now generally accepted to be identical with the mechanism which pumps 
potassium against the gradient into the cell and sodium out of the 
cell. 
The action of the Na-K ATPase system is counteracted by passive 
leakage of sodium and potassium according to the concentration gradient, 
resulting in a dynamic equilibrium with certain cation gradients. The 
extent of these passive movements is determined by the permeability of 
the cell membrane to these ions. 
Na-K ATPase is also found in the cell membranes of the formed elements 
of the blood, such as erythrocytes (Post et al., 1960; Bonting et al., 
1961) , leucocytes (Block & Bonting,1964) and platelets (Bull & Zucker, 
1965; Moake et al., 1970). Whereas the intracellular concentrations of 
potassium and sodium in erythrocytes and leucocytes are fairly well 
established, no close agreement exists about the platelet sodium and 
potassium concentrations. This seems to be due to the extreme liability 
to damage of blood platelets. 
The phenomena just described are related to membrane properties. Since 
we have found indications for a disturbed membrane function in the 
pathological platelets, it seemed worthwile to us to study the distri-
bution and movements of cations and the pump activity of these cells. 
Therefore, we have carried out comparative studies of the platelet 
cation distribution and chloride content, of the activity of the Na-K 
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ATPase system, as well as of the active transport Into and the passive 
о g α g 
leakage out of the platelets of the radioisotope Rb. Rb was used 
because it behaves similarly to potassium (Solomon, 1952; van Zwleten, 
1968; de Pont et al., 1971), but has a longer half-life time than the 
42 potassium isotope K. 
5.2. MATERIALS AND METHODS 
5.2.1. Platelet preparations 
Platelet-rich suspensions (PRS) were made by centrifugation of PRP for 
15 min at 1500 g. The packed platelets were washed in potassium-free 
Krebs-Ringer buffer solution (composition in mmol/1.: Na 145, CI 118, 
HC0 3" 23, H P 0 4 " 1.62, H 2P0 4" 0.39, glucose 11.1, EDTA 10; pH 6.5-6.7). 
After centrifugation of the platelets they were resuspended in a small 
volume of the same buffer (except for the omission of EDTA; glucose 
being 22.2 mmol/1) with a pH 7.3-7.5. Platelet concentrations usually 
q 
were 1 à 2 χ 10 platelets per ml of buffer. 
g 
Platelet-rich plasma (PRP) was used either unmodified (0.3- 0.4 χ 10 
platelets/ml; plasma potassium concentration 3.0 - 4.2 mM) or after 
dialysis in order to obtain varying plasma potassium concentrations. 
Dialysis was performed by dialysing one volume of PRP in a dialysis 
bag against 10 volumes of Tris-buffered saline solution, containing 
glucose (composition: Tris 10 mM; glucose 0.2%; NaCl 0.8%; final 
pH 7.4). After 60 min of dialysis the plasma K+-concentration varied 
between 0.4 and 0.7 mM. Intermediate potassium concentrations were 
obtained by varying the dialysis period. 
5.2.2. Flamephotometrlc measurements 
Intracellular Na and К concentrations were measured as follows. Into 
specially constructed glass tubes (2.3.3.) , 1.5 ml of PRP was pipetted 
and the tubes were centrifugated for 30 min at 1500 g. From the resul­
ting packed platelet column, contained in the narrow precision capil­
lary, a known length was cut off and the contents transferred into cold, 
double distilled water. After freezing and thawing two times, the 
mixture was centrifuged for 15 min at 10.000 g and the supernatant was 
analysed for Na and К by means of an Eppendorff flamephotometer. The 
apparatus was calibrated with a standard containing eguimolar concen-
trations of sodium and potassium in the range of 1 χ 10 to θ χ 10 M. 
14 The contamination by trapped plasma was corrected for by C-inulin 
methods, described in 2.3.3. Measurements of the plasma Na and К 
concentration were made on appropriate dilutions of platelet-poor 
plasma. 
5.2.3. Determination of chloride concentration 
Chloride was measured by means of the mercurimetric titration method, 
according to Natelson (1963) . Appropriate dilutions of plasma were made 
in order to determine the plasma CI concentrations. Platelet chloride 
concentrations were measured in the supernatants after the lysis pro­
cedure of 5.2.2. 
5.2.4. Determination of Na-K ATPase activity 
5.2.4.1. Tissue preparation. PHP was centrifuged for 20 min at 1500 g 
and the resulting platelet sediment washed once with a 0.9% NaCl-ACD 
(33:1 v/v) mixture. After centrifugation, the platelets were homogenized 
with 10 ml double-distilled water and centrifuged for 20 min at 10.000 g. 
This washing procedure was repeated twice. The final aqueous homogenate 
was lyophilized in 0.5 ml aliquots and stored at -20° С in vacuo. 
5.2.4.2. ATPase assay . Na-K ATPase activity was determined by 
measuring the amount of inorganic phosphate released from ATP upon 
incubation of tissue homogenates in two different substrate media 
according to the method of Bonting et al. (1963). The composition of 
the media were as follows (concentrations in mM final concentration): 
medium A-ATP, 2; Mg,l; Na, 56; K, 5; EDTA, 0.1; Tris-HCl (pH 7.5), 94; 
medium E - the same composition, except for the omission of К and the 
addition of 0.2 mM ouabain. 
In medium A the sum of Mg-activated and Na-K ATPase activities is 
determined, whereas in medium E only the Mg-activated ATPase activity 
is measured, due to the inhibition of the Na-K-activated ATPase by 
Determinations were carried out by Mrs. A. van Prooyen-van Eden, under 
the supervision of Dr. J.J.H.H.M. de Pont, Dept. of Biochemistry, 
University of Nijmegen. 
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ouabain and the absence of К . The activity of the Na-K ATPase is 
obtained by subtracting the activity obtained in medium E from the 
activity in medium A. Lyophilized platelet homogenate was weighed 
on a Cahn electrobalance and homogenized in double-distilled water 
(10 mg per ml). Aliquots of 10 μΐ homogenate were added to 150 yl 
of the two substrate media at 370C and analysed for total ATPase 
activity (Mg-ATPase and Na-K ATPase) and Mg-ATPase activity. Enzyme 
activity was expressed in moles inorganic phosphate released per 
kg dry weight of platelet material per hour (MKH). 
Θ6 5.2.5. Radioactivity measurements: Rb Influx and efflux 
86 + 
Rb was obtained as an aqueous chloride solution with a specific 
activity of 3-5 mC/mg Rb (Radiochemical Centre, Amersham, England). 
Depending on the preparation, a final activity of 0.5-2.5 pC per ml 
of platelet preparation was used. 
Θ6 
Per ml of unmodified PRP 2.5 ]iC Rb was added. The isotope contai­
ning PRP was incubated at 37° C. At various times, ranging from 0 
to 200 min,one-ml portions of PRP were pipetted into cytocrit tubes 
(chapter 2.3.3.) . Each tube was centrifuged for 15 min at 1500 g 
and the radioactivity of the resulting platelet sediment and super­
natant was determined by counting known amounts of each in Philips 
PW 4138 counting tubes by means of a Philips PW 4251 Counter. 
Correction for trapped plasma between the packed platelets was made 
14 by carrying out parallel experiments in the presence of C-inulin 
86 
as described in 2.3.3. The Rb uptake by the platelets was calculated 
from the tissue/medium ratio (counts per μΐ of platelet volume divi­
ded by counts per yl of plasma) and the plasma potassium concentra-
tion, assuming that at equilibrium the Rb/K ratio does not differ 
between plasma and platelets. Since the ratio between total cell 
volume and cell water volume of the pathological platelets could not 
be determined with sufficient accuracy, tissue ion concentrations 
are expressed hereafter on a total cell volume basis. 
The efflux of rubidium was determined as follows. One volume of 
platelet-rich suspension (5.2.1.) or PRP which had been previously 
incubated for 2 hours at 37° С with 0.5 or 2.5 pC Rb was trans­
ferred into a dialysis bag. The bag, containing the isotope-loaded 
platelet preparation, was dialysed in the first of a series of 
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test tubes each containing 10 volumes of modified Krebs-kmger buffer 
solution (composition in mmol/1: Na 142; К 3; Cl" 118: HC03"23; HPO" 4" 
1.62; Η,ΡΟ." 0.39; glucose 22.2; pH 7.3 - 7.5). Dialysis was performed 
by vertically rotating the tubes at 30 rpm. After t= 3 min, the dialy­
sis bag was transferred to the second tube. Transferring to the third, 
fourth and fifth tube occurred at times 6, 10 and 15 min respectively. 
Thereafter, the dialysis bag was transferred to each following tube 
86 
every 15 minutes. Since diffusion of Rb through the dialysis membrane 
is much faster than through the platelet membrane, the radioactivity 
appearing outside the dialysis bag is, after an initial fast outflow of 
extracellular Rb, determined by the efflux rate through the platelet 
membrane (fig. 13). 
The radioactivity in the dialysate was measured by counting 2-ml 
samples in a PW 4251 Geiger type counter. The activity in the dialysis 
bag at the beginning of the efflux period was calculated by adding 
the total counts in each of the test tubes to the activity in the 
dialysis bag at the end of the experiment. Subtracting the counts in 
test tube 1 from the total activity gave the activity remaining in the 
dialysis bag at the end of the first dialysis period of 3 minutes; 
subtracting the summed counts of test tubes 1 and 2 gave the remaining 
activity after 6 minutes and so on. In this way the activity remaining 
In the dialysis bag after each transfer to the next tube could be cal­
culated and a time-efflux plot could be constructed. 
5.3. RESULTS 
5.3.1. Sodium, potassium and chloride content of plasma and of normal 
and pathological platelets 
Plasma and platelet concentrations of sodium, potassium and chloride 
ions of normal controls and patients are given in tables XIV and XV. 
Both due to the presence of about 20 per cent plasma between the 
packed platelets and to the high content of sodium and chloride in the 
plasma to be corrected for, the values for platelet Na and CI are 
rather inaccurate. This applies especially to the pathological plate­
lets, since these are additionally contaminated by erythrocytes. 
Correction for contaminated erythrocytes was carried out by estimating 
in parallel experiments the haemoglobin content of lysed packed 
platelets (2.3.2.). The values for potassium are more reliable. In 
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TABLE XIV 
Plasma sodium, potassium and chloride concentrations in normal 
controls and patients 
Source of plasma 
Mean value of 11 
normal control 
persons (+ SD) 
Patients II- 5 
IÍI-11 
III-18 
III-22 
III-26 
IV- 1 
Sodium 
mM 
169 + 5 
172 
165 
158 
176 
180 
162 
Potassium 
mM 
3.6 + 0.2 
3.6 
3.6 
3.4 
3.0 
3.8 
3.6 
Chloride 
mM 
79 + 7 
83 
89 
79 
85 
84 
74 
Sodium and potassium were determined by flame photometry. Chloride was 
estimated according to Natelson (1963) . 
general, increased sodium, potassium and chloride values were found 
in the pathological platelets, when calculated on a cell count basis. 
When calculated as mmol per 1.cells, using the platelet volume values 
of 2.4.1., all potassium concentrations are essentially normal. 
Sodium and chloride concentrations in pathological platelets seem to 
fall within the rather wide range of these values in the normal 
controls. 
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TABLE XV 
Sodium, potassium and chloride concentrations in normal and pathological platelets 
Source of 
platelets 
Mean value of 
control persons (+ SD) 
(К and Na: 8 persons; 
Cl : 5 persons) 
Patients II- 5 
III-ll 
III-18 
III-22 
III-26 
IV- 1 
Sodium 
Mmol per mmol per 
10 1 1 cells 1. cells 
35 + 8.5 46 + 11 
74 38 
22 18 
53 41 
60 49 
Potassium 
pmol per mmol per 
10 1 1 cells 1. cells 
76 + 10.5 99 + 14 
142 96 
182 102 
260 112 
128 101 
133 103 
122 100 
Chloride 
ymol per mmol per 
10 1 1 cells 1. cells 
37 + 1 0 48 + 12 
60 41 
105 54 
85 37 
77 62 
55 42 
Sodium and potassium were determined by flame photometry and chloride according to Natelson (1963) 
on the lysates of a known amount of packed platelets. Correction for trapped plasma between the 
packed platelets was carried out by parallel experiments in the presence of 1,C-inulin (2.3.3.) . 
5.3.2. Na-K ATPase activity of normal and pathological platelets 
When the incubation time for the ATPase assay was varied between 15 and 
60 rain, a straight relation between incubation time and product for­
mation was observed both in the control and pathological platelet 
preparations. It is therefore permissible to compare the activity of 
the pathological platelets from the results after 60 min incubation. 
TABLE XVI 
ATPase activities of normal and pathological platelets 
Type of ATPase activity 
Mg + (Na-K)ATPase 
Mg - ATPase 
(Na-K)ATPase 
ibid. in percent 
of Mg + (Na-K)ATPase 
Control platelets 
(3 persons) 
mean 
0.98 
0.81 
0.16 
17 
SD 
0.17 
0.14 
0.05 
4 
Platelets of 
mean 
1.06 
0.98 
0.17 
16 
patient III-18 
SE 
0.10 
0.08 
0.02 
1.2 
ATPase activity is expressed as moles of inorganic phosphate released 
per kg dry weight of platelet lyophilisate per hour (MKH). The 
preparation of the platelets from patient III-18 was analysed 4 times. 
Assay conditions: incubation time 60 min; pH 7.5; temp. 370C. 
The ATPase activities of the pathological platelets of one patient 
showed no differences compared to normal platelets both absolutely and 
relatively. 
The inhibitory effect of ouabain was determined by carrying out a 
series of parallel experiments in which increasing amounts of ouabain 
-8 —3 
(10 to 10 M) had been added to medium A. No significant differences 
between control platelets and the platelets of III-18 were noticed. 
Half-maximum inhibition of the Na-K ATPase occurred in both prepara­
tions at ouabain concentrations of about 5 χ 10 M. Maximal 
inhibition was observed in both cases at an ouabain concentration of 
10"4 M. 
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5.3.3. Rb uptake by normal and pathological platelets 
86 The uptake of Rb by normal and pathological platelets is shown in fig. 
11. The equilibrium concentration of 87.5 mmol/l platelets for normal 
platelets does not differ much from the mean potassium concentration 
of 99 + 14 mmol/l platelets as determined directly in the platelets. 
Since the active Rb-uptake will continue during the centrifugation 
period after the moment of sampling, close attention was given to 
standardization of the procedure. When log (1- [Rb] / [Rb]^) is plotted 
as a function of time (fig. 12), the resulting straight line indicates 
86 that the Rb uptake obeys first-order rate kinetics. 
Fig 
86 
11 
Rb-uptake into normal and pathological platelets. Rb-concentrations 
were calculated from the T/M-ratio's observed and the potassium 
concentration of the plasma 
2 0 0 
sampling t ime (min) 
Assuming that at t=o (l-[Rb]t/ [Rb]^) is unity, it is possible to 
correct for the uptake which takes places during the period of 
centrifugation and separation of platelets from plasma. The half-
time for the active uptake can also be deduced from fig. 12, by taking 
the time at which (l-[Rb] / [Rb]^ )=0.5. This is 33 minutes, equivalent 
-2 -1 
to a rate constant (k) of 2.1 χ 10 min 
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Fig. 12 
86, Demonstration of first-order kinetics for the active Rb-uptake by 
platelets. Use is made of the data of fig. 11 
0.070-
Experiments with the pathological platelets of patients II-5, III-22 
and III-26 showed that the pathological platelets are able to achieve 
a normal cation gradient, which is in agreement with the normal 
intracellular potassium concentration established previously (5.3.1.) . 
The presence of ouabain (5 χ ΙΟ- M) caused a marked inhibition of the 
Rb uptake in normal platelets, lowering the uptake to about 20 percent 
of the control value. 
86 5.3.4. Rb efflux from normal platelet-rich plasma 
First the validity of the dialysis technique had to be established, 
namely whether the dialysis procedure as such would alter the platelets. 
No such changes could be demonstrated, as shown by the equal platelet 
counts before and after "dialysis periods up to 4 hours and by the 
unaltered ability of the platelets to respond on ADP by giving platelet 
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Fig. 13 
86 θ 
Efflux of Rb from platelet-rich plasma (2.7 χ 10 platelets/ml) 
previously incubated for 120 min at 370C with 2.5 yC 8 6Rb per ml PRP. 
20 4 0 βΟ 60 100 120 140 160 
t i m · ( m m ) 
aggregation. 
All efflux experiments were carried out at room temperature (+ 22 0C). 
In fig. 13 the resulting efflux from platelets in PRP as a function of 
86 time is presented. The efflux of Rb from the dialysis bag is bi-
phasic and reveals that the Rb is distributed between two compartments 
presumably corresponding to the extracellular space, which is 
responsible for the initial fast outflow, and the intracellular plate­
let compartment, from which the Rb is released much slower. When the 
radioactivity of the slow efflux component at any time during the first 
50 min is subtracted from that in the whole dialysis bag, then the Rb 
content of the extracellular fast-outflow compartment is obtained. 
Plotting the log of this activity as a function of time (fig. 14), this 
fast outflow again represents a single exponential process with a t, 
of about 5 min. This was in good agreement with the outflow kinetics 
66 
of experiments in which a dialysis bag with Rb (without platelets) 
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Fig. M 
86 Fast efflux of extracellular Rb. Calculated from the data of fig. 13 
percentage fast component 
in dialysis bag 
10O 
•
 e e R b efflux in KRB 
Rb efflux in KRB 
»ouabain ( S x X f ^ M ) 
20 
time (mm) 
was dialysed according to the same procedure. Addition of ouabain had 
no influence on this fast efflux cmmponent. The linearity of the log 
86 
of the Rb concentration as a function of time after 50 min indicates 
that the slow efflux process also obeys first order rate kinetics, at 
the same time indicating that the intracellular Rb-space behaves like 
a single compartment. The average half-efflux time (t·) determined on 
15 experiments with PRP from different normal controls is 98 min, equi­
valent to a mean rate constant of 0.71 (SD 0.11) χ 10 min " 1. 
In the presence of ouabain (5x10 M), the efflux rate constant is 1.08 
(SD 0.26; 10 determinations)xlO min ~ 1, equivalent with a t, of 64 
min. The differences in each experiment between the rate constants 
without and with ouabain are significant, the mean difference being 
55 (SD 18)% (Ρ < 0.01, Student t-test for paired observations). The 
86 degree of uptake of Rb in the platelets can also be calculated by 
analysis of the efflux kinetics. Extrapolation of the slow intracellu-
lar efflux component to t=o reveals the percentage of Rb initially 
present in the platelets. Dividing this percentage by the percentage 
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of Rb which would be present in the platelets under conditions of 
passive distribution of Rb between the extracellular and intracellu­
lar space, reveals a T/M ratio which is indicative of the gradient 
generated during the initial loading period. When this ratio is multi­
plied by the plasma potassium concentration, the Rb accumulation is 
found and should agree with that calculated in 5.3.3., fig. 11. It can 
be seen from fig. 16 that this is indeed the case. 
In cases where the potassium concentration was varied between 0.3 and 
4 mM by dialysing the PRP against potassium-free buffer solutions 
(5.2.1.) , the dependence of the T/M ratio on the plasma potassium 
concentration could be studied. In fig. 15 is shown that at higher 
potassium concentrations the Rb uptake is inhibited, which is under­
standable in view of the competition between potassium and rubidium. 
Inserting the appropriate plasma concentrations in the values for T/M, 
the absolute accumulation of the tissue potassium can be calculated 
(fig. 16) . At 3.5 mM, a level of 95 mmol "tissue potassium"/!· plate­
lets is reached. This value is in good agreement both with the value 
DC 
as determined directly by the Rb-uptake method (5.3.3.) and with the 
potassium concentration in the platelets, which implies that complete 
exchange of potassium for isotope is obtained at equilibrium. 
Fig. 15 Fig.16 
86 + 
Dependence of the Rb accumulation Tissue-K concentration as a function ratio on the plasma-K + concen­
tration 
Ήπ rotto -
of plasma-K + o cen ration, as cal­
culated from the values of fig. 15 
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86 5.3.5. Rb efflux from normal platelet-rich suspensions compared 
to that from platelet-rich plasma 
86 In the initial stages of this study the Rb efflux was studied with 
platelet-rich suspensions (PRS). The higher platelet concentration was 
thought to enable us to carry out the efflux studies more accurately 
66 because of the higher Rb uptake due to the favourable potassium/ 
rubidium ratio. In most of these experiments platelet concentrations 
9 
of 1 à 2 χ 10 platelets/ml were used. 
It appeared, however, that the use of these suspensions had considera­
ble disadvantages in comparison to the use of PRP. A comparison of the 
efflux characteristics for PRS with those for PRP is given in table 
XVII. 
TABLE XVII 
Efflux kinetics of PRP and platelet-rich suspensions (PRS) 
without ouabain 
PRP PRS 
with ouabain (5x10 M) 
PRP PRS 
Half-efflux time (tr, min) 
Efflux rate constant к 
SD 
Number of determinations 
98 
0.71 
0.11 
15 
58 
1.20 
0.29 
15 
64 
1.08 
0.26 
10 
40 
1.73 
0 . 3 0 
11 
-2 -1 Rate constants are expressed as xlO min 
It is apparent that both with and without ouabain the efflux rate 
constants of PRP are considerably smaller than those of PRS. The 
mean T/M ratio of 29 calculated from the efflux kinetics with PRS is 
comparable to a T/M ratio obtained in PRP with a plasma potassium 
concentration of about 2.5 mM (fig. 15). However, it should be noted 
that the platelets in PRS had been suspended in potassium-free buffer 
86 (5.2.1.), hence a higher accumulation of Rb ought to be possible. 
86 5.3.6. Rb efflux from the pathological platelets 
An example of an efflux experiment with the pathological platelets 
of patient III-18 is given in fig. 17. Distinct differences in efflux 
properties are apparent. The efflux rate constant is decreased by 
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7 
86 
of Rb from platelet-rich plasma of patient 111-18 and from 
1 platelets. Ouabain increased the efflux rate from control 
ets, but not from the platelets of patient III-18 
ι ι ι ι ι ι ι ι ' 
2 0 4 0 6 0 BO 100 120 140 160 
t i m e (min) 
han 50% (t, twice normal) and no ouabain effect is observed. 
periments carried out with the pathological platelets are listed 
le XVIII. In each patient a considerably lowered efflux rate of 
-4 
as observed. Addition of ouabain (5 χ 10 M) had no or weak 
nee on the efflux rate constant in patients III-ll, III-18 and 
Relative ouabain effects, comparable to those obtained in 
1 platelets were found with the platelets of patients II-5, 
and III-26, although in neither of these latter patients the 
onstants reached control values. 
M values, calculated from the exponential efflux component extra-
d to t=o, are shown in fig. 15. No differences with control 
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platelets were observed, the same being the case with the Rb-uptake 
determinations carried out with the direct method (fig. 11). 
TABLE XVIII 
86 Rate constants of Rb efflux from normal and pathological platelets 
Source of 
platelets 
Normal controls 
Patient II- 5 
III-ll 
III-18 
III-22 
III-26 
IV- 1 
Efflux rate constant 
χ IO - 2 min - 1 at 220C 
without ouabain 
0.71 
0.24 
0.38/0.37 
0.28/0.26/0.27 
0.36 
0.32 
0.38 
with ouabain 
1.08 
0.31 
0.38 
0.28/0.26/0.27 
0.69 
0.44 
0.40 
Percentage increase 
of к after 
ouabain addition 
55 
29 
0 
0 
48 
36 
5 
Replicate results of determinations on patients are shown. All deter­
minations on the patients' platelets were carried out with the normally 
occurring plasma potassium concentrations except for the second and 
third values reported for patient III-18 (0.65 and 0.36 mM К respec­
tively) . 
5.4. DISCUSSION 
5.4.1. Sodium and potassium aoncentratiOns and Na-K ATPase activity 
of normal platelets 
Considerable variation is noticed between the data of normal platelet 
sodium and potassium concentrations, reported by various workers. This 
is due to the difficulties encountered in keeping platelets intact 
during isolation and concentration procedures. Drastic treatments in 
order to remove the last traces of trapped plasma from between the 
platelets, will cause platelet damage, resulting in loss of potassium 
and gain of sodium. Normal potassium values reported in the literature 
vary from 69 (Hartmann et al., 1958) to 95 mmol/1. platelets (Cooley 
& Cohen, 1967), our values being 99 mmol/l. platelets. Concentrations 
expressed on platelet cell water volume basis are subject to even 
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larger variations, due to difficulties encountered in determining 
platelet cell water content. 
Reported normal sodium values vary from 13 (Aledort et al., 1968) to 
47 mmol/l. platelets (Hess & Mohler, 1968), our values being 46 mmol/1. 
platelets. The uncertainty in the normal cation levels is illustrated 
by the report of Aledort et al., who state that their potassium values 
of 135 mnol/l. platelet water are consistent with the values published 
by Hartman «t al. of 86 mmol/l. plateletvater (Hartman et al., 1958). 
Our normal platelet Na-K ATPase activity of 0.16 MKH (17* of the total 
ATPase activity) compares with the value of 0.21 MKH (23% of the total 
ATPase activity) reported by Moake et al. (1970). Aledort et al. (1968) 
reported a platelet Na-K ATPase activity of only 0.04 MKH (24% of total 
ATPase activity). The value for half-maximum inhibition with ouabain 
concentrations of 5 χ 10 M is of the same order as the value of 
1.5 χ 10~ 7 M, reported by Moake et al. (1970) 
5.4.2. Membrane potential of normal platelets 
The cell membrane considered as being highly permeable to chloride ions 
will allow these ions to be passively distributed between the intra-and 
extracellular space. The distribution ratio will be determined by the 
membrane potential. Insertion of the observed chloride concentrations 
in the Nernst equation: 
R T
 [«"] inside 
E = In 
n F
 [ C 1 1 outside 
{Щ; = - 25.4 mV at 220C) 
nF 
predicts a membrane potential of- 12.5 mV. A small correction towards 
a less negative potential difference would arise when [cl-]^ had been 
expressed in mmol/l. platelet water instead of mmol/l. platelets, used 
in this study. Assuming platelet cell water content of about 80% (ν/ν), 
the membrane potential would be -10 mV instead of -12.5 mV. Only one 
report of the platelet chloride distribution could be found (Cotlove, 
1963), giving a CI./CI ratio of 0.69, equivalent to a calculated mem­
brane potential of -9.5 mV. This is quite consistent with our value 
for the Cl./Cl ratio. The calculated platelet membrane potential of 
-10 mV is of the same order as that of erythrocytes which have a mem­
brane potential of also about -10 mV, either calculated from their 
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Chloride distribution or determined directly (Jay & Burton, 1969; 
Cotterell & Whittam, 1970) . 
86 5.4.3. Rb uptake of normal platelets 
Θ6 Our Rb uptake studies of normal platelets, either determined directly 
or by analysis of the efflux kinetics of platelets in PRP, indicate 
86 that at equilibrium complete exchange of potassium for Rb can be 
obtained. This could be concluded from the agreement between the 
calculated and determined rubidium and potassium concentrations. 
86 
The lowering of the Rb influx into platelets by ouabain (fig. 11) 
is understandable in view of the inhibitory effect of ouabain on the 
Na-K ATPase activity. Surprising however is the finding that in spite 
of totally inhibiting the Na-K ATPase with the concentration of ' 
-4 
ouabain used (5 χ 10 Μ ) , the platelets are still able to accumulate 
rubidium against a concentration gradient. A possible explanation 
might be that due to the existing morphological cavities and tubules 
(surface connected tubular system) in the platelets, a certain degree 
of sterical hindrance prevents ouabain from fully inhibiting the Na-K 
ATPase at these more or less hidden membrane sites. In this connection 
it has to be emphasized that the in-vitro inhibitory action of ouabain 
is determined in homogenized membrane preparations under ideal "inside 
out" ionic conditions. 
86 5.4.4. Passive Rb efflux from normal platelets in PRP 
-2 -1 Our efflux studies reveal an efflux rate constant k= 0.71 χ 10 min 
for normal platelets in PRP. Assuming that the efflux can be calculated 
according to 
Efflux= к χ ([Κ +] 1 - [K
+] 0), this gives an efflux of 40 
mmol potassium/1, platelets per hour from platelets in PRP. 
86 The considerable increase of the passive Rb efflux from platelets by 
ouabain (figs. 13 and 17) is rather unexpected. Since the efflux experi­
ments were carried out in a potassium-containing medium (5.2.4.)- the 
effect of back pumping of leaked-out isotope can be expected to be 
neglected in view of the dilution with non-labelled potassium as soon 
as the leaked-out isotope has entered the extracellular space. A pos­
sible influence of ouabain on the membrane potential cannot be ruled 
out. After Kimizuka t Koketsu (1964), the efflux rate constant is 
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related to the membrane potential according to the equation: 
, FE/2 RT 
where P„ is the potassium permeability constant, E the platelet mem-
brane potential and A/V the surface to volume ratio of the cells. 
Assuming that ouabain has no effect on the membrane permeability 
(Ussing, 1960) and the A/V ratio, it can be calculated that a change 
-2 -1 in the rate constant к from 0.71 to 1.08 χ 10 min would cause 
the membrane potential to become + 8.5 mV, the interior of the 
platelet being positive. Thus the change observed in efflux rate 
constant is much larger than can be explained by a mere effect of 
ouabain on the membrane potential. Moreover, when ouabain is indeed 
subject to sterical hindrance which prevents it from being fully 
active (5.4.3.) , then it may be expected that the membrane potential 
has not been fully abolished in the presence of ouabain. 
An alternative explanation would be yet to assume a certain degree 
of back pumping which will occur in the absence of ouabain. This 
explanation requires that the leaked-out isotope is not diluted as 
much with non-labelled potassium as assumed earlier in this section. 
This could be caused by the existence of a so-called "unstirred layer" 
surrounding the cells. In the region of this layer leaked-out isotope 
can accumulate more easily without being immediately diluted with 
potassium, giving rise to back pumping into the cell. In the presence 
of ouabain this back pumping would be inhibited, resulting in the 
-2 -1 increase observed for к --, from 0.71 to 1.08 χ 10 min 
5.4.5. Comparison of ΡRS and PHP 
Comparison of the efflux kinetics of concentrated platelet suspensions 
(PRS) with platelet-rich plasma (PRP) reveals that the rate constant 
к for the efflux from platelets in PRS is much larger than for plate­
lets in PRP (1.20 versus 0.71 χ IO - 2 min" 1). 
86 The mean T/M ratio of Rb of platelets in PRS after incubation for 
120 min at 370C was 29. This value is equivalent to the T/M ratio 
obtained in PRP with a plasma potassium concentration of about 2.5 mM 
(fig. 15). Since the concentrated platelets had been suspended in 
potassium-free buffer (5.2.1.), the expected T/M ratio has to be in 
the order of 100. This means that the platelets must have lost a 
part of their intracellular potassium during the washing and centri-
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fugation procedures o/ that they have been damaged, making them 
unable to generate the cation gradients needed for normal cellular 
metabolism. Possibly both events occur, since the highest concen­
tration of platelets used (2 χ 10 platelets/ml K-free KRB buffer) 
can only account for an extracellular potassium concentration of 
about 1.5 mM in case all intracellulax potassium would have been lost. 
The high standard deviation of the rate constant for the efflux from 
PRS (0.29 compared to 0.11 for PRP) and of the calculated mean T/M 
ratio (29 + 11) of PRS are also consistent with the occurrence of 
platelet damage during preparation of t' ~ PRS. 
All these findings indicate that plate1 ts in PRS are highly inferior 
to platelets in PRP. 
Assuming a Q 1 0 of 2 for the Na-K ATPase enzyme system (Bonting et al., 
1963; Bakkeren & Bonting, 1968), our influx and efflux studies can be 
related to each other. This means that for the rate constant of the 
—2 —l 
Rb influx into normal platelets a value of 0.74 χ 10 min at 
220C can be calculated. Comparison of this value with the rate constant 
-2 -1 for the Rb efflux fron normal PRP (0.71 χ 10 min ) reveals a 
close agreement between the two values. This means that the platelets 
under the circumstances used in this study are in reasonably good 
condition, showing ю ret efflax of rubidium. This finding contrasts 
with tue net efflax of potassium from blood platelets suspended in 
auiologous plasma of about 6 mmol K/l. platelets/hr, reported by 
Coolrv & Cohn (1967) . Since these workers carried out their experi­
ments with concentrated piatele^ suspensions, this demonstrates once 
more that centrlfugation and washing of platelets are very deleterious 
ti^  blood platelet». 
5.4.6. Findings in the pathological platelets 
lie sodium and potassium concentration in the pathological platelets 
n e hi^ /i when expressed on a platelet count basis but become normal 
when expressed as mmol/1. platelets. This is consistent with the 
normal Na-K ATPase activity observed in the platelet preparations 
of patient ΙΙΙ-1Θ and with the ability of the pathological platelets 
to generate normal cation gradients, shown in the Rb uptake studies 
oc 
(figs.11, 15 and 16). However, the efflux of Rb from the patholo­
gical platelets appeared to be considerably lower than that from 
control platelets (table XVIII). 
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As already stated (5.4.4.), the efflux rate constant can be expressed 
as 
FE/2RT 
k
 -
 PK $ e 
Before we can conclude that the pathological platelets have an altered 
potassium permeability constant, it has first to be established that 
the other factors which are of influence on к are not abnormal in the 
platelets. From our observations on the chloride distribution it is 
not likely that the membrane potential E of the pathological platelets 
is different from normal control platelets. 
Due to the existing tubular cavities in the disc-shaped blood platelets, 
the true surface to volume ratio (A/V) is difficult to determine. Sim­
plified calculations, assuming the blood platelets to be spherical 
yield an A/V ratio of 2.44 μ for normal platelets, with a platelet 
volume of 7.7 fl. In table XIX we list the calculated A/V ratio's 
for the pathological platelets and the consequences for the efflux 
rate constants in the patients studied. 
TABLE XIX 
Calculation of the possible change in к
 f f · . resulting from altered 
A/V ratio's in the pathological platelet!. 
A'/V 
*'^normal - A'/V· χ V/A 
k' 
observed 
к -к' 
normal _
 χ 1 0 0 1 
к -к 
normal observed 
II-5 
1.97 
0.B1 
0.57 
0.24 
30 
III-ll 
1.8S 
0.76 
0.54 
0.38 
52 
Patients 
III-18 
1.69 
0.69 
0.49 
0.27 
50 
III-22 
2.08 
0.85 
0.60 
0.36 
31 
III-26 
2.05 
0.84 
0.60 
0.32 
28 
IV-1 
2.10 
0.86 
0.61 
0.38 
30 
The normal values used are: V/A = 4.10 μ and kffi = 0.71 χ 10 min-* 
The prime indicates new values due to the changes in A/V 
It is shown that the observed changes in к
 f f l cannot be accounted 
for by the change in A/V of the pathological platelets. At best it can 
explain only half of the changes in IK. ... really observed. Although 
indicative for the assumption that indeed the potassium permeability 
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constant (P„) is changed in the pathological platelets, it has to be 
emphasized that no absolute evidence can be derived from the calcula­
tions above, since these are based on the assumption that the platelets 
are spherical. 
There is electronmicroscopical evidence for an increase of the surface 
connected tubular system in the platelets of patients III-ll and IV-1 
(Vosser. et al., 1968; Kurstjens, 1969). This will give rise to an 
increase in surface area without an increase in cell volume, resulting 
in A/V ratio's which are less different from the normal ones as in the 
case that both cell types were spherical. This makes the discrepancy 
between the rate constants of normal and pathological platelets more 
outspoken. 
A further difference with normal platelets is related to the absence 
of an efflux-increasing ouabain effect in the patients III-ll, III-18 
and IV-1, whereas patients II-5, III-22 and III-26 showed relative 
efflux-increasing ouabain effects comparable to those observed in 
control platelets (table XVIII). In view of the earlier (5.4.4.) 
explanation proposed for the efflux-increasing effect of ouabain in 
normal platelets, it can be postulated that due to the increase of the 
surface-connected tubular system the effective surface area available 
for ouabain action is decreased. This is the case when ouabain is 
assumed to diffuse more difficultly into the existing narrow tubules 
(see also 5.4.3.) . The back pumping of leaked-out isotope which occurs 
in these cavities will not be affected by ouabain, thus resulting both 
with and without ouabain in equal or nearly equal efflux rates. 
The finding of an efflux-increasing ouabain effect in patients II-5, 
III-22 and III-26 might imply that transition states of these morpho­
logical differences in the pathological platelets exist. 
5.4.7. Summary and conclusions 
Θ6 The Rb influx and efflux studies of normal blood platelets revealed 
that, under the conditions used in this study, the platelets in PRP 
show comparable rate constants for influx and efflux. This suggests 
that the system is in a steady state without net loss of potassium 
taking place. The k
e f f l u x in P
RS was much larger than that in PRP. 
Together with the much lower accumulation of isotope in PRS, this indi­
cates a qualitative superiority of the platelets in PRP over platelets 
in PRS. 
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The platelet membrane potential calculated from the chloride distri-
bution ratio appeared to be about equal to that for erythrocytes. 
The platelets from patients with hereditary thrombopathic thrombocyto-
penia have normal cation concentrations and a normal ability to gene-
rate cation concentration gradients. This was consistent with the 
normal Na-K ATPase activity in the platelets of patient III-18. A 
86 
markedly lowered efflux rate of Rb from the pathological platelets 
was found. It was shown that this is most likely caused by a decreased 
permeability of the pathological platelet membrane to potassium ions, 
rather than being due to changes in the surface to volume ratio or the 
platelet membrane potential. 
The absence of an efflux-increasing effect of ouabain in three of the 
patients studied has been explained in terms of an increased content 
of narrow tubular cavities in the membrane of these pathological 
platelets. 
The decreased potassium permeability provides further evidence that 
the haemostatic defect of the platelets is intimately related to a 
disturbed platelet membrane function. 
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6. OSMOTIC LYSIS STUDIES ON PLATELETS 
6.1. INTRODUCTION 
In the preceeding chapters evidence has been presented indicating that 
the platelets from patients with hereditary thrombopathic thrombocyto-
penia are suffering from a disturbed membrane function. In order to 
investigate additional relations between functional and structural 
aspects, the osmotic behaviour of normal and pathological platelets was 
studied. 
The osmotic resistance test consists of exposing cells to media of 
varying hypotonicity and measuring the degree of lysis. 
An "osmotic resistance test" or "osmotic fragility test" is often 
considered to reflect the stress a cell can withstand before it is 
ruptured by exposure to hypotonic conditions. Interpreted in this way, 
the osmotic resistance test would provide information about the mecha-
nical properties of the cell membrane. However, as will be described, 
the results of this test have to be explained in a different way. 
Most information on the osmotic behaviour of cells has been derived 
from studies on erythrocytes because of their easy accessibility 
(Hoffman et al., 1958; Danon, 1961; Mortensen, 1963; Canham & Parkinson, 
1970) . However, since the basic mechanisms underlying the response of 
cells to hypotonic environments are the same for different cell types, 
we may apply these findings to platelets, which, in addition, have 
similarities in membrane structure as compared to erythrocytes (Cohen 
& Derksen, 1969) . 
In the physiological situation, the balance of water and electrolytes 
entering and leaving the cell is in equilibrium. When the cells are 
subjected to a hypotonic environment, the tendency to restore this 
equilibrium primarily leads to a water flux from the extracellular 
space into the cells and consequently gives rise to swelling of the 
cells. 
Swelling can occur since under normal conditions the surface to volume 
ratio (A/V) is larger than its minimal value. The area of the cell 
membrane essentially being constant (Burton, 1969), swelling will 
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continue as long as the A/V ratio has not reached its minimal value. 
Under conditions of slow controlled osmotic lysis, the red cell, when 
reaching its minimal A/V ratio, remains spherical for a period of time 
before rupture. This observation has led to the false interpretation 
that the cell membrane has enough strength to withstand the osmotic 
tension for a while before it ruptures. The refractory spherical period, 
howevtr, is accompanied by a pre-lytic leakage of potassium in particu-
lar from the cell to the medium (Jacobs & Parpart, 1933; Canham & 
Parkinson, 1970) In this manner the cell is able to adapt itself for 
a while to the disturbed xonic equilibrium. The mechanical properties 
of the red cell membrane were determined by Rand (1964) . He concluded 
that the cell membrane in general has no great capacity to withstand 
an appreciable tension. In the latter sense the "osmotic resistance 
test" is a measure of the degree of swelling which a population of 
cells can tolerate without undergoing lysis, which is almost exclusi-
vely dependent on cell geometry, rather than being a measure of mem-
brane strength. Paraphrasing, the osmotic resistance test reveals the 
degree of variation in the normally occurring A/V ratio's of the 
total cell population. Therefore, this test can add to our knowledge 
of possible alterations in the pathological platelets with respect to 
the surface properties. 
6.2. TEST PRINCIPLES 
Determination of the osmotic resistance is nearly always based on the 
measurement of a substance which is released as soon as the cell is 
ruptured. The red cell is endowed with an excellent indicator for 
lysis; released haemoglobin can easily be measured by its spectral 
absorbance at 540 nm. Determination of platelet lysis is less easy, 
since they occur in much lower concentration in the blood (about one 
platelet per 20 red cells) and since an obvious parameter for lysis 
is lacking. Several methods have been proposed to solve these two 
problems. Most of the methods work with concentrated platelet sus-
pensions. Various reports in the literature (chapter 2.1.) as well 
as our own work (chapter 5.4.) indicate that one has to be very 
cautious with the results from these preparations, since these plate-
lets may be damaged with respect to their metabolism or to their 
membrane properties. Moreover, the concentration procedure by itself 
quite often induces release of substance which are later to be measured 
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as indicator for platelet lysis. 
Turbidimetric methods are based on the observation that lysed platelets 
("ghosts") show a larger light transmission than intact platelets. A 
complication arises from the fact that swelling of the platelets, 
however, causes a decrease in transmission. Turbidimetric methods were 
used by Baserga & Ballerini (1957) and by Rogner (1963). The results 
of their studies show considerable variation between normal platelet 
preparations. 
The release of material with clot-promoting activity as an indicator for 
lysis was used by Ulutin a Karaca (1959) and by Friedman et al. (1960). 
Since however, the clot-promoting activity may originate from intracel­
lular granular material as well as from membrane fragments and non-
sedimented platelets it is difficult to decide to which extent each of 
these activities contribute to the activity observed. 
Methods which are based on the release of cytoplasmatic enzymes (pyro­
phosphatase, Nelken et al., 1960) and of serotonin (Gurevitsch & Nelken, 
1956) have also been reported. 
Our method to measure platelet osmotic resistance is an extension of 
86 
the technique used to determine the passive efflux of Rb from plate­
lets (chapter 5). Use of this radioactive ion to determine lysis requi­
res relatively small numbers of platelets in their own plasma environ­
ment. In this way part of the drawbacks mentioned above are eliminated. 
6.3. MATERIALS AND METHODS 
86 Platelet-rich plasma was incubated with 2.5 pC Rb per ml plasma at 
37 С as described in 5.2.5. The same dialysis procedure was carried 
out for up to 60 min. Thereafter the dialysis bag was transferred 
every 5 min to another tube of a series containing as the dialysis 
medium NaCl solutions of decreasing tonicity buffered with 10 mM Tris-
HC1 (pH 7.4) and supplemented with 0.2% glucose. The NaCl concentration 
was lowered after every second tube, until the last four tubes contain­
ed only distilled water. During dialysis the tonicity of the plasma 
decreases in relation to the tonicity of the bathing solution and of 
of the time of incubation. The following relationship was obtained: 
time (min) 0-60 70 80 90 100 110 120 130 140 150 
tonicity of medium (mosM) 290 245 190 150 100 90 50 20 0 0 
tonicity of plasma (mosM) 290 268 224 188 146 122 78 47 34 30 
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86 Due to lysis of the platelets more and more Rb Is released during 
this procedure and this activity is found in the dialysis medium. 
Since the outflow of radioactivity from the dialysis bag into the me­
dium is subject to a half-outflow time of 5 min (5.3.4.), the total 
radioactivity found in a particular dialysis medium, after transfer 
of the bag to a following tube, will reveal somewhat less lysis than 
really occurs. However, under standardized conditions parallel obser­
vations of different platelet samples may reveal differences in osmo­
tic behaviour, if occurring. 
86 A parallel determination of the passive efflux of Rb, occurring 
under isotonic conditions, was carried out for each platelet sample 
by the procedure described in 5.2.5. (control efflux). 
Radioactivity was measured as described in 5.2.5. Tonicities of the 
bathing solutions and plasma were estimated in parallel determinations 
by measuring the osmolality of 2-ml aliquots in an osmometer (Scien-
'tif ic Instruments) . 
Fig 
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18 
Rb efflux from normal platelet-rich plasma under isotonic conditions 
(upper curve) and under conditions of gradually decreasing tonicity of 
the dialysis medium (lower curve). Plasma tonicities are shown at the 
time at which these tonicities are reached. 
percentage radioactivity 
remaining In dialysis bag 
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6.4. RESULTS 
The results of a lysis experiment in comparison with the control 
efflux are given in fig. 18. Evalution of the results was carried out 
by calculating at various times (plasma tonicities) the difference 
86 
between the percentages Rb present in the dialysis bag of the lysis-
experiment and that present in the bag of the control-efflux-experiment. 
86 Taking the controtefflux as 100%, the efflux of Rb resulting from 
lysis can be calculated on a percentage basis. In this way "percentage 
lysis" may be calculated as a function of plasma tonicity. The results 
with platelets from 5 normal controls are presented in fig. 19. 
Fig. 19 
Osmotic resistance of normal blood platelets, determined by a dialysis 
procedure. Outflow of "(¡Rb during lysis was corrected for the normally 
occurring passive efflux. Tonicities shown on the abscissa are those 
of the plasma in the dialysis bag as determined after various times of 
dialysis against hypotonic bathing solutions. Average results for 
platelets from 5 different normal controls (+ SD). 
percentage lysis 
320 гткмМ 
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The effect of constant hypotonlcity on the passive efflux of Rb was 
also studied. In these experiments the normal efflux procedure (5.2.5.) 
under isotonic conditions was carried out for 60 min, followed by 
dialysis in bathing solutions with one particular hypotonic tonicity 
value. Figs. 20 (normal control) and 21 (patient ΙΙΙ-1Θ) reveal that 
during a period of time after which the dialysis medium has been changed 
from an isotonic to a hypotonic one (t= 60 min), an increased outflow 
86 
of Rb occurs. 
Fig. 20 
Rb-efflux from normal platelet-
rich plasma under conditions of 
constant hypotonicity of the 
bathing solutions after t=60 min 
percentage radioactivity 
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This increased outflow is assumed to originate from the fraction of 
platelets which is lysed under these hypotonic conditions. After this 
extra outflow has ceased, the remaining part of the curve follows a 
course almost parallel to the control-efflux at 290 mosM. This finding 
proves the existence of a passive efflux under hypotonic conditions 
which is about equal to the efflux rate at 290 mosM. Since the same 
holds true for the platelets of patient III-18 (fig. 21), this 
strongly suggests that it is permissable to compare the pathological 
platelets with normal platelets by use of the osmotic lysis technique 
described here. The finding that the percentage of radioactivity 
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remaining in the pathological platelets of patient III-18 (fig. 21) 
is about twice as large as in the control platelets (fig. 20) is in 
accordance with the data presented in chapter 5. 
The percentage of lysis of the pathological platelets as a function 
of gradually decreasing plasma tonicity is given in tabel XX. 
TABLE XX 
Percentage lysis at various plasma tonicities of normal and pathologi­
cal platelets 
Plasma 
tonicities 
(mosM) 
290 
268 
260 
241 
224 
206 
188 
165 
146 
133 
122 
96 
78 
61 
47 
32 
5 normal 
mean 
0 
2.9 
4.8 
6.2 
7.8 
10.9 
15.0 
20.3 
27.4 
35.4 
46.0 
57.2 
67.4 
74.1 
78.5 
81.9 
controls 
SD 
0 
1.9 
1.8 
1.8 
1.7 
1.3 
0.9 
1.3 
2.6 
3.5 
4.1 
4.2 
6.4 
4.9 
5.7 
4.4 
Patients 
III-ll 
0 
0.7 
0.9 
2.1 
3.7 
5.2 
9.7 
15.5 
25.5 
34.0 
45.5 
59.0 
70.5 
78.0 
83.0 
85.0 
III-13 III-18 IV-1 
0 0 
1.6 0.7 
2.1 1.1 
2.9 1.8 
4.4 3.2 
7.7 6.4 
12.6 10.9 
16.4 17.8 
24.2 26.2 
35.2 37.8 
46.4 49.6 
57.2 62.5 
67.4 72.5 
76.0 79.0 
78.9 83.3 
81.2 85.9 
0 
1.0 
1.1 
1.2 
1.8 
1.9 
5.4 
11.0 
20.0 
34.0 
50.0 
59.0 
74.0 
82.0 
86.0 
88.0 
P-value 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
-
-
-
-
-
-
-
-
All values expressed as percentage lysis. Meaning of the symbols in 
column "P-value" + +: Ρ ^0.02 and -: Ρ > 0.10 (two sample test of 
Wilcoxon). 
It is apparent from the results with the pathological platelets that 
during the initial moderate hypotonic stages significantly less 8 6Rb 
is released as compared to normal control platelets. At plasma tonici­
ties below 150 mosM (+ 25% lysis) there is no longer a difference 
between the pathological platelets and the normal control platelets. 
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6.5. DISCUSSION 
In comparing the earlier techniques for the determination of platelet 
osmotic resistance with out dialysis technique, it is to be noted that 
for platelets from 5 normal controls a time-lysis curve with a rather 
small standard deviation is obtained (fig. 19) . Apart from showing that 
normal platelets from different donors do not differ much in osmotic 
behaviour, this demonstrates the reliability of the method. In addition, 
it is apparent that this method represents a suitable tool for recog-
nizing deviations from the normal lysis pattern. Analysis of the form 
of the curve reveals that already in moderately hypotonic environments 
part of the platelets ruptures. In this respect platelets are different 
from erythrocytes, since erythrocytes show no appreciable lysis until 
tonicities of about 180 mosM are reached,giving rise to a much steeper 
sigmoidal lysis curve than platelets do. As can be seen from fig. 19, 
"100% lysis" was never obtained. This may be explained by the observa-
tion that in the dialysis bag the tonicity never falls below 30 mosM., 
in spite of a four times refreshed dialysis medium of distilled water. 
Most likely this is caused by the presence of proteins both from plasma 
and from lysed platelets, which cannot pass through the dialysis mem-
brane. The presence of radio-isotope within the dialysis bag also 
during the last stages of the dialysis procedure may then be explained 
either by Donnan type of equilibria or by binding of small amounts of 
isotope to the non-dialyzable proteins. 
The obvious advantage of the sensitive and reproducable technique des-
cribed here is the use of relatively small amounts of platelets in 
their own plasma environment, obtainable by a very mild procedure. 
However, some disadvantages also should be mentioned. It is a rather 
laborious and time-consuming method, only feasible in laboratories 
equipped to 1andle radio-active substances. In addition, no exact 
lysis-tonicity relationship can be obtained, since the half-outflow 
time of the dialysis membrane of 5 min prevents taking "snapshots" 
of this relationship. Fortunately, this does not prevent comparative 
experiments, if they are carried out under standardized conditions. 
As shown in table XX, it was possible to demonstrate that part of the 
pathological platelets had a higher "osmotic resistance" as compared to 
normal platelets. In 6.1. we showed that the osmotic resistance test 
is a measure for the degree of variation in the surface to volume ratio 
rather than being a measure for the mechanical strength of the cell 
-96-
membranes. Those platelets rupturing first when submitted to hypotonic 
environments are nearest to their minimal A/V ratio. Since In this 
region the lysis pattern of the pathological platelets la shifted 
towards more "resistant", this implies that the pathological platelets 
are more remote from their minimal surface to volume ratio. This 
explanation is in good agreement with the suggestion (5.4.6.) that at 
least in some of the patients the platelets have an increased surface-
connected tubular system. Further electron microscopic evaluation of 
this point might be in order. 
Θ6 In our discussion of the Rb-efflux from the pathological platelets it 
has been suggested that transition states may exist in the severity of 
the platelet defect with respect to the ouabain effect on the efflux 
rate. The same seems to hold true for the observations of the osmotic 
resistance of these pathological platelets, since the percentages 
lysis observed for patient III-13 were intermediate between the normal 
values and the values of the three other patients studied. Unfortunate­
ly and unintentionally, only those patients in which no efflux-increa­
sing ouabain effect was observed were studied for the osmotic behaviour 
of their platelets. Since a relationship between both phenomena seems 
possible,additional studies are indicated. It is expected that the 
platelets of patient III-13 will show an efflux-increasing ouabain 
effect as was observed for patients II-5, III-22 and III-26. 
In summary, we have presented additional evidence for the existence 
of morphological changes in the pathological platelets. These changes 
are believed to influence the altered passive efflux behaviour in the 
presence of ouabain (5.4.6.). 
It is tempting to suggest that the existing qualitative platelet defect 
is not only due to the differences in membrane properties but also that 
the Increase of surface-connected tubules results in a lower accessibi­
lity of membrane sites which are normally involved in triggering the 
physiological platelet release reaction. \ 
\ 
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GENERAL SUMMARY 
The functional platelet defects which exist in patients with hereditary 
thrombopathic thrombocytopenia have been characterized earlier by 
clinical evaluation, by routine haematological screening tests (prolong­
ed bleeding time and disturbed prothrombin consumption in combination 
with a normal plasma clotting ability; Kurstjens et al., 1968), by more 
specific physiological platelet tests (no aggregation under the influ­
ence of collagen, disturbed thromboplastin generation and decreased 
platelet factor-3 availability; Kurstjens et al., 1968; Kurstjens, 1969) 
and by electronmicroscopic studies (Vossen et al., 1968;KurstJens,1969). 
The studies in this thesis deal with the biochemical factors underlying 
the disturbed platelet function in this bleeding disorder. 
In chapter-Ί a survey of the current views regarding the role of blood 
platelets in haemostasis is given. Then a brief description is given of 
the several distinguishible stages of platelet function in haemostasis: 
platelet adhesion, platelet aggregation, platelet fusion and release, 
followed by fibrin formation and the contribution in clot retraction. 
The clot-promoting activity of platelet lipids, which has received 
considerable attention, is discussed. In-vitro experiments have shown 
that excellent correlation exists between clot-promoting activity and 
net surface charge of the lipid mixtures tested. However in the 
physiological situation the activating sites appear to be masked, 
while on the other hand when these sites are made available by washing 
and centrifugation of platelets, it appears that the activating 
capacity exceeds the activity of comparable amounts of isolated phos­
pholipids several times. 
Finally, the first chapter describes the definition of thrombocytopa-
thies. It appears that familial thrombopathic thrombocytopenia has 
much in common with other platelet disorders, but on genetical and 
morphological grounds this type of disease must be considered as a 
distinct entity. 
Chapter 2 opens with a review of the literature regarding the 
metabolism of normal and pathological platelets. After a survey of the 
clinical data from previous studies on these patients, the results of 
studies of the glycolytic enzyme pattern, the content of energy-rich 
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phosphates, the lactate production and oxygen consumption of the 
pathological platelets are presented. When related to the increased 
cell volume normal enzyme activities were found in general. The lactate 
production and the content of adenine nucleotides were also normal. 
The oxygen consumption of these platelets was decreased to half the 
normal value. The distribution of the hexokinase activity between 
the soluble and particulate fraction after collagen-treatment appeared 
to be altered (patient 111-18). The abnormal results could be explained 
by a possible disturbance of the membrane function in these pathologi-
cal platelets. This conclusion would agree with the disturbance observ-
ed in the platelet aggregation under the influence of collagen, which 
is dependent on the release of endogenous ADP. 
Since possible changes in membrane structure can be caused by altera-
tions in lipid composition, chapter 3 describes the results of studies 
of the lipid composition of the pathological platelets. After correc-
tion for the increased platelet volume, no changes in the content of 
total lipids, phospholipids and cholesterol were found. Only slight 
changes in phospholipid composition were observed. The contents of 
phosphatidylethanolamine and phosphatidylserine were decreased and the 
diphosphatidylglycerol and phosphatidic acid contents were increased. 
The fatty acid composition of the total lipid fraction revealed 
distinct changes. The decrease of arachidonic acid and the increase of 
the stearic acid content, resulting in an elevated molar ratio of 
saturated to unsaturated fatty acids is explained in terms of a transi-
tion of a dynamic membrane type to a more stable kind of membrane. 
Investigations of possible correlations between the altered phospholi-
pid composition and the decreased clot-promoting activity of the 
pathological platelets and the possible consequences for the negative 
surface charge of the pathological platelet lipids are described in 
chapter 4. 
Following the routine washings, the pathological platelets showed a 
marked decrease of thromboplastic activity as compared to normal 
platelets. However, the activity was normalized upon treatment of the 
platelets with distilled water. Lipids, extracted from the pathological 
platelets, also showed normal clot-promoting activity, though slightly 
more lipid was needed for this. Micro-electrophoresis of platelets and 
platelet lipids revealed no alterations in surface charge in the 
pathological condition. The slightly altered phospholipid composition 
thus cannot explain the pathological behaviour. The disturbed thrombo-
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plastin generation by intact pathological platelets is explained by 
the more stable membrane structure, requiring higher destructive 
forces for maximal exposure of the active thromboplastic membrane 
sites. The observed alterations in fatty acid composition are consis­
tent with this view. 
Chapter 5 describes the study of some important parameters of membrane 
function. Intra- and extracellular contents of sodium, potassium and 
chloride ions were determined. The sodium- potassium activated ATPase 
activity of the platelets from one of the patients was studied. The 
66 
active uptake and passive leakage of the radioisotope Rb was studied. 
Use was made of a dialysis technique, which has so far not been used 
in blood platelet research. It was thus possible to demonstrate that 
platelets which have been enriched by centrifugation and resuspension 
in a small volume of buffer, are functionally defective as compared 
to platelets in platelet-rich plasma. This was shown by the marked 
B6 decrease in Rb-uptake as well as by the increased efflux rate from 
86 the concentrated platelet suspensions. The Rb-uptake could be studied 
both by a direct method and by analysis of the efflux kinetics. It 
appeared that a complete exchange of potassium for rubidium could be 
obtained. 
Ouabain in fully inhibitory concentration did not completely inhibit 
Θ6 the Rb-uptake. This is explained by assuming that ouabain is not 
able to reach the most hidden membrane sites. This receives some 
support from the electronmicroscopic observation of a surface-connected 
tubular system existing in platelets. 
86 Ouabain increased the efflux of Rb from normal blood platelets. This 
cannot be completely explained by its effect on the membrane potential 
which is decreased. It is proposed that the normally existing backpum-
ping of leaked-out isotope is inhibited by ouabain, resulting in a 
higher net efflux. 
The pathological platelets have normal concentration gradients for 
sodium and potassium. This is in agreement with the normal uptake of 
86 
Rb by these platelets, as well as with the normal Na-K ATPase acti­
vity observed in the platelets of patient III-18. However, in all 
86 patients a markedly decreased efflux rate of Rb from the platelets 
was observed. This appears to be due to the decreased permeability of 
the pathological platelet membranes. From the 6 patients studied, three 
86 
showed no increase of Rb-efflux in the presence of ouabain. These 
findings are explained as likely to be related to the increase of the 
surface-connected tubular system in the latter three patients, reducing 
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the effective surface area available for ouabain action. 
In chapter 6 the osmotic behaviour of normal and pathological platelets 
was studied. The "osmotic resistance test", often thought to measure 
the mechanical properties of cell membranes, actually reveals the 
variation in the normally existing surface to volume ratio of the 
various cells of a particular cell population. In this way, studies 
on the pathological platelets are thought to be able to add to our 
information about the postulated morphological alterations in these 
platelets. 
In contrast to red cells, a well-defined procedure for determination of 
platelet osmotic resistance is lacking. A brief survey of the techni-
ques used by various investigators is presented. The technique used in 
this study is a modification of the dialysis technique used for deter-
mining the passive Rb permeability. Outflowing Rb originating from 
lysed platelets, superimposed on the efflux under isotonic conditions, 
is measured. This technique permits the use of relatively small numbers 
of platelets in their own plasma environment. The results obtained 
with this procedure showed to have good reproducibility. The pathologi-
cal blood platelets showed a distinct shift towards more "resistant" 
platelets. This finding is consistent with an increase of the surface-
connected tubular system, which had been suggested earlier by electron-
microscopic observations and also by the results of the efflux ex-
periments in the presence of ouabain. 
In conclusion, the results of our investigations point to the existence 
of an intrinsic membrane defect in the pathological blood platelets. 
The haemostatic function of platelets is intimately related to their 
lability, being able to adhere, to give release and to undergo fusion. 
Apart from the thrombocytopenia, the main cause df the bleeding tenden-
cy in the patients with hereditary thrombopathic thrombocytopenia seems 
to be that the pathological platelet membranes have a less dyneunic 
structure and an increased ratio of membrane surface area to platelet 
volume. Both phenomena are believed to be the cause that the pathologi-
cal platelets require stronger stimulation in order to force them to 
function. However, still more information is required on the origin of 
platelet disorders(Obtained by methods in which the physiological si-
tuation is maintained as far as possible. In this respect the use of 
platelets in platelet-rich plasma, as developed in this study, is to be 
highly preferred over the use of platelets in concentrated suspensions, 
since the latter show distinct functional déficiences. 
-101-
3ΑΜΕΝνΛΤΤΙΝ0 
De funktionele defekten in de bloedplaatjes van patiënten met een fami-
liaire trombopathische trombocytopenie waren reeds eerder gekarakte-
riseerd aan de hand van klinische verschijnselen en met behulp van de 
gebruikelijke hematologische onderzoekmethoden (verlengde bloedings-
tijd en gestoord protrombineverbruik in kombinatie met een normaal 
gehalte aan plasma stollingsfaktoren; Kurstjens et al., 196Θ) . Nadere 
karakterisering vond plaats met meer specifieke fysiologische onder­
zoekmethoden voor bloedplaatjes (afwezige aggregatie onder invloed van 
collageen, verlaagde tromboplastine vorming en gestoorde plaatjes 
faktor-3 "availability"; Kurstjens et al., 1968; Kurstjens, 1969) en 
door middel van elektronenmicroscopische waarnemingen (Vossen et al., 
1968; Kurstjens, 1969). 
In dit proefschrift wordt het onderzoek beschreven dat werd uitgevoerd 
naar de biochemische afwijkingen welke aan deze bloedplaatjesafwi^king 
ten grondslag liggen. 
In hoofdstuk 1 wordt een kort overzicht gegeven van de huidige inzich­
ten omtrent de rol die bloedplaatjes spelen in het hemostatisch proces. 
Vervolgens wordt kort ingegaan op de verschillende te onderscheiden 
fasen van de bijdrage die bloedplaatjes aan het bloedstelpingsproces 
leveren: plaatjesadhesie, plaatjesaggregatie, plaatjesfusie en 
"release", gevolgd door fibrinevorming en de bijdrage aan de stolsel-
retraktie. 
Een belangrijke eigenschap van bloedplaatjes is ook de stollingsak-
tiverende rol van de plaatjeslipiden. In-vitro blijkt er een goede 
correlatie te bestaan tussen stollingsbevorderende kapaciteit en de 
negatieve oppervlaktelading van geteste lipidemengsels. Onder fysiolo­
gische omstandigheden blijkt enerzijds dat deze aktiverende eigenschap­
pen gemaskeerd voorkomen en anderszijds, wanneer ze beschikbaar 
gemaakt zijn door middel van wassen en centrifugeren van de plaatjes, 
dat ze veel aktiever zijn dan vergelijkbare hoeveelheden geïsoleerd 
fosfolipide. 
Tot slot wordt in het eerste hoofdstuk het begrip trombocytopathie om-
schreven. Het blijkt dat de familiaire trombopathische trombocytopenie 
wel overeenkomsten heeft met verschijnselen van andere typen bloed-
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plaatjesafwijkingen, maar dat het op çenetische en morfologische 
gronden als een aparte aandoening moet worden geschouwd. 
In hoofdstuk 2 wordt eerst een literatuuroverzicht gegeven van de be-
staande kennis van het metabolisne van normale en pathologische bloed-
plaatjes. Na een overzicht van de reeds bestaande gegevens betreffende 
de in deze studie te beschrijven patiënten, worden de resultaten gege-
ven van een onderzoek naar de aktiviteiten van hoofdzakelijk glycoly-
tische enzymen, van de gehaltes aan adenine nucleotiden alsmede van 
de laktaatproduktie en het zuurstofverbruik van de pathologische 
bloedplaatjes. Gerelateerd aan het gevonden grotere celvolume werden 
over het algemeen normale enzymaktiviteiten gevonden; bestond er een 
normale laktaatproduktie en was het gehalte aan adenine nucleotiden 
normaal. Het zuurstofverbruik van deze plaatjes bleek, eveneens gere-
lateerd aan het celvolume, slechts de helft van normaal te bedragen. 
De verdeling van de hexokinase aktiviteit over de oplosbare en mem-
braangebonden frakties na behandeling van de plaatjes met collageen 
bleek gestoord (patient III-18). De afwijkende resultaten worden in 
verband gebracht met een mogelijk defekt in de bloedplaatjesmembraan. 
Deze stoornis zou dan tevens ten grondslag liggen aan de gestoorde 
aggregatie onder invloed van collageen, die namelijk berust op het 
vrijkomen van endogeen ADP, 
Daar mogelijke veranderingen in membraanstruktuur veroorzaakt kunnen 
worden door een verandering in lipidesamenstelling, beschrijft hoofd-
stuk 3 het onderzoek naar de lipidesamenstelling van de pathologische 
bloedplaatjes. Gekorrigeerd voor het grotere plaatjesvolume bevatten 
deze plaatjes een normaal totaal lipide, fosfolipide en cholesterolge-
halte. Lichte veranderingen in fosfolipidensamenstelling werden vast-
gesteld, waarbij bleek dat het gehalte aan fosfatidylserine en fosfa-
tidylethanolamine was verlaagd en dat het difosfatidylglycerol en 
fosfatidezuurgehalte was verhoogd. In de vetzuursamenstelling van de 
totaallipide-fraktie bleken de onderzochte patiënten enkele duidelijke 
veranderingen te vertonen. Een duidelijke afname van het arachidonzuur 
en een verhoging van het stearinezuurgehalte, resulterend in een ver-
hoogde verhouding van verzadigde tot onverzadigde vetzuren, wordt 
uitgelegd als mogelijk verband te houden met een overgang van een meer 
dynamisch membraantype naar een meer stabiel type membraan. 
-103-
In hoofdstuk 4 wordt nagegaan of de gevonden veranderingen in fosfo-
lipidensamenstelling mogell]kerwi]s verband houden met zowel een ver-
laagde stollingsbevorderende aktiviteit als een veranderde negatieve 
oppervlaktelading van de uit de pathologische bloedplaat]es geëxtra-
heerde lipiden. Na de normale voorbehandeling met fysiologisch zout 
vertoonden de pathologische bloedplaatjes, vergeleken met normale 
plaatjes, een verlaagde tromboplastische aktiviteit. Gelijke aktiviteit 
kon echter bereikt worden na een lyserende voorbehandeling met gedestil-
leerd water. De uit de plaatjes geëxtraheerde lipiden vertoonden even-
eens een gelijke stollingsbevorderende aktiviteit, maar meer lipide 
materiaal was daarvoor benodigd. Micro-elektroforese van bloedplaatjes 
en lipide dispersies brachten geen afwijkingen in oppervlaktelading 
aan het licht. De licht veranderde fosfolipidensamenstelling is dus 
niet in staat het pathologische gedrag te verklaren. De gestoorde trom-
boplastinevorming van intakte pathologische bloedplaatjes wordt ver-
klaard door een meer rigide plaatjesmembraan welke hogere destruktieve 
behandelingen vereist om de aktieve membraangedeelten beschikbaar te 
doen maken. De gevonden veranderingen in vetzuursamenstelling zijn 
met dit beeld in overeenstemming. 
In hoofdstuk 5 wordt het onderzoek naar enkele belangrijke maatstaven 
voor een goede membraanfunktie beschreven. De intra- en extracellulaire 
natrium, kalium en chloride concentraties werden bepaald. Van de bloed-
plaatjes van een der patiënten werd de Na-K ATPase aktiviteit bepaald. 
86 De aktieve opname en de passieve lek van de radioisotoop Rb werd 
bepaald. Hierbij werd een tot nu toe voor het onderzoek van bloedplaat-
jes onbekende dialysetechniek toegepast. Hiermee was het mogelijk aan 
te tonen dat bloedplaatjes die zich door middel van centrifugeren en 
resuspenderen in een gekoncentreerde suspensie bevinden, in een zeer 
slechte konditie verkeren, vergeleken met plaatjes in plaatjesrijk 
86 plasma. Een verminderde Rb opname en een verhoogde leksnelheid uit 
de plaatjes waren duidelijke indikaties daarvoor. 
86 
De Rb opname in bloedplaatjes kon zowel bestudeerd worden door middel 
van een direkte methode als wel door middel van analyse van de efflux-
kinetiek. Hierbij bleek dat een komplete uitwisseling van kalium tegen 
rubidium mogelijk was. Onder invloed van ouabaine bleek de aktieve 
86 
Rb opname niet geheel geremd te worden. Dit wordt verklaard door aan 
te nemen dat ouabaine niet geheel in staat is alle betrokken membraan 
"sites" te bereiken. Deze opvatting wordt ondersteund door het elek-
tronenmicroscopisch vastgestelde "surface-connected tubular system" in 
bloedplaatjes. 
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De waargenomen verhoogde leksnelheid van Rb uit bloedplaatjes 
onder invloed van ouabaine kan niet geheel verklaard worden door de 
invloed van ouabaine via afname van de membraanpotentiaal. In aanwezig­
heid van ouabaine wordt het onder normale omstandigheden kennelijk aan­
wezige terugpompen van uitgelekt rubidium geremd, resulterend in een 
hogere netto-efflux. 
De pathologische bloedplaatjes bleken normale koncentratiegradienten 
voor natrium en kalium te hebben. Dit werd bevestigd door de vastge-
Θ6 
stelde normale influx van Rb in deze plaatjes, alsmede door de 
normale Na-K ATPase aktiviteit van de bloedplaatjes van een der patiën-
ten die hierop werd onderzocht. Echter werd in alle onderzochte patien-
ten een sterk vertraagde leksnelheid van Rb vastgesteld. Aangetoond 
werd dat dit zonder meer verband houdt met een lagere permeabiliteit 
van de pathologische bloedplaatjesmembraan. Van de bloedplaatjes van 
de zes onderzochte patiënten bleken er drie bloedplaatjes te hebben 
die een efflux-versnellend ouabaine effekt vertonen dat, relatief 
gezien, vergelijkbaar is met dat van normale bloedplaatjes. De bloed-
plaatjes van de andere drie patiënten vertoonden echter geen versnel-
86 de lek van Rb onder invloed van ouabaine. Deze bevinding wordt in 
Verband gebracht met de toename van het "surface-connected tubular 
system", bij de laatst genoemde patiënten, waardoor minder effektief 
membraanoppervlak beschikbaar zou zijn voor de werking van ouabaine. 
In hoofdstuk 6 worden de waarnemingen beschreven verkregen met het 
onderzoek naar het gedrag van bloedplaatjes tijdens osmotische lysis. 
Ten eerste wordt vermeld dat vaak ten onrechte een osmotische "resis-
tentie"test in verband wordt gebracht met de mechanische sterkte van 
de celmembraan. Veel eerder echter brengt deze test de spreiding aan 
het licht in de normaal voorkomende verhoudingen van oppervlakte tot 
volume van de onderzochte cellen. Als zodanig geeft het onderzoek van 
de pathologische bloedplaatjes voornamelijk inlichtingen over het 
bestaan van morfologische veranderingen. 
In tegenstelling tot erytrocyten bestaat er voor de bepaling van de 
osmotische resistentie van bloedplaatjes geen goede en betrouwbare 
methode. 
Na een kort overzicht van in de literatuur beschreven technieken wordt 
een nieuwe techniek beschreven. De methode berust op een modifikatie 
van de dialysetechniek ter bepaling van de passieve membraanpermeabili-
66 telt. Het door lysis veroorzaakte uitstromende Rb, gesuperponeerd op 
de efflux onder isotone omstandigheden, wordt hierbij gemeten. Deze 
-105-
techniek laat toe dat er van relatief weinig bloedplaatjes kan worden 
uitgegaan, die zich bovendien nog in hun eigen plasma milieu bevinden. 
De met deze techniek verkregen resultaten getuigden van een goede re-
produceerbaarheid. Het bleek dat de bloedplaatjes van de onderzochte 
patiënten een duidelijke verschuiving naar verhoogde "resistentie" 
vertoonden. Dit is in overeenstemming met de elektronenmicroscopisch 
al eerder waargenomen en op grond van de efflux experimenten gepostu-
leerde toename van het "surface-connected tubular system" in de patho-
logische bloedplaatjes. 
Samenvattend, wijzen de resultaten van dit onderzoek primair op het 
bestaan van een intrinsiek membraandefekt in de pathologische bloed-
plaatjes . 
De funkties van de bloedplaatjes in het hemostatisch principe blijken 
alle samen te hangen met de labiliteit van deze cellen. Afgezien van 
de bestaande trombocytopenie lijkt de oorzaak voor de bloedingsneiging 
bij deze patiënten gelegen te zijn in het feit dat de pathologische 
bloedplaatjesmembraan een minder dynamische struktuur heeft, alsmede 
dat de verhouding van membraanoppervlak tot celvolume vergroot is. 
Aangenomen wordt dat beide verschijnselen tot gevolg hebben dat de 
pathologische bloedplaatjes een sterkere stimulatie nodig hebben om 
te kunnen funktioneren. 
Ondanks de verworven kennis van de Pathogenese van vele bloedplaatjes-
afwijkingen blijven er nog vele aspekten die nadere bestudering 
vereisen. Het meest belovend zullen die resultaten zijn welke verkregen 
zijn met onderzoekmethoden welke de bloedplaatjes zoveel mogelijk in 
"natieve" toestand laten. In dit verband moet benadrukt worden dat het 
gebruik van bloedplaatjes in plaatjesrijk plasma, zoals in dit onder-
zoek ontwikkeld, in vergelijking met het gebruik van gekoncentreerde 
suspensies van bloedplaatjes in artificiële media verre de voorkeur 
verdient. 
-106-
REFERENCES 
Adam, H. (1961) : NucleotidspezlfitÄt glykolytiecher Kinaeenr enzymatische Bestlramung dee 
AdenylsSuresyeteiu. Blochem. Ζ., 335, 25, 
Adam, Η. (1963) : Adenoilne-S-dlphosphate and adenoBlne-S-monophosphate. In: Methoden der 
enzyraatlachen Алаіуа« (Ed. by H.U,Bergmeyer). Chenle GmbH, Weinhelm, p. 573. 
AledortfL.H.,Troup,S,B. λ Weed,R.I. (1968) ι Inhibition of sulfhydryl-dependent platelet 
functions by penetrating and non-penetrating analogues of parachloromercuribenzene. 
Blood, 31, 471. 
Baadenhuljeen,H., Rombout,T., Ewale,M, ft Haanen,c. (1970): Phospholipid content and composi­
tion in normal and pathological blood platelets. Fol. Med. Neerl. 13^ 134. 
Baadenhuijsen,H., lfirschhäuser,C., Kuretjena,R., Evale,M. ft Haanen,C. (1971): Metabolic 
observations on platelets from patients with familial thrombopathlc thrombocytopenia. 
Brit. J. Haemat., 20, 417. 
Bakkeren,J.A.J.M. « BontingrS.L. (1966) ι Studies on Na-K activated ATPase. XX. Properties of 
Na-K activated ATPase in rat liver. Вlochim, Biophys. Acta, 150, 460. 
Ball,G., Fulvood,M., Ireland,D.H. ft Vates,?. (1969) ι Effect of some inhibitors of platelet 
aggregation on platelet nucleotides. Blochen. J., 114, 669. 
Bangham,A.D., Flemane,R., Heard,D.H. ft Seaman,G.V.P. (195Θ): An apparatus for microelectro­
phoresis of email particles. Nature, 182, 642. 
Banghan
r
A.D. (1961) : A correlation between surface charge and coagulant action of phospholi­
pids. Mature, 192, 1197. 
Barkhan,P., Newlands,M.J. ft Wild,F. (1956) ι Phospholipids from brain tissue as accelerators 
and inhibitors of blood coagulation. Lancet, 271 (1), 234. 
Barkhan.P., Silver,H.J. ft 0'Keefe,L.H. (1961)ι The lipids of human erythrocytes and 
platelets and their effects on thromboplastin formation. In: Blood platelets (Ed. by 
S.A.Johnson/ R.M.Konto, J.W.Rebuck ft R.C.Born,Jr.). Little, Brown, Boston, p. 303. 
Bartlett,G.R. (1959): Phosphorus assay in column chromatography. J. Biol. Chem., 234, 466. 
Baserga,A. я Ballerini,G. (1957): La résistance osmotique plaquettalre dans différentes 
conditions hfimatologlguee. Schweiz. Hed. Wechr. 82, 1218. 
Bernard,J. ft Soulier,J.P. (1948): La dystrophie thrombocytaire hëmorragipare congénitale. 
Sam. HÛp. Paris, 24, 217. 
Bettex-Galland,H. ft LQscher,E.F. (i960) : Studies on the metabollem of human blood platelets 
in relation to clot retraction. Thromb. Dlath. Haemorrh., 4, 17Θ. 
Bettex-Galland,H. · LSecher,E,F. (1961): Thrombosthenin - a contractile protein from throm­
bocytes. Its extraction from human blood platelets and some of its properties. Biochim. 
Biophys. Acta, 49, 536. 
Biggs,R. ft Douglas,A.S. (1953): The thromboplastin generation test. J. Clin. Path., 6, 23. 
BilllAorla,J.D., Irani,V.J. ft Haclagan,N.F. (1965): Phospholipid fractionation and blood 
clotting. J. Atheroscl. Res., 5, 90. 
Blzzozero,J. (1882): Ueber einen Formbestandthell des Blutes und dessen Rolle bei der 
Thrombose und der Blutgerinnung. Vlrchows Arch. path. Anat. 9¿, 261. 
Bligh.E.G. ft Dyer,W.J. (1959): A rapid method of total lipid extraction and purification. 
Can. J. Вiochem. Physiol., 37, 911. 
Block,J.В. ft Bonting,S.L. (1964): Studies on (Na-K)-activated adenoelnetriphoaphatase. XIII 
SodiuB-potaseium activated adenosinetriphosphatase and cation transport in normal and 
leukemic human leucocytes. Enzymol. Biol. Clin./ 4, 183. 
Blomstrand,R. Nakayama,F. ft ΝΙΙΒΒΟΠ,Ι.Μ. (1962): Identification of phospholipids in human 
thrombocytes and erythrocytes. J. Lab. Clin, Hed., 59, 771, 
Bock,H.E., Karges,0., Löhr,G.W. л Waller,H.D. (1958) ι Fermenteigenschaften roter Blutzellen 
bei Lebererkrankungen. KlIn. Wechr., 36, 56. 
Bontlng.S.L., Simon,K.A. t Hawkins,N.M. (1961): Studies on (Na-K)-activated adenoslnetri-
phosphatase. I. Quantitative distribution in several tissues of the cat. Arch. Blochem. 
Biophys., 95, 416. 
-107-
Bonting,S.L., Caravaggio.L.L. ft Hawkins,N.M. (1963) ι Studies on (Na-K)-activated adenoeine-
triphosphatase. VI. Ite role in cation transport in the lens of cat, calf and rabbit. 
Arch. BiocheiD. Biophys., 101, 47. 
Bounaneaux,Y. (1961): L'accolement dea plaquettes aux fibres sous-endothëliales. Thromb. 
Diath. Haemorrh., 6, 504. 
Bowie,E.J.W. ft Owen,C.Α., Jr. (1968): Thrombopathy, Semin. Haematol. 5, 73. 
Böttcher,C.J.F., van Gent,СИ. ft Pries,C. (1961): Rapid and sensitive sub-micro phosphorus 
determination. Anal. Chim. Acta., 24, 203. 
Brante,G. (1949) ι Iodine as a means of development in paper chromatography. Nature, 163, 
651. 
Bridges,J.M., Dalby.A.M., Millar,H.D. ft Weaver,J.A. (1965): An effect of Ь-glucose on 
platelet stickyneaa. Lancet, !_, 75. 
Broekhuyee,R.M. (196Θ) : Phospholipids in tissues of the eye. I. Isolation, characterization 
and quantitative analysis by two-dimensional thin-layer chromatography of diacyl and 
vinyl-ether phospholipids. Biochim. Biophys. Acta, 152, 307. 
Bull,B.S. ft Zucker,M.B. (1965) ι Changes in platelet volume produced by temperature, meta­
bolic inhibition and aggregating agents. Proc. Soc. Exp. Biol. Med., 120, 296. 
Burton,A.C. (1969): The stretching of 'pores' in a membrane. In: Permeability and function 
of biological membranes. Proc. third Int. Conf. on Biological membranes. Stresa, Italy. 
Caen,J. (1963) : Ratio adenosine triphosphate/adenosine diphosphate in platelet-rich plasma 
in haemorrhaglc disorders (von Willebrand and Glanzmann disease). Nature, 197, 504. 
Caen,J., Castaldi,P.A., Ledere,J.C., Inceman,S., Larrieu,M.J., Probst,M. ft Bernard,J. 
(1966) ι Congenital bleeding disorders with long bleeding time and normal platelet count. 
I. Glanzmann'β thrombosthenia. Amer. J. Med., 41^ , 4. 
Canham,P.B. ft Parkinson,D.R. (1970)s The area and volume,of single human erythrocytes during 
gradual osmotic swelling to hemolysis. Can. J. Physiol. Pharmacol., 48^ 369. 
Chambers,D.A., Salzman,E.H. ft Neri,L.L. (1967)ι Characterization of "ecto-ATPase" of human 
blood platelets. Arch. Blochen. Biophys., 119, 173. 
Chargaff,E. (1944): The thromboplastic activity of tissue phosphatides. J. Biol. Chem., 155, 
ЭВ7. 
Cohen,P. ft Derksen,A. (1969): Comparison of phospholipid and fatty acid composition of 
human erythrocytes and platelets. Brit. J. Haematol., 17, 359. 
Collingwood,B.J. ft MacMahon,M.T. (1912)з The anticoagulants in blood and serum. J. 
Physiol., 45, 119. 
Cooley,M.H. ft Cohen,P. (1967) : Potassium transport In human blood platelets. J. Lab, Clin* 
Med., 70, 69. 
Cotlove,E. (1963): Determination of the true chloride content of biological fluid and tiaeues. 
II. Analysis by simple nonisotopic oethods. Anal. Chem., 35, 101. 
Cotterrell,D. ft Hhittam,R. (1970): An increase in potassium efflux in human red cells associa­
ted with reversing the sign of the membrane potential. J. Physiol., 210, 136 P. 
Cullum
r
C., Cooney,D.P. ft Schrier,S.L. (1967)t Familial thrombocytopenic thrombocytopathy. 
Brit. J. Haematol.,13, 147. 
Daemon,F.J.M. (1963): Synthesis of phosphatidyl ethanolanine· and application of synthetic 
phosphatides In studies on blood coagulation. Thesis, Utrecht, The Netherlands. 
Daemen,F.J.M., v.Arkel,C., Hart,H.Ch., v.d. Drift,C. ft van Deenen,L.L.M. (1965): Activity 
of synthetic phospholipids in blood coagulation. Throab. Diath. Haemorrh., ¿3, 194. 
Danon,D. (1961): Osmotic hemolysis by a gradual decrease in the ionic strength of the 
surrounding medium. J. Cell, ft Comp. Physiol., 57, 111. 
Davey,M.G. ft LilBcher,E.F. (1968) ι Biochemical aspects of platelet function and hemoatasie. 
Seminars Hematol., 5^  5. 
Delbrück,Α., Zebe,E. ft Bucker,T. (1959): Über Verteilungsmuster von Enzymen des Energie-
liefernden Stoffwechsels im Flugmuskel, Sprungmuskel und FettkSrper von Locusta 
migratoria und ihre cytologische Zuordnung. Biochem. Z., 331, 273. 
Doery,J.C.G., Hlrach,J., Loder,P.B. ft De Gruchy, G.C. (1967): Distribution of platelet 
hexokinase and the effect of collagen. Nature, 216, 1317. 
-108-
ErickBon,B.N., Иі11іаиэ,Н.Н., ΑντΙη,Ι. i Lee.P. (1939) i The lipid distribution of hunaη 
platelets in health and disease. J. Clin. Invest., 1_β, Θ1. 
FeisBly,R., ft Lüdin,H. (1949)ι Microscopie par contraetee de phases. Rev. Hénat., 4. 4Θ1. 
Fleischer,S. ft Rouser,G. (1965)t Lipids of subcellular particles. J. Amer. Oil Chem. 
Soc, 42, 5ΘΘ. 
Folch,J. (1949) : Complete fractionation of brain cephalint Isolation from it of phospha-
tidylserine, phoephatidylathanolamine and diphosphoinositlde. J. Biol, Chem., 177, 
497. 
Folch.J., LeeB,H. ft Sloane-Stanley,G.H. (1957): К simple method for the isolation and 
purification of total lipides fron animal tissues. J. Biol. Chem., 226, 497. 
Friedman,I.A., Wilson,N.R., Higginn,?. « Spurrler,W.A. (1960): Phase and electron micros­
copy osmotic fragility and thromboplastin generation studies of platelets in patients 
with thrombocytopenia. J. Lab. Clin. Med., 5£, Θ16. 
Gaarder,Α., Joneon,J., Laland,S., Hellem,A.J. ft Owran,P.A. (1961) ι Adenosine diphosphate 
in red cells as a factor in the adhesiveness of human blood platelets. Nature, 192, 531. 
Garrett,J.V. (1956)ι The platelet-like activity of certain brain extracte. J. Lab. Clin. Med. 
47, 752. 
Gretta,К. (1962)t Studies on the mechanism of thrombiη-catalyzed hemostatic reaction in 
blood platelets. Acta Physiol. Seand., 56. Suppl. 195, 5. 
Grignfini.F. ft L5hr,G.H. (1960): Über die Hexokin&se in menschlichen Blutzellen. Klin. Wechr., 
38, 796. 
Gross,R. ft Schneider,W. (1968)" Heuere Untersuchungen über den Stoffwechsel dqr Thrombozyten. 
In: Metabolism and membrane permeability of erythrocytes and thrombocytes (Ed. by 
E.Deutsch, E.Gerlach I К.Moser). Thlerne, Stuttgart, p. 206. 
Gross,R. ft Schneider,W. (1971)t Energy metabolism. Int The circulating platelet (Ed. by 
S.A.Johnson). Academic Press, Hew York., p. 123. 
Gr8ttuD,R.A. ft Solum,N.O. (1969) ι Congenital thrombocytopenia with giant platelets: a defect 
in the platelet membrane. Brit. J. Haemat., i£, 277. 
Gur«vitsch,J. ft Heiken,0. (1956): Osmotic fragility of human blood platelets. Blood, U , 
924. 
Haanen,C. (1968): Haemostasis - General aspects. In: Platelets in haemoetasls (Ed. by 
E.Hagen, W.Wechsler, F.Zilllken) Karger, Basel. Exp. Biol. Med., 3, 1. 
Haanen,C. (1971) ι Bloedstelping en bloedstollingsonderzoek. Scheitema ft Holkema, Amsterdam., 
p. 83. 
Hampton,J.R. ft Mitchell,J.R.A. (1966): Effect of glass contact on the electrophoretic 
mobility of human blood platelets. Nature, 209, 470. 
Hardisty,R.M., Dormandy,K.M. ft Hutton,R.A. (1964): Trombasthenia. Studies on three cases. 
Brit. J. Haematol., 10, 371. 
Hardlety,R.M. ft Hutton,R.A. (1967): Bleeding tendency associated with "new" abnormality of 
platelet behaviour. Lancet I, 983. 
Hardiety,R.M. (1968): Platelet aggregation and platelet factor-3 availability in bleeding 
disorders. In: Platelets in haemostasis (Ed. by E.Hagen, W.Wechsler ft F.Zilllken). 
Karger,Basel. Exp. Biol, and Med. 3, 169. 
Hartmann,H.C., Auditore,J.V. ft Jackson,D.P. (1958)ι Studies on thrombocytosis. I Hyperkalemia 
due to release of potassium from platelets during coagulation. J. Clin. Invest., 37, 699. 
Hayem,G. (197Θ) ι Sur la formation de la fibrine du sang etudifi au microscope CR. Acad. 
Sci., (Paris) 86, 58. 
Hellem,A.J. (1960): The adhesiveness of human blood platelets in vitro. Scan. J. Clin. Lab. 
Invest., 12, Suppl. 51, 1. 
Heinker,H.C. ft Kahn,M.J.P. (1967): Reaction sequence of blood coagulation. Nature, 215. 1201. 
Hess,CE. ft Mohler,D.N. (1968): Studies on membrane permeability in platelets of patients 
with hereditary spherocytosis. Proc. Soc. Exp. Biol. Med., 128, 1042. 
Hjort,P., Rapaport,S.I. ft Owren,P.A. (1953): A simple specific one-stage prothrombin assay. 
J. Lab. Clin. Med., 46, 89. 
Hoffman,J.F., Eden,M., Barr,J.S., Jr., ft Bedell,R.H.S. (1958): Hemolytic volume of human 
erythrocytee. J. Cell, ft Comp. Physiol., 5^, 405. 
-109-
HohorsttH.J., KreutZfF.H. i Bücher,Th. (1959): Über Metabolitgehalt und Metabolit- Kon-
zentrationen in der Leber der Ratte. Biochem. Z., 332, 1Θ. 
Но1швеп,и.
г
 Day^H.J. è Stormorken,H. (1969): The blood platelet release reaction. Scand. 
J. Haematol., Suppl. B, 3. 
Honour,A.J. t Mitchell,J.R-A. (1964): Platelet cluaping in injured vessels. Brit. J. Exp. 
Path., 45, 75. 
Horecker,H.L. t Smyrniotle,P.Z. (1955) : 6-Phoaphogluconic dehydrogenase. Methods in En-
zynology (Ed. by S.P. Colovick and N.O.Kaplan). Academic Press, New York, vol. I, p.323. 
Horowitz,H.I.(1969)ι Non-aedimentable platelet factor 3 during coagulation and after 
inmune platelet injury. Thromb. Diath. Haemorrh., Suppl. 17, 24Э. 
Hovmand,L.L., Br0ns,D.K. λ Gormeen,J. (1969): Platelet phospholipids and atypven clotting 
time β. Thromb. Diath. Haemorrh., 2i_, 463. 
Howell,H.H. (1912)) The nature and action of the thromboplastic (zymoplaetic) substance 
of the tissues. Amer. J. Physiol., 3¿, 61. 
Howell,W.H. (I935)i Theories of blood coagulation. Physiol. Rev. 15, 435. 
Jay,A.H.L. ft Burton,A.C. (19Б9)t Direct measurement of potential difference across the 
human red blood cell membrane. Biophys. J., £, 115. 
van Kampen,E.J. ft Zijlstra,W.G. (1961): Standardization of hemoglobinometry. II. The hemiglo-
bincyanide method. Clin. Chin. Acta, 6, 53Θ. 
Karaca,M. ft Stefanini,M. (1966)ι Studies on platelets XXV. Chemical analysis of platelets 
from patients with congenital and acquired throabocytopathy, with special reference to 
phospholipids. J. Lab. Clin. Med., 67, 229. 
Karpatkin,S. (1967): Studies on human platelet glycolysis. Effect of glucose, cyanide, 
insulin, citrate and agglutination and contraction on platelet glycolysis. J. Clin. 
Invest., 46, 409. 
Karpatkin,S. ft Langer,R.M. (1968) ι Blochenlcal energetics of simulated platelet plug forma­
tion. Effect of thrombin, adenosine diphosphate, and epinephrine on intra- and extra­
cellular adenine nucleotide kinetics. J. Clin. Invest., 47, 215Θ. 
Karpatkin,S. (1971)t Heterogenity of human platelets. Metabolic and kinetic evidence 
suggestive of young and old platelets. Ser. Haemat., 4, 75. 
Kerby,G.P. ft Tailor,S.M. (1965)t The role of human platelets and plasma in the metabolism 
of adenosine diphosphate and monophosphate added in-vitro. Thromb. Diath. Haemorrh., 13, 
510. 
Kinizuka,H. ft Koketsu,K. (1964): Ion transport through cell membrane. J. Theoret. Biol., 6, 
290. 
Klenk,E. ft Debuch,H. (1959)t The lipids. Ann. Rev. Biochem., 28, 39. 
Kornberg,A, ft Horecker,B.L. (1955) i Glucoee-6-phosphate dehydrogenase. Methods in Enzymology 
(Ed. by S.P.Colovick and N.O.Kaplan). Academic Press, New York, vol. I, p. 323. 
Kubowitz,F. ft Ott,P. (1943) : Isolierung und Krietallisation eines Gärungsferraentes aus 
Tumoren. Biochem. Z., 314, 94. 
Kur st jene, R., BoltjC, Vossen, M. t HaanenrC. (1968): Familial thrombopathic thrombocytopenia. 
Brit. J. Haematol., 15, 305. 
Kurstjene,R. (1969)ι Familiaire trombopathische thrombocytopenic. Thesis, Nijmegen, The 
Netherlands. 
Lamprecht,И. ft Trautschold,!. (1963): Adenosin-5-triphosphat. Bestimmung mit Hexokinase und 
Zwlschenferment. Methoden der enzymatlschen Analyse. (Ed. by H.U. Bergmeyer). Chemie GmbH, 
Weinhein, р. 543. 
Larrieux,M.J., Caen,J., Lelong,J.C. ft Bernard,J. (1961): Maladie de Glanzmann. Etude clinique 
biologique et pathogenique. A propos de cinq observations. Nouv. Rev. Franc. Hémat., \_, 
662. 
Lechner,K., Moser,H. ft Deutsch,E. (1968): Biochemical and ultrastructural findings in throm-
basthenia. Exp. Biol. Med., 3, 155. 
Ling,K.H. Byrne,W.L. ft Lardy,H. (1955): Phosphohexokinase. Methods in Enzymology (Ed. by S.P. 
Colovick and N.O.Kaplan). Academic Press, New York, Vol. I, p. 306. 
Loder,P.B., Hirsch,J. ft De Gruchy,G.C. (1968): Effect of collagen on plateletglycolysis and 
nucleotide metabolism. Brit. J. Haemat., l_4, 563. 
-110-
Lowry,O.H., Ro3ebrough,N.J., Farr,A.L. λ Randall,R.J. (1951): Protein meaeurement with the 
folln phenol reagent. J. Biol. Chem., 193, 265. 
Löhr,G.W., Waller,Η.D. A Karges,0. (1957) ι Quantitative Ferraentbeatlmaungen In roten Blut­
zellen. Kiln. Wschr., 35, 871. 
Löhr,G.H. A Gross,R. (1961a): Beziehungen zwischen Plättchenstoffwechsel und Retraktion des 
Blutgerinneeis unter besonderer Berücksichtigung der Thrombopathie Glanzmann-Naegell. 
Deutsch. Med. Wechr., 86, Θ97. 
LöhrfG.W., Gross,R. (1961b)ι Beziehungen zwischen Plättchenstoffwechsel und Retraktion des 
Blutgerinsels unter besonderer Berücksichtigung der Thrombopathie Glanzmann-Naegll. 
Deutsch. Med. Wschr., Θ6, 946. 
L5hr,G.W. (1966)ι Der Stoffwechsel des normalen und pathologischen Thrombocyten. Im Metabo­
lism and membrane permeability of erythrocytes and thrombocytea (Ed. by E.Deutsch, 
E.Gerlach A K.Moser). Thieme, Stuttgart, p. 196. 
Madoff,Μ.Α., Ebe,5. A Baldini,M. (1964)t Sialic acid of human blood platelets. J. Clin. Invest., 
43, 870. 
Marcus,A.J. A Spaet,T.H. (1958) ι Chromatography studies on platelet phospholipids. Clin. Res., 
6, 199. 
*fcrcuB,A.J., oilman,H.L., Safler,L.B. A Ballard,H.S. (1962): Platelet phosphatides. Their fatty 
acid and aldehyde composition ада activity In different clotting eystema. J. Clin. Invest., 
41^ , 219Θ. 
Marcus,A.J. « Zucker,M.B. (1965)t The physiology of blood platelets. Crune A Stratton, New 
York and London. 
Marcus,A.J. (1966): Role of lipids In blood coagulation. Advances In lipid Res., ±, 1. 
Marcus,A.J. (1969): Platelet Function. New Engl. J. of Med., 280, 1213. 
MarcuB,A.J.,Ullnan,H.L. A Safler,L.B. (1969): Lipid composition of subcellular particles of 
human blood platelets. J. Lipid Res., 10, 108. 
Marcus,A.J., Safler,L.B. A Ullman,H.L. (1971): Functions of platelet membranes. In: The 
circulating platelet (Ed. by 6.A. Johnson). Academic Press, New York, p. 241. 
Mead,J.F. (1961): Synthesis and metabolism of polyunsaturated acids. Fed. Proc., 20, 952. 
MerlBhl,J.N. (1970) : Phosphate groups (receptors ?) on the surface of human blood platelets* 
Nature, 226, 452. 
Mille,D.C.B., Robb,I.A. A Roberts,G.C.K. (1968): The release of nucleotides, 5-hydroxy-
tryptamlne and enzymes from human blood platelets during aggregation. J. Physiol., 
195, 715. 
Moake.J.L., Ahmed,K., Bachur,N.R. A Gutfreund,D.E. (1970): Mg2+-dependent, (Na+ + K*)-
stliDulated ATPase of human platelets - Properties and Inhibition of ADP. Blochim. 
Biophys. Acta, 2П, 337. 
Horteneen,E. (1963) : Studies on the osmotic fragility of normal human erythrocytes. A method 
for the determination of the effect of hypotonic solutions. Acta Med. Scand., 173, 6Θ3. 
Mortensen,E. (1963): Studies on the osmotic fragility of normal human erythrocytes. II. 
The effect of incubation on the fragility of erythrocytes. Acta Med. Scand., 174, 2Θ9. 
Moser,К. Lechner,Χ. A Vinazzer,H. (196Θ) ι A hitherto not described enzyme defect in thrombast-
thenia: glutathione reductase deficiency. Thromb. Diath. Uaemorrh., 19_, 46. 
Murphy,E.A. A Mustard,J.F. (1961) ι Dicumarol therapy and platelet turnover. Circulation Res., 
9, 402. 
Nachinan,R.L. A Marcus,A.J. (1966) : Immunological studies of proteins associated with the 
subcellular fractions of thrombasthenic afibrinogenaeaic platelets. Brit. J. Haematol. 15, 
161. 
Natel8on,S. (1963): Microtechniques of clinical chemistry (Ed. by S.Natelson). C.C. Thomas, 
Springfield, p. 175. 
Nelken,D., Gllboa-Garber,N.A Gurevitech,J. (1960): Studies on osmotic fragility of human blood 
platelets. J. Lab. Clin. Med., 56, 120. 
Nordoy.A., Day,H.J. A Lund,S. (1969): Subcellular localization of human plalelet phospholipids 
and their fatty acid and aldehyde composition. Scand. J. Clin. Lab. Invest., 23, 169. 
O'Brien,J.R. (1967): Platelets: a Portsmouth syndrome? Lancet, II, 256. 
-Ill-
O'Brien,J.S. (1965): Stability of the myelin membrane. Science, 147, 1099. 
Olson,J.A. * Anflneen,C.B. (1952): The crystallization and characterization of L-glutanlc acid 
dehydrogenase. J. Biol. Chem., 197, 67. 
Odegaard,A.E., S)calhegg,B.A. ft Hellem,A.J. (1964): Investigation on adenosine diphosphate 
(ADP) Induced platelet adhesiveness in vitro. Part III. The inactlvation of ADP in plasma. 
Thromb, Diath. Haemorrh., J_i, 317. 
Papahadjopoulos,D. Hougle.C. ft Hanahan,D.J. (1962): Influence of surface charge of phospholi-
pids on their clot-promoting activity. Proc. Soc. Exp. Biol. Med., Ill, 412. 
Parker,F. ft Peterson,N.F. (1965): Quantitative analysis of phospholipids and phospholipid fat-
ty acids from elllcagel thin-layer chromatograms. J. Lipid Res., $, 455. 
Pavloveky,A., de Tezanos Pinto,M. Martinez Canaveri,A. 4 Pavlovsky,S. (1967)! A propos d'un 
cas de trombopathle hËmorragique congenitale. Nouv. Rev. franc. Hfimat., 7' 559. 
Pette,D., Brosemer,R.W. ft Vogell,H. (1964) ι Glutamate dehydrogenase. Hoppe-Seyler/Thlerfelder, 
Handbuch der physiologisch- und pathologisch-chemischen Analyse (Ed. by K.Lang and E. 
Lehnartz). Springer, Berlin, Band 6/Tell A, p. 307. 
de Pont,J.J.H.H.M., Duncan,G. ft Bontlng,S.L. (1971) t Biochemical aspects of the visual pro­
cess. XI. Light-stimulated ion movements in the retina of the cuttlefish (Sepia offi­
cinalis) . Pflügers Arch., 322, 27Θ. 
Poole,J.CF. (1956)i The blood lipids and the clearing factor. Proc. of the 3rd. Int. Conf. 
on Biochemical Problems of Lipids. Brüssel, p. 379. 
Poet,R.L. (1959)i Relationship of an ATPase in human erythrocyte membranes to the active 
transport of sodium and potassium. Fed. Proc, 1_θ, 121. 
Pullman,И.E. ft Schatz,G. (1967)t Mitochondrial oxidations and energy coupling. Ann* Rev. 
Blochem., 36, 539. 
Quick,A.J. 4 Hussey,C.V. (1963)t Hereditary thrombopathic thrombocytopenia. Amer. J. Med. 
Sci., 245, 643. 
Racker,E. (1947)t Spectrophotometrie measurement of hexokinase and phosphohexoklnase acti­
vity. J. Biol. Chem., 167, 843. 
Rík,K. Szarvas,F. ft Benkd,A.(1958): Durch die Störung der Thrombocyten-Punktion verursachte 
Hämorrhagie. Deutsches Arch. Klin. Medizin., 205, 139. 
Rand,R.P. (1964) : Mechanical properties of the red cell membrane. II. Viscoelaetic break-
down of the membrane. Biophys. J., 4, 303. 
Renaud. S., Kuba,К., Goulet,С, Lem ire, Y. 4 Allard,С. (1970) ι Relationship between fatty-acid 
composition of platelets and platelet aggregation in rat and roan. Circ. Res., 26,, 553. 
Rock,R.С ft Nemerson,Y. (1969) : Energetics of human blood platelets: Uncoupling of oxidative 
phosphorylation in intact cells. J. Lab. Clin. Med., ^3, 42. 
Rogner,G. (1963)t Die Bestimmung der osmotischen Trombozyten-resietenz mit dem Elektrophoto-
meter. Acta Haematol., 29, 346ь 
Rossi,E.С. (1967) : Effects of ethylenedlanlnetetraacetate (EDTA) and citrate upon platelet 
glycolysis. J. Lab. Clin. Med., 69, 204. 
RouoerjG., White,S.G. ft Schloredt,D. (1956): Phospholipid structure and thromboplaetic 
activity. I. The phosphatide fraction active in recalclfied normal human plasma. Biochim. 
Biophys. Acta, 28, 71. 
Rudy,H. ft Page,I.H. (1930): Über das Cephalin aus Menschenhirn. Hoppe-Seyleг Ζ. Physiol. Cham., 
197, 251. 
Schettini,F. (1962)t Deficit metabolici plastrinici in casi di trombopatia tipo Glanzmann-
Naegell e nuove possibilità classificative. Clin. Pediat., 44, 271. 
Schneider,H., Hubner,G., Scheurlen,P.G., Joist,J., Kubier,W., Lechler,E., Hellriegel,К.P. 
4 Gross,R. (1971) ι Morphologische, biochemische und eiweissanalytlsche Untersuchungen bei 
einem Fall von Riesenplättchen-Thrombozytopathle mit Bence-Jones-Proteinurie. Thromb. 
Diath. Haemorrh., 25, 201. 
Silver,M.D., Stehbene,W.E., ft Silver,M.M. (1965): Platelet reaction to adenosine diphosphate 
in vivo. Nature, 205, 91. 
Silver,M.J. (1965): Role of calcium ions and phospholipids in platelet aggregation and plug 
formation. Amer. J. Physiol., 209, 1128. 
-112-
SkidAore,W.D. « Entenman,C. (1962)] Two-dimensional thin-layer chromatography of rat liver 
phoephatides. J. Lipid Res., 2* 4 7 1 · 
Skou^J.C. (1957): The Influence of some cations on A adenoeinetrlphosphatase from peripheral 
nerves. Blochlm. Blophys. Acta, 23, 954. 
SkjflJrten.F. (1968) ι Studies on the ultrastructure of pseudopod formation In human blood 
platelets. I. Effect of temperature, period of Incubation, anticoagulants and mechanical 
forces. Scand. J. Haematol., 5, 401. 
Sleln,M.H. (1955): Phosphoglucose Isomerase. Methods In Enzymology (Ed. by S.P.Colowlck and 
N.O.Kaplan). Academic Prees, New York, Vol. I, p. 304. 
von Smoluchow8kl,M. (1921)ι Handbuch der Elektrizität und des Magnetismus. (Ed. by L.Graetz). 
J.A. Barth, Leipzig, Vol. II, p. 366. 
SpaetfT.H. « Zucker,Μ.В. (1964) ι Mechanism of platelet plug formation and role of adenoaine 
diphosphate. J. Physiol., 206, 1267. 
Speer,R.J. t Ridgway,H. (1962): The Identity of lipid throroboplastlnogen. Proc. 9th Congr. 
Intern. Soc. Hematol. U. Nacional Autonoma de Mexico, Mexico City, Vol. II, p. 175. 
Solomon,A.K. (1952): The permeability of the human erythrocyte to sodium and potassium, J. Gen. 
Physiol., 36, 57. 
Troup,5.В., Reed,С.F., Marlnetti.G.V. A Swisher,S.N. (I960): Thromboplaetic factors and red 
blood celisi obeervatlons on their chemical nature and function in in-vitro coagulation. 
J. Clin. Invest., 39, 342. 
Ulutin,O.N. « Karаса,M. (1959): A study on the pathogenesis of thrombopathla using the plate­
let osmotic-resistance test. Brit. J. Haematol., 5, 302. 
Useing,H.H. (I960)ι The alkali metal ions in isolated systems and tissues. In: Handbuch der 
experimentellen Pharmakologie. Band XIIItThe alkali metal ions in biology. (Ed. by 
0.Eichler λ A.Farah). Springer, Berlin, p. 64. 
Vogali,Η., Biehal,F.R., Bücher,?., KlIngenberg,M., Fette,D. * Zebe,E. (1959)t Über struk-
turelle und enzymatische Muster In Muskeln von Locusta migratoria. Biochemische Ζ., 332, 
βΐ. 
Vorbeck,M.L. I Marinetti,G.V. (1965)t Separation of glycosyl diglycerides from phosphatides 
ne ing silicic acid column chromatography. J. Lipid Res., 6, Э. 
Vossen,M.E.M.H., Stadhouders,Α.Μ., KurstjenSfR. è Haanen,C. (1968): Observations on platelet 
ultrastructure in familial thrombocytopathic thrombocytopenia. Amer. J. Pathol., 53, 1021. 
Wallach,D.F.H., Maurice,P.A., Steele,B.B. a Surgenor,D.M, (1959): Studies on the relation-
ship between the colloidal state and сlot-promoting activity of pure phosphatidylethano-
lamlne. J. Biol. Chem., 234, 2829. 
Waller,H.D., L6hr,G.W., Grlgnani,F. A Gross,R. (1959): Über den Energiestoffwechsel normaler 
menschlicher Trombozyten. Thromb. Diath. Haamorrh., 3, 520. 
Walther,G. (1953): Über eine erbliche Thrombopathie mit Neigung zur Thrombopenie. Z. Ges. 
Inn. Medizin, 8, 221. 
Warehaw,A.L., Laster,L. t Shulman,N.R. (1966)t The stimulation by thrombin of glucose oxida-
tion in human platelets. J. Clin. Invest., 45, 1923. 
Ways,?. A Hanahan,D.J. (1964)t Characterization and quantification of red cell lipids in 
normal man. J. Lipid Res., 5, 318. 
WeisSfH.J. (1967): Platelet aggregation, adhesion and adenosine diphosphate release in thrombo-
pathla (platelet factor 3 deficiency). A comparison with Glanzmann's thrombastenia and 
von Wlllebrand's disease. Am. J. Med., 43, 570. 
Weiss,H.J. * Aledort,L.M. (1967)ι Impaired platelet-connective tissue reaction in man after 
aspirin ingestion. Lancet, II, 495. 
Weiss,L. (1971) : Personal communication* 
white,J.G. λ Krlvit,W. (1967) : An ultrastructural basis for the shape changes induced in 
platelets by chilling. Blood, 30, 625. 
Woodside,E.E., Therrlault,D.G. A Kochol&ty,W. (1964)ι Lipids of human platelets and their 
action on the blood coagulation process. Blood, 24, 76. 
Wooldrldge,L.C. (1883)ι Further observations on the coagulation of the blood. J. Physiol., 
4, 226. 
-113-
tfufR., Sesea,G. ft Натегтаап,0. (1964)t PI transport and glycolyaia in leucocytes and platelets. 
Вlochim. Blophys. Acta, 93, 614. 
ZlatklSfA.f Zak,B. ft Boyle,A,J. (1953) ι A new method for the direct determination of ••rum 
cholesterol. J. Lab. Clin. Med., 4_1, 4B6. 
Zucker,M.B. ft Sorelli,J. (1954)t Reversible alterations in platelet morphology produced by 
anticoagulants and by cold. Blood, 9, 602. 
Zucker,M.B. t BorellifJ. (1960)t Viscous mebamorphosis produced by chilling and by clotting. 
Failure to find specific defect of viscous ntetamorphosie in PTA syndrome. Thromb. 
Diath. Haemorrh., 4, 424. 
Zucker,M.B. ft BoreHi,J. (1962) : Platelet clumping produced by connective tissue euepensions 
and by collagen. Proc. Soc. Exp. Biol. Med., 109, 779. 
Zucker,M.B. ft Levine,R.U. (1963) ι Microelectrophoresis of washed and unwashed human blood 
platelets, with additional studies of platelets from patients with von Hlllebrand's di­
sease and thrombasthenia* Thromb. Diath. Haemorrh., 10, 1. 
van Zwieten,P.A. (1968) : The use of Rubidium for the determination of changes in membrane 
pbnrcability In guinea pig atrial tissue. Pflugers Arch,, 303, Bl. 
-114-
S T E L L I N G E N 
1 
De door Cooley en Cohen waargenomen netto efflux van kalium uit geïsoleerde bloedplaatjes 
kan toegeschreven worden aan de door hen toegepaste centnfugatie- en wasprocedures. 
Cooley,Μ.Η. en Cohen.P., J.Lab.Clin.Med. 
70,69(1967) 
Dit proefschrift (hoofdstuk 5) 
2 
Een osmotische resistentietest geeft geen inzicht omtrent de sterkte van de cel membraan. 
Dit proefschrift (hoofdstuk 6) 
3 
Gezien de proefomstandigheden kan aan de door Hampton en Mitchell gevonden relatie tussen 
de verandering in oppervlakteladingen in-vitro aggregatie van bloedplaatjes onder invloed van 
adenosmedifosfaat weinig waarde worden toegekend. 
Hampton.J.R. en Mitchell, J.R.A., Brit.Med.J., 
1,1074 (1966) 
Hampton,.!.R., Exp.Biol.Med., 3.40 (1968) 
4 
De bijdrage die biofysisch onderzoek aangaande celcontactverschijnselen kan leveren aan het 
inzicht in de adhesie en aggregatie eigenschappen van bloedplaatjes wordt nog voldoende onder­
kend. 
Weiss.L. en Woodbndge.R.F., Fed. Proc, 
261.88 (1967) 
5 
Het l i j k t onwenselijk om bloed, afkomstig van donoren die recentelijk aspirine hebben gebruikt, 
aan te wenden voor de bereiding van trombocytenconcentraten voor therapeutische toepassingen 
Zucker,M.В., Owen,CA. en Mustard,J.F., 
J.Am.Med.Ass. 2 1 7 , 1 8 7 2 ( 1 9 7 1 ) 
6 
De argumenten welke Emrich aanvoert voor het plaats hebben van een overgang van retmalde-
hydevan fosfatidylethanolamme naar lysine tijdens de metarhodopsme I—» metarhodopsme I I-
reaktie zijn niet overtuigend. 
Emrich,Η.Μ.,Ζ. Naturforsch., 
26 b. 352 (1971) 
7 
Er zijn onvoldoende argumenten om, met Kaskebar en Durbm, te stellen dat de anionen-gesti-
muleerde Mg^-ATPase m de kikkermaagmucosa op analoge wijze werkt als het (Na*+K+)-ATPase 
in andere weefsels. 
Kaskebar,D.K. en Durbm,R.P., Biochim.Biophys. 
Acta, 1 0 5 , 4 7 2 ( 1 9 6 5 ) 
8 
De konklusie van Hirschman en medewerkers betreffende de aanwezigheid van een RNA-alhan-
kelijke DNA polymerase in Australia antigeen positieve sera wordt niet voldoende door hun 
experimenten gesteund. 
Hirschman et al., The Lancet, I, 1103(1971) 
9 
De door Lai en Thompson gebruikte benaming (Na*+lO-ge5timuleerde ATPase voor de door hen 
gevonden ATPase aktiviteit in membraanfrakties van de zaadlob van de boon (Phaseolus 
vulgaris) moet als misleidend worden beschouwd. 
Lai,Y.F. en Thompson,.!.E., Biochim.Biophys. 
Acta, 2 3 3 , 8 4 ( 1 9 7 1 ) 
10 
Een mogelijke oorzaak van de overmaat osteoied in het skelet na behandeling met ethaan-1-
hydroxy-1,1- difosfonaat kan gelegen zijn m de demmeralisatie als gevolg van de eigenschap van 
deze stof om bivalente kationen te komplexeren. 
Kabachmk.M.I. et al., Dokl Akad Nauk SSSR, 
177.582 (19671 
11 
Vele van de bezwaren die Lindeboom aanvoert tegen het gebruik van de nieuwe eenheden in de 
klinische chemie missen een rationele basis. 
Lindeboom,G Α., De Blinde Mol 
De Erven F.Bohn N.V., Haarlem, 1971 
12 
Een sterkere verhoging van de bezmeaccijns bij gelijkblijvende kosten van de motorrijtuigenbe­
lasting verdient de voorkeur boven een kostenverhoging van beide genoemde lasten. 
13 
Het omineuze karakter van het getal 13 dient bewaard te blijven. 

